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Abstract 
Statement of Problem: In the field of developmental psychopathology, there has been a historical debate 
colloquially referred to as “nature versus nurture” in the continued pursuit of understanding the genetic 
and environmental origins of mental illness. The emergent field of behavioral epigenetics has posited that 
the underlying dichotomy and conceptual separation between gene and environment influences itself is 
false. Epigenetic processes show that environmental influences act on genes mechanistically as 
environmental inputs biologically influence the expression of key genes in vital systems. In translating 
technological advances in epigenetics from the biomedical world, developmental psychopathologists 
have largely contextualized psychological phenotypes within the same biomedical disease model. 
However, psychological phenotypes are not automatically amenable to the same methodological 
framework, as they are uniquely complex in their classification and measurement and are best 
understood to be calibrated in early life during crucial periods of development. Methods and Procedures: 
Therefore, the central aim of this thesis was to apply epigenetic theory, methodology, and technology to 
clinically relevant psychological phenotypes in methodologically novel ways that take into account 
phenotypic complexity and developmental context. Using a longitudinal design from the Avon 
Longitudinal Study of Parents and Children (ALSPAC), this thesis explored the epigenetic underpinnings 
(i.e. DNA methylation) of risk and resilience for internalizing and externalizing disorders during sensitive 
periods of development. Results: Study 1, published in Development and Psychopathology in 2017, used a 
candidate gene approach examining epigenetic changes in the oxytocin receptor gene (OXTR) to study 
resilience to prenatal stress. Results showed that children who were resilient in the conduct problem 
domain only had differential DNA methylation profiles at birth than those who were not resilient. Study 2 
used an epigenome-wide approach to explore potential novel epigenetic correlates of depression 
trajectories in adolescence with follow-up bioinformatic analyses. Results did not show any fetal 
programming effects when assessing DNA methylation at birth, but several novel genes were identified 
when DNA methylation was measured in adolescence. Conclusion: Because these epigenetic changes 
are heritable and potentially reversible, insights from epigenetic research have profound implications in 
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ABSTRACT 
LONGITUDINAL ANALYSES OF EPIGENTIC CORRELATES OF 
EXTERNALIZING AND INTERNALIZING DISORDERS 
Izabela Milaniak
Sara R. Jaffee
Statement of Problem: In the field of developmental psychopathology, there has been a 
historical debate colloquially referred to as “nature versus nurture” in the continued 
pursuit of understanding the genetic and environmental origins of mental illness. The 
emergent field of behavioral epigenetics has posited that the underlying dichotomy and 
conceptual separation between gene and environment influences itself is false. Epigenetic 
processes show that environmental influences act on genes mechanistically as 
environmental inputs biologically influence the expression of key genes in vital systems. 
In translating technological advances in epigenetics from the biomedical world, 
developmental psychopathologists have largely contextualized psychological phenotypes 
within the same biomedical disease model. However, psychological phenotypes are not 
automatically amenable to the same methodological framework, as they are uniquely 
complex in their classification and measurement and are best understood to be calibrated 
in early life during crucial periods of development. Methods and Procedures: 
Therefore, the central aim of this thesis was to apply epigenetic theory, methodology, and 
technology to clinically relevant psychological phenotypes in methodologically novel 
ways that take into account phenotypic complexity and developmental context. Using a 
longitudinal design from the Avon Longitudinal Study of Parents and Children 
(ALSPAC), this thesis explored the epigenetic underpinnings (i.e. DNA methylation) of 
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risk and resilience for internalizing and externalizing disorders during sensitive periods of 
development. Results: Study 1, published in Development and Psychopathology in 2017, 
used a candidate gene approach examining epigenetic changes in the oxytocin receptor 
gene (OXTR) to study resilience to prenatal stress. Results showed that children who 
were resilient in the conduct problem domain only had differential DNA methylation 
profiles at birth than those who were not resilient. Study 2 used an epigenome-wide 
approach to explore potential novel epigenetic correlates of depression trajectories in 
adolescence with follow-up bioinformatic analyses. Results did not show any fetal 
programming effects when assessing DNA methylation at birth, but several novel genes 
were identified when DNA methylation was measured in adolescence. Conclusion: 
Because these epigenetic changes are heritable and potentially reversible, insights from 
epigenetic research have profound implications in the classification, identification, and 
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In the field of developmental psychopathology, there has been a historical debate 
colloquially referred to as “nature versus nurture” in the continued pursuit of 
understanding the genetic and environmental origins of mental illness. A strong research 
base of twin and adoption studies supports the heritability of psychological disorders (e.g. 
Larsson et al., 2014; Lohoff, 2010; Verhulst et al., 2015). At the same time, a wealth of 
research supports the strong impact of environment (i.e. trauma, maltreatment, poverty) 
on the development of psychopathology, especially in early sensitive periods of 
development (e.g. Carr et al., 2013; McCrory et al., 2012; McLaughlin & Lambert, 2017; 
Reiss, 2013). In the past two decades, the “nature versus nurture” debate has been 
effectively resolved with the understanding that genes and environment both play vital 
roles through dynamic interplay with one another. Gene-environment interaction research 
has shown a moderation relationship between genetic influences and the environment 
where the presence of a particular genotype influences the impact of an environmental 
stressor and vice versa (e.g. Brown & Harris, 2008; Koenen et al., 2008; Lau et al., 2007; 
Nugent et al., 2011). However, the interaction of genes and environmental exposures in 
these paradigms are purely statistical and still operate under the conceptualization that 
they are distinct and separate processes. The emergent field of behavioral epigenetics has 
posited that the underlying dichotomy and conceptual separation between gene and 
environment influences itself is false. Epigenetic processes show that environmental 
influences act on genes mechanistically as environmental inputs biologically influence 
the expression of key genes in vital systems such as the stress response and immune 
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systems. Thus, the theory underpinning behavioral epigenetics suggests that epigenetic 
mechanisms serve as the mediator of the relationship between life experiences and 
psychopathology. Because these epigenetic changes are heritable and potentially 
reversible, insights from epigenetic research have profound implications in the 
classification, identification, and treatment of mental illness.  
 Research on epigenetic changes as potential mechanistic explanations for disease 
began in the biomedical world, particularly in cancer research. In translating 
technological advances in epigenetics from the biomedical world, developmental 
psychopathologists have largely contextualized psychological phenotypes within the 
same biomedical disease model. However, psychological phenotypes are not 
automatically amenable to the same methodologic framework, as they are uniquely 
complex in their classification and measurement and are best understood to be calibrated 
in early life during crucial periods of development. Therefore, the central aim of this 
thesis was to apply epigenetic theory, methodology, and technology to clinically relevant 
psychological phenotypes in methodologically novel ways that take into account 
phenotypic complexity and developmental context. Using a longitudinal design from the 
Avon Longitudinal Study of Parents and Children (ALSPAC), this thesis explored the 
epigenetic underpinnings of risk and resilience for internalizing and externalizing 
disorders during sensitive periods of development. Study 1, published in Development 
and Psychopathology in 2017, used a candidate gene approach examining epigenetic 
changes in the oxytocin receptor gene (OXTR) to study resilience to prenatal stress. 
Study 2 used an epigenome-wide approach to explore potential novel epigenetic 
correlates of depression trajectories in adolescence.  
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 CHAPTER 1: Epigenetic Molecular Mechanisms and Bioinformatic Methods 
Molecular Mechanisms of Epigenetics 
The term “epigenetic” means “in addition to changes in genetic sequence” and the 
term “epi”-genome references the epigenetic signaling layer that sits “on top of” the 
genome. There has been much debate over the definition of “epigenetic” including what 
the term means conceptually and what processes it is describing. Over time, it has 
evolved to a broad definition to include any process that alters gene activity without 
changing the underlying DNA sequence (Weinhold, 2006).  
The term epigenetics was first introduced by Conrad Waddington in the 1940s to 
describe the process that allows genotypically identical cells to be phenotypically distinct 
and differentiate into diverse tissue types with specified functions (Waddington, 1957). 
For example, a neuron is different from a liver cell, which is different from a skin cell, 
though they all originated from the same identical nucleotide sequence. During 
embryogenesis, epigenetic mechanisms govern the process of cell differentiation, which 
results in the permanent and stable specialization of cellular function that is then “stored” 
in the transcriptional profile of every cell and maintained throughout the lifespan 
(O’Donnell & Meaney, 2020). During this process, certain aspects of a cell’s genome that 
are not needed for its specialized function are silenced at the level of transcription and 
subsequent expression due to epigenetic signaling. In this way, epigenetic mechanisms 
can be thought of as defining the bounds of cellular function for a particular cell. Today, 
we now understand that in addition to maintenance of cellular identity, epigenetic 
processes co-ordinate a wide range of biological processes including stress response, 
immune function, and neurodevelopment (Handy et al., 2011). 
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Epigenetic mechanisms regulate the process in which a DNA nucleotide sequence 
is transcribed and subsequently expressed to produce a phenotype. There are several 
interrelated molecular processes that fall under the epigenetic umbrella including histone 
modifications and chromatin remodeling, DNA methylation, and non-coding RNAs (Kim 
et al., 2008; Peschansky & Wahlestedt, 2014). The best-known epigenetic process by far 
is DNA methylation, largely because it has been the easiest and least expensive to study 
with existing technology. DNA methylation refers to the addition of a methyl group 
(CH3) to a cytosine guanine dinucleotide (CpG) at the 5-position of the pyrimidine ring 
through a covalent bond (Deaton & Bird, 2011; Klose & Bird, 2006). This process is 
catalyzed by enzymes known as DNA methyltransferases (DNMTs) that transfer methyl 
groups to CpG sites within a continuous stretch of DNA. The addition of a methyl group 
is typically associated with reduced binding access of transcription factors to the DNA 
sequence and subsequent reduction gene expression or gene “silencing”- though this is 
not always the case. In the promoter regions that are upstream from a transcription site, 
DNA methylation leads to gene suppression (Bird, 2002). However, in other regions such 
as the gene body, DNA methylation increases transcription levels and subsequent 
expression through processes that are still unknown (Maunakea et al., 2010; Shenker & 
Flanagan, 2012). 
DNA methylation only occurs at the cytosine-guanine dinucleotide (CpG site). 
CpG sites are rare in the genome due to mutation of methylated cytosine into thymine 
over evolutionary time (Saxonov et al., 2006). Therefore, CpG sites frequently cluster 
together in CpG “islands” near promoter regions of genes (i.e. areas that initiate gene 
transcriptions), particularly near the transcription start sites of housekeeping genes that 
are necessary for basic functions of the cell (Deaton & Bird, 2011). CpG islands are 
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defined as regions with at least 500bp, a CG percentage greater than 55%, and an 
observed-to-expected CpG ratio greater than 65% (Takai & Jones, 2002). CpG islands are 
largely unmethylated, do not vary across individuals, and their methylation status tends to 
be more stable over time. DNA methylation is more dynamic (i.e. prone to change) and 
variant between individuals in regions flanking CpG islands called shores and further out 
called shelves, where CpG sites are less dense (Irizarry et al., 2009; Ziller et al., 2013). 
DNA methylation can be extracted from any relevant tissue. In psychological research, 
peripheral tissues including saliva, buccal epithelial cells and most commonly blood are 
most typically used as brain tissue availability is limited to post-mortem sampling.    
DNA Methylation Bench Science 
The most common method to analyze DNA methylation is through the technique 
of bead-type hybridization using micro-arrays. The Illumina Infinium HumanMethylation 
Beadchip has become the default array of choice for DNA methylation studies across 
disciplines. The Illmunia micro-array was designed to detect levels of DNA methylation 
at CpG sites through quantitative genotyping of C/T polymorphisms (Dedeurwaerder et 
al., 2014). The following protocol information was obtained from the Infinum HD Assay 
Methylation Protocol Guide (2015) from Illumina’s website. The Beadchip is a hand-
sized silicone based array with 12 arrays (6 rows, 2 columns) each array representing one 
participant’s DNA sample. In each individual array, there are tens of thousands of grids. 
Each grid has beads that are coated with hundreds of thousands of “probes” which are 
synthetic single strands of DNA fragments, also known as oligonucleotides, each with 
their own specific DNA sequence that is designed to be complimentary to human 
genomic DNA. Extracted single strand genomic DNA from an individual will bind to 
these complimentary probes to create double stranded DNA. 
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After single strand extraction, a participant’s DNA is bisulfite converted, a 
process that turns all the unmethylated cytosine bases into thymine while all the 
methylated cytosine bases are protected from the biological reaction and remain 
unchanged. The treated DNA is then transferred to the Illumina Beadchip for processing 
of DNA hybridization, where the single strand of human DNA recombines with another 
single strand of synthetic DNA by complimentary nucleotide bases. The unmethylated 
cytosines form single nucleotide polymorphisms that are identified by fluorescent 
staining that represents the level of DNA methylation in that region. The fluorescence is 
scanned using Illumina IScan and then quantified into beta values that represent the 
proportion of methylation in that genomic region using a ratio of the methylated probe 
fluorescent intensity (methylated signal) over the overall intensity (sum of methylated 
and unmethylated signal). Each CpG site has a corresponding beta value representing a 
ratio from 0 (no cytosine methylation) to 1 (complete cytosine methylation) (Bibikova et 
al., 2011). 
There are 28 million CpG sites in an individual’s epigenome and the Illumina 
interrogates a small subset of them based on theoretical functional importance selected 
with the guidance of a consortium comprised of 22 methylation researchers representing 
19 institutions worldwide (Bibikova et al., 2011). Illumina is consistently evolving its 
biotechnology to not only increase the coverage of the array but also to incorporate 
research findings into choosing more relevant regions to target. The first edition of the 
array had coverage of 27,000 CpG sites. The 450k array, which was the technology used 
to generate data for this thesis, covered 485,000 CpG sites. The new EPIC array covers 
850,000 CpG sites in the human epigenome. The Illumina 450k focuses on CpG islands 
(covers 96% of all islands in the human epigenome), shores (92%), and shelves (86%) 
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and also other functional elements including 3´- and 5´-UTRs, gene bodies, DNAse 
hypersensitive sites, miRNA promoters and other ncRNAs that also may be important 
sites for changes in DNA methylation (Bibikova et al., 2011). The 450k also covers 99% 
of the Reference Sequence (RefSeq) database, which is a comprehensive annotation of all 
nucleotide sequences and their protein products in the human genome (Pruitt et al., 2005). 
While whole-genome sequencing techniques are able to interrogate every single CpG 
site, they are often resource and cost heavy (e.g. $1,000 per participant). In addition, 
research has shown that the results from the Illumina arrays are correlated R2 = .95 with 
results drawn from whole-genome sequencing, suggesting that the arrays are efficiently 
targeting functionally important CpG sites (Bibikova et al., 2011).  
Once DNA methylation has been assayed, a matrix data file is created with each 
CpG site interrogated and its corresponding DNA methylation beta value. The data 
undergoes pre-processing which includes various quality checks and normalization to 
correct for batch effects. During the data analysis phase, any differentially methylated 
CpG sites or “hits” are annotated to their respective genes. In order to examine whether 
multiple hits are functionally related, the annotated genes are entered into a gene network 
analysis. More details on quality checks and normalization are available in Chapter 3, 
Section C. Data analysis of DNA methylation data is described further in subsequent 
empirical chapters.  
Most early DNA methylation studies in developmental psychopathology used a 
candidate gene approach where specific genes were chosen a priori due to known 
biological, physiological, or functional relevance based on theoretical importance and 
empirical evidence from genetic studies. A candidate gene approach is useful because it 
allows for researchers to understand the functional elements of epigenetic changes in a 
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larger system. The design allows a drill down approach where all parts of the biological 
cascade including DNA methylation, access to transcription factors, and gene expression 
can be studied in unison. However, a candidate gene approach is limiting in that it is only 
able to explore already identified and well-known genes. A complimentary approach is 
the epigenome-wide association study (EWAS), a “hypothesis-free” approach, where an 
individual’s whole epigenome is interrogated and CpG sites or regions that are 
differentially methylated across individuals or “hits” are annotated to nearby genes. This 
approach allows for the discovery of potentially novel biological correlates and can 
contribute to a more comprehensive and holistic understanding of etiology of 
psychopathology.  
CHAPTER 2: Application of Epigenetics to Etiology of Psychopathology 
Role of Epigenetics in Risk for Psychopathology 
Epigenetic mechanisms are normative background processes that are essential to 
many organism functions. Researchers across disciplines are studying when and how 
these processes are altered to function improperly and confer risk for disease. 
Environmental inputs have shown to be an important trigger for altered epigenetic 
signaling. It has been well documented that the epigenome is highly susceptible to 
environmental input and certain environmental exposures including cigarette smoking ( 
Lee & Pausova, 2013), pollutants or toxins (Ho et al., 2012), exercise (Voisin et al., 
2015), and diet (Anderson et al., 2012) alter DNA methylation patterns. Importantly for 
psychologists, thousands of studies in the field of behavioral epigenetics have also 
demonstrated the link between psychosocial stressors and DNA methylation across 
developmental stages (for a review of maternal prenatal stressors see Sosnowski et al., 
2018; for a review of child maltreatment see Lutz & Turecki, 2014).   
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Due to the vital role that adverse life experiences play in the development of 
mental illness, epigenetic processes present a novel way to unify the biological and 
environmental origins of risk and resilience to psychopathology. Epigenetic changes 
including DNA methylation have emerged as potential mechanisms that can both capture 
the effects of stressful early life experiences and explain their propagation into adulthood. 
The promise of a mediational model suggests that exposure to stressful early life 
experiences during crucial periods of development sets individuals on relatively stable 
biological trajectories via epigenetic mechanisms that then alter key systems such as the 
stress response and immune systems, that result in the development and maintenance of 
psychopathology later in life.  
A seminal study using an animal model done by Weaver and colleagues (2004) 
demonstrated the potential of this mediational framework in describing how early life 
experiences can lead to behavioral phenotypes via epigenetic mechanisms. Results 
showed that pups who were raised by anxious, low nurturing mothers (i.e. characterized 
by decreased pup licking, grooming, and arched-back nursing) were more likely to 
demonstrate a stable, anxious phenotype into adulthood than pups who were raised by 
nurturing mothers. Pups who were neglected had higher levels of DNA methylation in the 
region of the glucocorticoid receptor gene (NR3C1), had decreased transcription factors, 
and subsequent gene expression in the hippocampus. NR3C1 is integral in the modulation 
of the HPA axis and a key player in the stress response system. This was the first study to 
demonstrate the link between early life experiences and an animal model of 
psychopathology via epigenetic mechanisms.  
Prenatal Calibration of Risk: Fetal Programming Hypothesis 
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It is clear that adverse environmental inputs early in the lifespan have long range 
health consequences into adulthood. In the past couple of decades, researchers have been 
asking the question of exactly how early in development can risk be embedded. A vast 
empirical base suggests that prenatal exposure to environmental stress can set a child on 
disease trajectories with long lasting effects into adulthood before the child is even born. 
A seminal example of this is findings from the Dutch Hunger Winter cohort (N = 2141), 
conceived during a famine in the Netherlands in 1944 as a result of WWII and followed 
up in adulthood. Results showed that prenatal exposure to famine in general lead to 
higher rates of Type II diabetes in middle adulthood and exposure to famine particularly 
in early gestation was linked to coronary heart disease, breast cancer, increased stress 
responsiveness, and higher rates of obesity (Roseboom et al., 2006).  
The long-lasting effects of prenatal exposures have been explained by the “fetal 
programming hypothesis” which posits that risk for psychopathology later in the lifespan 
is biologically programmed in the uterine environment during a period of rapid 
neurodevelopment when the fetus is particularly susceptible to environmental influences 
(Barker, 1995). The fetus incorporates signals about the maternal environment including 
diet and stress into its developmental trajectory via epigenetic changes related to 
neurodevelopment of key brain areas and networks in an effort to most adaptively match 
development to future postnatal environment (Barker, 1995; Gluckman, Hanson, Cooper, 
& Thornburg, 2008). Within this framework, vulnerability to psychopathology has been 
described as the “three hit hypothesis.” Genetic predisposition is hit 1, the prenatal 
environment is hit 2, both calibrate susceptibility to hit 3, life experiences and exposures 
postnatally (Daskalakis et al., 2013). In recent follow up studies of the Dutch Hunger 
Winter, researchers found that even 60 years after the event, siblings who were prenatally 
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exposed to the famine showed lower DNA methylation of the insulin like growth factor 2 
(IGF2), a gene essential in fetal growth and development, compared with their unexposed 
same-sex sibling (Heijmans et al., 2008). Using an epigenome-wide approach, 
researchers identified additional differentially methylated genes associated with prenatal 
famine exposure including the insulin receptor gene (INSR), a gene involved in prenatal 
growth and insulin signaling, and the carnitine palmitoyltransferase 1A gene (CPTA1), 
which is involved in fatty acid oxidation (Tobi et al., 2014).  
The fetal programming hypothesis has also been used to understand the early 
embedding of risk for psychopathology as well. A large number of studies have shown 
that exposure to prenatal maternal psychopathology such as depression and anxiety is 
associated with both internalizing and externalizing behavioral outcomes in children such 
as depression, anxiety, ADHD symptoms, and conduct problems, above and beyond the 
quality of the child’s postnatal environment (Barker et al., 2011; O’Connor et al., 2002; 
O’Donnell et al., 2014; Van den Bergh & Marcoen, 2004). Prenatal exposure to maternal 
mood disorders may account for 10–15% of the variance in children’s behavior problems, 
accounting for concurrent levels of maternal mood symptoms (Glover, 2015). A wealth 
of research has emerged studying the process by which prenatal stressors via DNA 
methylation confer risk for psychopathology later in the lifespan. One study found that 
higher perceived maternal stress in the second trimester was associated with higher DNA 
methylation of hydroxysteroid 11-beta dehydrogenase 2 (HSD11B2), a gene that is 
integral in the deactivation of cortisol, which was in turn associated with a lower score on 
an index of fetal neurodevelopment in the third trimester (Monk et al., 2016). Another 
found that decreased prenatal maternal mood was related to increased DNA methylation 
in NR3C1 in the newborn, which was associated with increased cortisol response at 3 
 12 
months (Oberlander et al., 2008). Utilizing the ALSPAC sample, researchers found 
variation in DNA methylation at seven loci across the epigenome in cord blood 
differentiated children who go on to develop early-onset conduct problems in middle 
childhood (Cecil et al., 2018). The prenatal period may be an essential stage of 
development in which to study epigenetic processes as embedding risk for 
psychopathology as the rate of DNA synthesis is high and the epigenetic marks needed 
for normal tissue differentiation and development are being established (Dolinoy et al., 
2007). 
Applying Epigenetics to Psychological Phenotypes 
The study of epigenetic alterations as mechanisms for disease was first 
appreciated in cancer research where DNA methylation is among the most common 
somatic errors involved in carcinogenesis and accounts for a high proportion of tumor 
suppressor gene inactivation. Momentum has also been building in studying DNA 
methylation in the context of aging and other disease including autoimmune disorders, 
cardiovascular diseases, diabetes, and neurodegenerative disorders. Epigenetic research 
in the biomedical world commonly employs the case-control study design where a 
population is divided into a “disease” group and a “non-disease” group to examine 
epigenetic differences between the two. In translating technological advances in 
epigenetics from the biomedical world, developmental psychopathologists have largely 
contextualized psychological phenotypes within the same biomedical disease model, 
frequently using convenience sampling of adults (i.e. dividing a sample into individuals 
that meet criteria for depression and comparing their epigenetic profiles to controls). Due 
to their heterogeneity and comorbidity, psychological phenotypes are uniquely complex 
in their classification and measurement and are not automatically amenable to the same 
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methodologic framework. Many psychological disorders are better understood as 
occurring on a continuity of “normative” human experiences rather than discrete disease 
entities and psychological disorders have more complex continuity and discontinuity over 
time. 
It is clear that the roots of both psychological and biomedical disorders can be 
traced back to early life development. However, unlike most biomedical disorders studied 
through the lens of epigenetic alterations, many psychological disorders have their initial 
onset in childhood. According to the World Health Organization, externalizing or 
impulse-control disorders across the world have the earliest onsets with median 7-9 years 
for ADHD, 7-15 for Oppositional Defiant Disorder (ODD), 9-14 years for conduct 
disorder. Research has shown that specific phobias tend to being in early to middle 
childhood, social anxiety in early to mid-adolescence, obsessive compulsive disorder in 
mid to later adolescence, and panic disorder in early adulthood (Kessler et al., 2005). 
Studies on depression have shown that the prevalence rates are generally low in children 
and grow to near-adult prevalence levels in adolescence (Merikangas et al., 2010). 
Because most adult psychopathology has its origins in childhood, it is imperative that in 
seeking biological mechanisms for the origins of psychological disease, researchers must 
examine epigenetic mechanisms early in the lifespan and in the developmental contexts 
in which these disorders initially occur. Utilizing longitudinal designs not only allows 
researchers to study epigenetic changes in a relevant sensitive period, they also have the 
advantage of establishing temporal order of epigenetic changes and disease outcome. In 
case-control designs, DNA methylation and disease outcome is usually measured 
concurrently, which limits interpretations of epigenetic changes as causative as it is 
equally reasonable to assume that epigenetic changes can be interpreted as a biomarker of 
 14 
“wear and tear” of a debilitating and often chronic mental illness rather than a causal 
mechanism that explains its origin.  
Therefore, the central aim of this thesis was to apply epigenetic theory, 
methodology, and technology to clinically relevant psychological phenotypes in a 
longitudinal framework that take into account phenotypic complexity and developmental 
context. 
CHAPTER 3: Description of the Study Population 
Description of the Avon Longitudinal Study of Parents and Children (ALSPAC) 
cohort 
The Avon Longitudinal Study of Parents and Children (ALSPAC) also known as 
“Children of the 90s” is an ongoing epidemiological study of children born in the city of 
Bristol in the United Kingdom in the 1990s (see cohort profiles Boyd et al., 2013; Fraser 
et al., 2013). The recruitment sample (N=14, 541) was all women residing in the Avon 
county catchment area with an expected date of delivery between April 1, 1991 and 
December 31, 1992. Data collection is still ongoing as ALSPAC participants transition 
into adulthood as well as efforts to gain information on the next generation.. Recruitment 
for the multi-generational cohort ALSPAC-G2 or “Children of Children of the 90s” 
began in 2012 and aimed to recruit all children of the (now adult) original ALSPAC 
children to continue recurring biological, psychosocial, and physiological assessments on 
the next generation and examine intergenerational connections to health and disease.  
 The families have been followed up with frequently, with 68 data collection time 
points between birth and age 18 including self, mother, father, and teacher reports. Self-
reported questionnaire measures focused on mother’s health included mental health 
(focusing largely on anxiety and depression), reproductive health (e.g. contraception, 
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menstrual patterns, repeatedly assessed pregnancies), cardiometabolic health (e.g. 
hypertension, cholesterol, musculoskeletal health (e.g. falls and fractures, arthritis), 
respiratory health (e.g. asthma, bronchitis), and health-related behaviors including 
substance use, diet, physical acitviity. Environmental measures include life course 
characteristics (e.g. retrospective measures of their child abuse and/or neglect, parental 
socioeconomic status and childhood housing conditions) and current life stressors 
including social support networks and romantic relationship functioning.  
 Self-reported child questionnaires included environmental measures assessed 
throughout the lifespan include diet, physical activitiy, hosuing, socioeconomic 
background, life stressors, air polluants (e.g. cigarette smoking in the home, home close 
to heavy traffic), and school environment. Physiological measures include 
anthropometry, blood pressure, pulse rate, lung function, fitness, skin, eye, and dental 
observations. Cognitive measures include IQ, speech and language ability, motor skills, 
and reading abiliy. As the ALSPAC children matured into pre-adolescennce, puberty and 
mensutration measures were collected. Psychosocial questionnaires focused on gender 
bhavior, self-esteem, peer relationships, romantic relationships, eating disorders, and 
alcohol and drug use. Psychopathology information was also collected assessing 
internalizing symptoms (e.g. mood and anxiety disorders), externalizing symptoms (e.g. 
ADHD, conduct and impulse control diosrders), as well as symptoms related to bipolar 
disorder and psychosis. The study website contains details of all the data that is available 
through a fully searchable data dictionary: http://www.bris.ac.uk/alspac/researchers/data-
access/data-dictionary/.  
 Like with all longitudinal cohorts, attrition over the years has been a challenge. 
Attrition rates were highest in the early neonatal stage of the study (66%) and decreased 
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over time, ranging from 48%-60% in childhood, 49% in adolescence, and 39.44% in 
transition to adulthood. However, mean attrition rates largely exaggerate the numbers of 
pariticpants lost to follow up due to the high volume and frequency of data collection 
points and different response patterns across nearly three decades. For example, some 
participants return to the study after years of no follow up. In fact, it seems that ALSPAC 
has a core of 3,000 devoted families that have completed all possible assessments, with 
close to 5,777 families completing 75% of all assessments throughout a 30 year period.  
The ALSPAC cohort presents an unprecedented breadth and depth in assessment 
of health across the lifespan in an epidemiological cohort. One major limitation of the 
cohort, however, is the under-representation of non-White minority ethnic groups (2.2% 
of ALSPAC mothers were non-white) which limits external validity when generalizing 
findings to other populations. Under-representation is laregly due to the demographic 
profile of the original catchment area of Avon (4.4% non-White mothers) as well as the 
effects of differential attrition based on socioeconomic status. Children lost to follow-up 
are more likely to have a lower educational attainment, are more likely to be eligible for 
free school meals, and are more likely to be male. In order to address differential attrition 
and enhance the data resource, researchers used data linkage to link participants to 
publically available public health and administrative records including medical records, 
education records, economic, emplyment and social support records, criminal 
convictions, and neighborhood data. 
Description of the Data Resource Profile: Accessible Resource for Integrated 
Epigenomic Studies (ARIES) 
 In 2012, a sub-project of ALSPAC named the Data Resource Profile: Accessible 
Resource for Integrated Epigenomic Studies (ARIES), was established to create a 
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population-based resource of DNA methylation data with the aim to understand the role 
of DNA methylation in health and development in the ALSPAC cohort (see cohort 
profile Relton et al., 2015). Based on available retrospective DNA sampling, 1,018 
mother-child dyads (50% female offspring) from the original ALSPAC cohort were 
chosen to obtain epigenome-wide DNA methylation samples using the Illumina Infinium 
HumanMethylation450 BeadChip (450 K) array. DNA samples for offspring were 
available at three separate time points: at birth and extracted from cord blood drawn from 
the umbilical cord upon delivery, at mean age 7.5 years, and at mean age 15.5 years, both 
extracted from peripheral blood. Maternal samples were collected during pregnancy at 
mean 26 weeks gestation and again approximately 15-17 years later. The ARIES sub-
sample is considered to be reasonably representative of the main study population. 
Though mothers included in ARIES were slighltly older, more likely to have a non-
manual occupation, and are less likely to have smoked during pregnancy.  
 The ALSPAC cohort sample is one of a kind as its large scale and in-depth rich 
analysis of mental and physical health across the lifespan is unprecedented in 
epidemiological studies. Due to recurrent measuring of key phenotyoes and genetic and 
biological samples at multiple time points, this data set is uniquely suited to explore 
questions of epigenetic origins of risk and resilience for psychopathology within a 
developmental and ecological framework.  
Processing of the ARIES DNA Methylaton Data  
DNA methylation data processing using the Illumina 450k array was conducted at 
the University of Bristol. DNA samples from all participant ages (cord, middle 
childhood, adolescence) were distributed across slides using a semi-random approach to 
minimize the possibility of confounding due to batch effects. DNA methylation data went 
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through several quality checks to ensure accuracy. In order to remove sample 
mismatches, genotype probes were compared with SNP data from the same indidivudal 
in the ALSPAC sample and samples were flagged if there was a sex mismatch based on 
X-chromosome methylation. The Illumina 450k array also has 850 quality control probes 
on each array that asses various aspects of the data collection process to determine the 
status of staining, extension, hybridization, target removal, bisulfite conversion, 
specificity, non-polymorphic and negative controls. Samples failing quality control were 
repeated and, if unsuccessful, excluded from further analysis. Micro-arrays have been 
shown to have very strong batch effects that can mask true biological differences between 
samples. Statistical controlling for batch effects during the data analysis phase is not 
sufficient and data needs to be initially normalized to remove any artificial variation 
between samples. There are several statistical methods that can be used to normalize the 
450k array using packages in R.  
There are two confounders present in the set-up of the Illumina microarray: 
polymorphic probes and cross-reactive probes. Polymorphic probes are probes that target 
CpG sites that are on or near SNPs. Since the Illumina platform uses quantitative 
genotyping of C/T SNPs, probes with polymorphisms at the target C or G have the 
potential to confound a difference in genotype rather than a difference in DNA 
methylation. By utilizing genotype and DNA methylation information from the same 
individuals, researchers have found that DNA methylation profiles of probes located on 
or near a SNP were typically explained by patterns of the SNP genotype and do not 
reflect any underlying epigentic mechanisms (Chen et al., 2013; Price et al., 2013). 
Cross-reactive probes are probes that hybridize to multiple genomic locations that are 
similar. The level of DNA methylation at these probes likely reflects a combination of 
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DNA methylation at the various locations to which they hybridize (Chen et al., 2013; 
Price et al., 2013) . Both polymorphic and cross-reactive probes have been annotated by 
researchers who recommend removal of these probes for analyses examining differences 
in DNA methylation.  
Like most exisitng cohort studies, ALSPAC has been utilizing stored whole blood 
samples for DNA methylation analyses. Whole blood is a heterogenuous collection of 
different cell types, which carry their own unique DNA methylation profile as a blueprint 
for cell differentiation (Reinius et al., 2012). For each individual, the proportion of cell 
types within their specific blood sample can vary widely, which in turn can confound 
DNA methylation measurement. The overwhelming majority of the ALSPAC DNA 
samples did not have whole blood cell counts assessed prior to DNA extraction and 
therefore a post hoc correction is necessary. First, the fraaction of CD8, CD4, NK, B, 
monocyte, and granulocyte cells in each individual is estimated and those estimated cell 
type proportions serves as covariates in any subsequent analyses. For cord blood obtained 
at birth, the Bakulsi method was used (Bakulski et al., 2016). For peripheral blood 
obtained in adolescence, the Houseman method was utilized (Houseman et al., 2016).  
Introduction to Empirical Chapters 
 
The first study describes a manuscript titled “Variation in DNA Methylation of 
the Oxytocin Receptor Gene Predicts Children's Resilience to Prenatal Stress” published 
in Development and Psychopathology in 2017. It is a candidate gene approach examining 
epigenetic changes in the oxytocin receptor gene (OXTR) as it relates to resilience to 
prenatal stress. It is an early training step into behavioral epigenetic research, theory, and 
methods. The second, not yet published, study represents a more in-depth and 
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methodologically sophisticated epigenome-wide approach examining epigenetic 
correlates of depression trajectories in adolescence and follow up gene annotation, gene 
network analyses, and regional analyses.  
CHAPTER 4: Variation in DNA Methylation of the Oxytocin Receptor Gene 
Predicts Children's Resilience to Prenatal Stress 
Introduction  
Resilience is defined as successful emotional, behavioral, or social adaptation or 
adjustment despite experience of significant adversity, stress, or trauma (Luthar et al., 
2000; Rutter, 2012). In children, researchers have operationally defined this adaptation in 
a myriad of ways such as mastering normative developmental tasks (Luthar et al., 2015), 
absence of psychopathological outcomes (Martinez-Torteya et al., 2009) or functioning 
that is “better than expected” given a level of exposure to risk (Kim-Cohen et al., 2004). 
Some children show resilience across multiple domains of functioning. More commonly, 
however, at-risk children show resilience in one domain of functioning but not in others 
or they may be resilient at one time period but not another (Masten, 2013). Thus, 
resilience as a construct may be better defined as a dynamic process (not a trait or 
characteristic) that depends on the balance of risk and protective factors available to an 
individual at a given point in time (Jaffee et al., 2007; Rutter, 2006, 2012). Understanding 
the mechanisms that promote resilient functioning in addition to the processes that confer 
risk for psychopathology, and the dynamic balance between them, is essential to 
understanding how normative and maladaptive developmental trajectories form.  
Researchers have long posited the importance of adverse life events during early 
critical periods in understanding risk and resilience. The prenatal period, specifically, is 
one in which the fetus is especially vulnerable to a wide range of environmental 
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exposures that have the potential to confer risk for emotional, cognitive, and behavioral 
problems in childhood (Braithwaite et al., 2014; Rice et al., 2007). A large number of 
studies have shown that exposure to prenatal maternal psychopathology such as 
depression and anxiety is associated with both internalizing and externalizing behavioral 
outcomes in children such as depression, anxiety, ADHD symptoms, and conduct 
problems (Barker et al., 2011; O’Connor et al., 2002; O’Donnell et al., 2014; Van den 
Bergh & Marcoen, 2004). Prenatal exposure to maternal stressful life events, such as 
death of a close relative or friend, divorce, marital problems, and job loss, has also been 
linked to ADHD, behavioral problems, and internalizing symptoms (Laucht et al., 2000; 
Pawlby et al., 2009; Ronald et al., 2010). It is clear that a range of stressors during the 
prenatal period increases risk for child psychopathology. However, not all children 
exposed to environmental stressors in utero go on to develop psychopathology and some 
children seem to be less vulnerable than others. There are several hypotheses that can 
potentially account for this differential vulnerability. One possibility is that a supportive 
postnatal environment can attenuate or reverse the effects of prenatal stress. For example, 
researchers have found that sensitive caregiving moderates the effect of prenatal maternal 
stress on infant fearfulness (Bergman et al., 2008) and cognitive outcomes (Bergman et 
al., 2010) 
A second possibility is that individual differences in genotype confer protection 
against prenatal stressors. For example, researchers have found that variation in the 
glucocorticoid receptor gene (NR3C1), a gene integral to the functioning of the 
hypothalamic-pituitary-adrenal (HPA) axis which is involved in stress reactivity, 
moderated the effect of prenatal maternal psychological symptoms on later emotional and 
behavior problems, such that children whose mothers were depressed or anxious when 
 22 
they were pregnant with the child had an increased risk of emotional and behavioral 
problems at age 3 if they possessed the minor allele C (CC or CG), but not if they were 
homozygous for the major allele (GG) (Pluess et al., 2011). Using data from 1513 
children in the Generation R cohort, Pluess and colleagues (2011) found that infants 
whose mothers were more anxious during pregnancy had higher scores on a measure of 
negative emotional temperament than infants whose mothers were not anxious and this 
effect was significantly stronger for infants who carried the short ‘s’ form of the serotonin 
transporter gene (5-HTTLPR) compared with infants who carried two copies of the long 
‘l’ form of the gene. In addition, Oberlander and colleagues (2010) found that prenatal 
exposure to maternal anxiety predicted internalizing symptoms in children with 2 copies 
of the 5-HTTLPR ‘s’ allele (but not in children who carried the ‘l’ allele). In contrast, a 
mother’s anxiety during pregnancy predicted her child’s externalizing problems only if 
her child had 2 copies of the ‘l’ allele and not if the child carried at least one ‘s’ allele 
(Oberlander et al., 2010). 
In addition to identifying structural variants in the genome that buffer against the 
effects of prenatal stress, new research in the field of behavioral epigenetics has started to 
elucidate the underlying biological mechanisms of the relationship between stress 
exposure and later developmental outcomes, including emotional and behavioral 
problems. Epigenetic research sits at the intersection of social and biological explanations 
for developmental psychopathology and has enormous potential for describing how 
stressful life events “get under the skin” and have lasting effects on mental and physical 
health. The epigenome describes the chemical switches that sit on top of genes and 
modulate gene expression. Stress-induced epigenetic modifications are typically 
measured by examining DNA methylation, where methyl groups are added to cytosine-
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guanine-phosphate (CpG) sites on the regulatory or promoter regions of genes to silence 
transcription factors or block access to recognition elements of a gene (Bick et al., 2012). 
DNA methylation is typically related to lower gene expression in promoter regions. 
However, DNA methylation in other genomic regions can have the opposite effects on 
expression (e.g. gene body) and there is little known about the functional role of DNA 
methylation in other locations such as the intergenic region (Jones, 2012). Studies have 
shown that DNA methylation patterns are under significant control – as evidenced by the 
discovery of a large number of methylation quantitative trait loci (mQTL; Gaunt et al., 
2016; Jones, 2012) – but are also sensitive to environmental influences (McGowan & 
Roth, 2015). Although the environment modifies the epigenome throughout the lifespan, 
there is some evidence that the in utero environment has the largest effect (Billack et al., 
2012). These prenatal effects have been largely interpreted in terms of the fetal 
programming hypothesis in which the fetus adapts its phenotype – such as stress 
reactivity or metabolism – to what it anticipates its postnatal environment to be on the 
basis of the biological cues from the mother’s environment (Gluckman et al., 2008b). 
The majority of studies investigating the association between prenatal exposure to 
maternal stress and methylation have focused on NR3C1. Prenatal stressors such as 
maternal depression (Conradt et al., 2013a; Hompes et al., 2013), exposure to intimate 
partner violence (Radtke et al., 2011) and exposure to war (Mulligan et al., 2012) have 
been associated with increased methylation of NR3C1 at birth. There is, however, 
variability in these methylation profiles, even among newborns whose mothers reported 
high levels of stress and this variability may be predictive of children’s risk for emotional 
or behavioral health problems versus their resilience. To date, few biologically informed 
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prospective studies have explored gene-specific methylation patterns in the context of 
resilience. We focus on methylation of the oxytocin receptor gene (OXTR). 
Oxytocin is an essential neuropeptide and hormone in the regulation of social and 
affiliative behavior such as empathy, attachment, bonding, emotion recognition, and 
processing of social stimuli (Jack et al., 2012). Oxytocin has also been shown to have 
anxiolytic effects by dampening physiological, hormonal, and brain-level responses to 
stressful or aversive signals (Heinrichs et al., 2009). Thus, stress-related epigenetic 
changes in the oxytocin system may confer risk for the development of psychopathology 
by shaping socio-emotional, socio-cognitive, and stress response systems that underlie 
temperament and children’s relationships with peers and adults.  
It is biologically plausible to predict that prenatal (or postnatal) stressors would be 
associated with increased DNA methylation and, in turn, increased emotional and 
behavioral problems. That is, if DNA methylation acts as a gene silencer, increased 
methylation in the promoter region of the gene would result in lower messenger RNA 
(mRNA) levels, blocking of transcription factors, and in turn, decreased gene expression 
and decreased circulating oxytocin in the blood. Indeed, a number of studies have found 
evidence for these relationships. For example, increased OXTR methylation leads to 
decreased OXTR mRNA expression in hepatoblastoma human cells (Kusui et al., 2001) 
and in murine cells (Mamrut et al., 2013) in the promoter region of the gene. Gregory and 
colleagues found increased promoter region OXTR methylation in peripheral blood as 
well as in temporal cortex tissue in individuals with autism compared with controls. 
Increased methylation resulted in a 20% reduction in mRNA expression (Gregory et al., 
2009) . 
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Consistent with the possibility that OXTR methylation may be a mechanism by 
which prenatal exposures increase risk for psychopathology, Dadds and colleagues (2014) 
found that elevated methylation in OXTR in a sample of 4- to 16-year-olds was associated 
with lower levels of circulating oxytocin and higher levels of callous-unemotional traits. 
Similarly, in a sample of youth with early-emerging and persistent conduct problems, 
Cecil and colleagues found that higher methylation at birth at the OXTR locus was 
associated with higher levels of callous-unemotional traits at age 13, although the effect 
was only observed in youth with low levels of internalizing problems (Cecil et al., 2014). 
Moreover, mothers’ reports of behaviors that might have caused stress to themselves or 
the fetus (e.g., their own criminal behavior, their partner’s criminal behavior, their own 
psychopathology and substance use) were associated with elevations in OXTR 
methylation at birth.  
Despite the plausibility of a pathway by which prenatal stressors lead to increased 
OXTR methylation, a number of studies have found the inverse relationship between 
OXTR methylation and prenatal stress as well as psychological outcomes. For example, 
one study focusing on prenatal stress found that the more life-changing stressful events a 
mother experienced when she was pregnant, such as being a victim or witness of assault 
or experiencing the severe illness or death of a loved one, the lower the OXTR 
methylation levels in cord blood at birth (Unternaehrer et al., 2015). Reiner and 
colleagues found that depressed women had lower OXTR exon 1 DNA methylation levels 
compared to non-depressed women (Reiner et al., 2015). Moreover, Ziegler and 
colleagues found in a sample of adults that decreased OXTR methylation was associated 
with a diagnosis as well as symptoms of social anxiety disorder, increased cortisol 
responses to a stress test, and increased amygdala responsiveness during social anxiety 
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word processing (Ziegler et al., 2015). In addition, in a brain imaging study, researchers 
found that higher OXTR methylation was related to increased brain activity in areas 
associated with social perception such as the temporoparietal junction and the dorsal 
anterior cingulate cortex (Jack et al., 2012). Thus, the evidence is mixed as to whether 
prenatal stressors are associated with increased or decreased OXTR methylation and 
whether individual differences in OXTR methylation are associated with positive or 
negative child (or adult) outcomes. Direction of effects could be highly dependent on the 
location of the probes examined.  
 The present study is the first to make use of a longitudinal design to examine if 
OXTR methylation at birth can differentiate resilient and non-resilient youth as measured 
by hyperactivity, conduct problem, and emotional problem outcomes in mid-childhood. 
Additionally, a strength of the study is that only children with pre- and post-natal 
adversity were included which ensures that resilience is not driven by differences in the 
quality of the postnatal environment. Given mixed findings in the literature about the 
direction of the relationship between stress in pregnancy and methylation levels at birth 
as well as the relationship between methylation levels and later behavior, we do not 
propose a directional hypothesis. Understanding plasticity at this critical period in 
development can help us examine how early stress can “get under the skin” and alter 
developmental trajectories. We hypothesize that this variability will be predictive of 
which newborns grow up to have low levels of psychopathology, despite their exposure 
to prenatal risk factors. 
Methods   
Participants 
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 The Epigenetic Pathways to Conduct Problems Study consists of a subsample of 
youth (n = 339, 50% female) nested within ALSPAC and ARIES with established 
trajectories of conduct problems from ages 4 to 13 (Barker & Maughan, 2009) and have 
epigenetic data at birth and/or childhood. This subsample is comparable to the full 
trajectory sample (n = 7,218) in terms psychiatric comorbidity (Barker et al., 2010). 
DNA methylation measures were available for 326 youth at birth. Children with missing 
ethnicity information were removed, leaving a total sample of 321. Except for factor 
analyses, in which we used data from all youth, the present study only included youth 
who scored above the sample average on our measure of prenatal and postnatal (birth to 
age 7) environmental risk exposure. Although exposure to prenatal risk was the focus of 
our study, we wanted to ensure that differences in the postnatal environment did not 
account for any observed associations between methylation profiles at birth and resilience 
in middle childhood. These measures of prenatal and postnatal risk are described below 
in the section “Environmental Risk.” The final analytic sample was n = 91, all of whom 
had complete data including DNA methylation at birth, had been exposed to pre- and 
post-natal adversity, and for whom information on emotional and behavioral outcomes 
was collected. See Figure 1 for a flow chart representing which youth were included in 
the analysis sample.  
Measures 
   DNA Methylation data at Birth. DNA methylation was assayed according to 
standard protocol described in the Introduction section of this thesis (p. 19-22). Samples 
were quantile normalised using the dasen function within the wateRmelon package 
(wateRmelon_1.0.3; 19) in R and batch corrected using the ComBat package (Johnson et 
al., 2007).  
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              We extracted data for probes located within the OXTR CpG island (n = 12), as 
this area has been previously investigated and shown to play a key role in modulating the 
transcriptional activity of OXTR (Kusui et al., 2001). For each probe, methylation levels 
were indexed by beta values (corresponding to the ratio of methylated signal divided by 
the sum of the methylated and unmethylated signal). Factor analysis was used to reduce 
the 12 OXTR probes into a smaller set of factors, which accounted for shared variance 
between them. A 3-factor solution showed the best fit to the data as well as good 
temporal stability. See Supplement 1 and 2. We present findings relating specifically to 
Factor 1, three probes located in the 5'UTR region – Probe 1 (cg00078085), Probe 5 
(cg03987506), and Probe 10 (cg12695586) – because Factor 2 and 3 scores were not 
significantly associated with any type of resilience.  
 Environmental Risk. The prenatal risk score comprised items that were 
reported by mothers and summed to create 4 conceptually distinct but related domains: (i) 
Life events (e.g. death in family, accident, illness), (ii) Contextual risks (e.g. poor housing 
conditions, financial problems), (iii) Parental risks (e.g. maternal psychopathology, 
criminal involvement and substance use), (iv) Interpersonal risks (e.g. intimate partner 
violence, family conflict). Measures of post-natal environmental risk were created for the 
early childhood (birth-age 7) and middle childhood (age 8-9) periods. These included all 
domains represented in the prenatal risk composite as well as a measure of Direct 
victimization (e.g. child bullied by peers or physically hurt; available only postnatally).  
 Risk domains were positively and significantly correlated, both within and 
between developmental periods, with the majority of correlations ranging from r =.20-
.40. For the prenatal and postnatal periods, we used confirmatory factor analyses (CFAs) 
to assess the internal reliability of the risk domains and to extract one global cumulative 
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risk score for each developmental period, showing good model fit. Higher scores indicate 
greater environmental risk exposure. See Supplement 3 for full item descriptions, details 
of inter-correlations between risk domains and factor analysis fit indices. To ensure that 
youth who were defined as resilient or non-resilient had been exposed to at least some 
moderate level of environmental risk, the sample was restricted to youth who scored 
above the mean on the measures of prenatal and postnatal cumulative environmental risk, 
as described in the Participants section.  
 Internalizing and Externalizing Problems. Repeated assessments of conduct 
problems, hyperactivity, and emotional problems were made at ages 4, 7, 8, 10, 12, and 
13 via maternal reports on the Strengths and Difficulties Questionnaire (SDQ) 
(Goodman, 1997). The SDQ is a widely used screening instrument with reliability and 
validity demonstrated in a large national sample (Goodman, 2001). The SDQ comprises 
five subscales, each consisting of five items rated by mothers as ‘certainly true’, 
‘somewhat true’, or ‘not at all true’. In the current study, we utilized the conduct 
problems subscale (e.g., ‘often fights with other children or bullies them’, ‘often lies or 
cheats’), the hyperactivity/inattention subscale (e.g., ‘restless, overactive, cannot stay still 
for long’, ‘constantly fidgeting or squirming’) and the emotional problems subscale (e.g., 
‘often unhappy, down-hearted or tearful’, ‘many worries, often seems worried’). In order 
to obtain more robust and reliable estimates of symptomatology, we performed a 
confirmatory factor analysis for each of the three subscales that included data from age 4 
to 13, so as to generate a single factor score for each subscale that accounted for shared 
variance across time points. We also created a ‘global symptomatology’ factor score 
combining all three SDQ subscales as a measure of more general overall functioning. See 
Figure 2 for summary statistics as well as full details of the confirmatory factor analysis.  
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Psychosocial Functioning. We used factor scores from the peer problems (e.g. 
‘rather solitary and tends to play alone’, ‘generally liked by other children’) and prosocial 
behavior (e.g. “considerate of other people’s feelings’, ‘kind to younger children’) 
subscales from the SDQ. We also utilized a six item callous-unemotional traits 
questionnaire completed by mothers when the child was 13 (e.g., ‘makes a good 
impression at first but people tend to see through him/her after they get to know him/her’, 
and ‘shallow or fast changing emotions’) (Moran et al., 2008). Items were rated on a 
three-point scale ranging from ‘not true’ to ‘certainly’ true. Social cognition was assessed 
using the 12-item Social Communication Disorder Checklist (Skuse et al., 2005) 
completed by mothers when the child was 7 years old. Items included for example: ‘not 
aware of other people’s feelings’, ‘does not notice the effect of his/her behavior on other 
members of the family’. Higher scores indicate lower social cognition.  
 Classification of Resilience. In order to classify the sample into resilient (1) and 
non-resilient (0) groups, we conducted four ordinary least squares regressions to predict 
(i) global, (ii) conduct problems, (iii) hyperactivity, and (iv) emotional problems, 
respectively, from the prenatal cumulative risk factor score. We utilized residuals from 
these regressions to classify youth into resilient and non-resilient groups in each domain. 
Specifically, youth with negative residual scores were classified as resilient (indicating 
that they had lower-than-predicted levels of psychopathology, given their exposure to 
prenatal risk) and youth with non-negative residual scores were classified as non-resilient 
(indicating that they had predicted or higher-than-predicted levels of psychopathology, 
given their exposure to prenatal risk). One subject with conduct, hyperactivity, and global 
symptomatology residual scores > 3 s.d. from the mean was removed from all the 
analyses.  Retention of the outlier results in a non-normal distribution of resilience 
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residuals although findings remain unchanged with the subject’s inclusion. For all 
domains, the distributions of the residuals were normal. See Figure 3 for resilience 
classification. 
 For resilience as defined by global problems, n = 44 (48%) youths were classified 
as resilient and n = 47 (52%) were not resilient. For resilience as defined by conduct 
problem scores, n = 44 (48%) youth were classified as resilient and n = 47 (52%) were 
not resilient. For resilience as defined by hyperactivity scores, n = 50 (55%) youth were 
classified as resilient and n = 41 (45%) were not resilient. Finally for resilience as defined 
by emotional problem scores, n = 50 (55%) youth were classified as resilient and n = 41 
(45%) were not resilient.  
Data Analysis 
Factor analyses were conducted in Mplus version 6.1.128 and all other analyses in 
SPSS 21. Regression analyses were conducted to test whether resilience (defined globally 
and in terms of specific domains) was associated with the Factor 1 methylation score. 
Post-hoc analyses were conducted to test whether resilience was associated with the 
individual probes (Probes 1, 5, 10) that make up Factor 1. Covariates in all models 
included sex and cell-type composition, estimated using the approach described in 
Houseman and colleagues (2012). Analyses were bootstrapped 10,000 times. 
Bootstrapping is advantageous with small samples as it derives an approximation of the 
sampling distribution via repeated resampling of the available data to yield bias corrected 
95% confidence intervals (CI). Significant associations were only presented if they 
survived bootstrapped confidence intervals. Then, further analysis on any resilient 
domains that had significant methylation results was conducted. Resilient and non-
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resilient groups in that domain were compared on additional psychosocial functioning 
factors.  
Results 
 As shown in Table 1, children who had lower conduct problem scores than 
predicted given their exposure (to pre-natal environmental risk; i.e. resilient group) had a 
higher OXTR methylation Factor 1 score than non-resilient children. In contrast, when 
resilience was defined globally or in terms of hyperactivity or emotional problems, 
resilience scores were not associated with OXTR methylation.  
When examining the individual probes that make up the OXTR methylation factor 
(Probes 1, 5, and 10), we found that youth who were resilient in terms of conduct 
problems had significantly higher methylation levels across all three probes compared to 
the non-resilient group. Interestingly, resilience as defined in terms of global problems 
and hyperactivity problems predicted increased methylation only within one probe (Probe 
5). Figure 4 highlights percent methylation differences across groups who were resilient 
versus non-resilient in terms of conduct problems.  
 Table 2 provides descriptive information regarding the groups who were resilient 
and non-resilient in terms of conduct problems. The groups did not differ in terms of 
gender or in environmental risk at any developmental period (prenatal – age 9). 
Furthermore, in an ANCOVA controlling for sex, we found that youth who were resilient 
in terms of conduct problems also had lower hyperactivity, emotional problems and 
callous-unemotional traits, higher prosocial behavior and better social cognition as 
compared to youth who were non-resilient in terms of conduct problems. Thus, youth 
who were resilient to prenatal risk in terms of having relatively low levels of conduct 
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problems were functioning well across multiple domains that are typically compromised 
when youth have conduct problems. 
Post-hoc Analysis: Exploring Potential Genetic Influences. We explored 
potential genetic factors that may influence the DNA methylation sites associated with 
resilience to conduct problems. Because our sample was underpowered to directly 
examine genetic polymorphisms (SNPs) affecting DNA methylation, we used the 
mQTLdb resource (http://www.mqtldb.org/) to search for known methylation quantitative 
trait loci (mQTLs) associated with our methylation sites of interest. The mQTLdb 
database contains the results of a large-scale study based on the ARIES sample in 
ALSPAC (from which our subsample is derived), characterizing genome-wide significant 
cis effects (i.e. SNP within ±1000 base pairs of the DNA methylation site) and trans 
effects (i.e. ±1 million base pairs) on DNA methylation levels across Illumina 450k 
probes at five different life stages, including cord blood DNA methylation at birth (Gaunt 
et al., 2016). Here, we searched for mQTLs based on results from the conditional 
Genome-wide Complex Trait Analysis (GCTA), which was used to identify mQTLs with 
the most representative, independent effect on each DNA methylation site in order to 
account for linkage disequilibrium (Gaunt et al., 2016). Based on mQTLdb search, we 
found that 2 out of 3 of Factor 1 probes (Probe 1 and Probe 10) were associated with 
known cis SNPs, suggesting that DNA methylation levels across these sites are likely to 
be under considerable genetic control. Interestingly, Probe 1 and Probe 10 are specific to 
conduct problems, while Probe 5 was significant in both hyperactivity and global 
problems. This suggests that these probes are likely to be influenced by genetic factors as 
well as environmental adversity and may suggest a specific GxE effect for conduct 
problems. See Table 3 for more details on SNP influences on Probe 1 and 10. 
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Discussion 
Our goal in this study was to examine whether variability in OXTR DNA 
methylation profiles at birth predicted resilience as defined by psychopathological 
outcomes that were better than expected based on prenatal risks. Consistent with our 
hypothesis, Factor 1 methylation – as well as methylation of the individual probes (1, 5, 
10) that make up the factor – was predictive of resilience to conduct problems in mid-
childhood. In contrast, OXTR DNA methylation profiles did not predict resilience in 
domains of emotional, hyperactivity, and global symptomatology suggesting a potential 
role for OXTR in the development of conduct problems in particular. This is consistent 
with the fact that many social-cognitive processes such as empathy, attachment, bonding, 
and emotion recognition are disturbed in children with conduct problems. In addition, 
problems in social cognition associated with conduct-disordered behavior are typically 
marked by deficits in oxytocin levels.  
Children who were resilient in the conduct problems domain in mid-childhood 
also had significantly fewer hyperactivity, emotional, and peer problems, higher levels of 
prosocial behavior, better social cognition, and lower scores on a measure of callous-
unemotional traits compared with non-resilient youth. Thus, the group that was resilient 
to conduct problems was broadly resilient across multiple domains. However, this was 
probably not due to OXTR methylation profiles, which were not predictive of resilience 
as defined by emotional or hyperactivity problems. One possibility is that children who 
have fewer-than-expected conduct problems get along better with their peers, are both 
innately more prosocial and observe higher levels of prosocial behavior in their 
interactions with peers, and are thus buffered against the emergence of other forms of 
psychopathology relative to children with higher levels of conduct problems (Oland & 
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Shaw, 2005; Patterson et al., 1989). The role of OXTR DNA methylation in resilience 
beyond the conduct problems domain remains unclear. 
It is important to note that there were no significant differences between resilient 
and non-resilient youths in levels of environmental risk in any of the developmental 
periods from prenatal to age 9. This rules out the possibility that resilient youth exhibited 
fewer conduct problems than non-resilient youth because they were exposed to less 
environmental risk after they were born. If epigenetic modifications in OXTR are 
consequences of exposure to stress, why would youth with similar levels of exposure to 
prenatal adversity vary in terms of OXTR methylation profiles? Recently, researchers 
have recognized that DNA methylation patterns may be allele-specific and the 
relationship between exposure to stress and DNA methylation may be moderated by gene 
variants. For example, one study found that adolescents that were homozygous for the l-
allele of 5HTTLPR and experienced more stressful life events had higher levels of 
5HTTLPR methylation. Stressful life events were not associated with methylation for s-
allele carriers (van der Knaap et al., 2015). Another study found that decreased DNA 
methylation in the FK506 binding protein 5 (FKBP5) gene depended on early childhood 
abuse and the rs1360780 risk allele (Klengel et al., 2013). Although we could not 
examine direct SNP effects because of small sample size, our post-hoc analyses using the 
mQTLdb demonstrated that methylation of Probes 1 and 10 is significantly influenced by 
SNPs rs62243375 and rs237900 respectively. Interestingly, our results showed that 
Probes 1 and 10 were only related to conduct problems, while Probe 5 was related to 
global problems and hyperactivity. This provides indirect evidence for OXTR genotype 
moderating the relationship between adversity and DNA methylation in conduct 
problems. However, studies examining allele specific DNA methylation effects earlier in 
 36 
child development, especially in the prenatal/neonatal period are lacking. More research 
is needed to examine the integrative effects of OXTR genotype and DNA methylation on 
the oxytocin pathway, especially during the critical prenatal period.  
Increased methylation of OXTR is associated with decreased gene transcription 
and protein expression, which theoretically represents the molecular building blocks for 
behavioral phenotypes (Kumsta et al., 2013; Kusui et al., 2001; Mamrut et al., 2013).  
Interestingly, our results showed that higher levels of DNA methylation of OXTR at birth 
predicted resilience to conduct problems in mid-childhood. This pattern was unexpected 
in light of results showing that elevations in OXTR methylation are also associated with 
relatively high levels of callous-unemotional traits (Dadds et al., 2014; Cecil et al., 2014).  
However, this traditional view has been recently challenged with more and more studies 
finding an inverse relationship, highlighting the complexities in predicting behavioral 
phenotypes from DNA methylation (Jack, Conolley, & Morris, 2012; Reiner et al., 2015; 
Ziegler et al., 2015). In a human cohort, researchers found that only a minority of 
individual CpG sites had significant negative correlations with mRNA signaling across 
individuals and in a number of genes, higher DNA methylation was associated with 
higher gene expression (Lam et al., 2012). This can also be because the relationship 
between methylation, transcription, and expression can vary depending on the location of 
the CpG site. Of note, the three probes in our study mapped onto the 5’ UTR region of 
gene, where an inverse correlation between DNA methylation and mRNA expression has 
previously been reported (Eckhardt et al., 2006). Thus, although we might theoretically 
predict that higher methylation would be associated with a lack of resilience to conduct 
problems, the mechanics of methylation are likely to be more complex than this. 
Interestingly, our findings conflict with Cecil and colleagues (2014) work also 
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using data from the ALSPAC sample in which they found that higher OXTR methylation 
at birth was associated with higher callous-unemotional traits at age 13. Of note, Cecil et 
al (2014) found this relationship in OXTR probes that make up Factor 2, while Factor 1 
probes were not associated with callous-unemotional traits in their study. Furthermore, 
the sample (N=39) was highly selected to include only youth who had early-onset and 
persistent conduct problems and the relationship between higher OXTR methylation at 
birth and callous-unemotional traits was only observed in the subgroup with low levels of 
internalizing profiles. Thus, although our analysis sample and Cecil et al’s ostensibly 
come from the same cohort, they reflect very different groups of children.   
The present findings should be interpreted in light of a number of limitations. This 
study focused specifically on DNA methylation of annotated probes located within the 
CpG island of OXTR and it is likely that differences across groups may be found in other 
genes (i.e. glucocorticoid or serotonergic pathways). Future studies may employ an 
epigenome-wide approach that would enable researchers to examine group differences in 
DNA methylation across the genome. In addition, we did not examine RNA expression 
and cannot explore the functional relevance of the probes in regards to gene expression 
and downstream biological mechanisms. However, we did select a region of OXTR that 
has previously demonstrated to be functional in utero. Although we provided indirect 
evidence for a potential GxE effect on DNA methylation via the mQTLbase data, we 
could not directly test it due to sample size. In general, the findings are based on a 
relatively small sample of youth, which limits statistical power to detect effects.  
In summary, this is the first longitudinal study to examine the role of OXTR 
methylation in resilience across multiple domains. Our findings show that OXTR 
methylation at birth is exclusively related to resilience in the conduct problems domain in 
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middle childhood. This may be potentially reflective of a GxE effect where genotype 
moderates the relationship between environmental stressors and DNA methylation. These 
findings highlight the importance of the prenatal period for the development of childhood 
psychopathology and suggest a potential mechanism by which early experiences may be 
biologically embedded. Because of the important role of oxytocin in social impairment, 
understanding individual variations in OXTR methylation patterns might increase insight 
into risk and resilience factors that can bridge translational efforts in treatment and 
intervention approaches. 
CHAPTER 5: A Longitudinal Epigenome-wide Analysis of Depression Trajectories 
in Adolescence (Part 1) 
Introduction 
Major Depressive Disorder (MDD) in children and adolescents represents a major 
worldwide public health burden. In the US, an estimated 3 million adolescents 
experienced an episode of depression in 2017, representing around 13% of the US 
population aged 12 to 17 (National Survey on Drug Use and Health, 2017). According to 
the Centers for Disease Control and Prevention, in 2014 rates of death by suicide 
surpassed deaths by traffic accidents among adolescents for the first time ever (Morbidity 
and Mortality Weekly Report-MMWR, 2016). The suicide rates among even younger 
youths (age 10 to 14) has doubled in the US between 2007-2014 (MMWR, 2016). 
Depression in adolescence predicts major depressive disorder in adulthood, other mental 
health disorders, substance abuse, suicide attempts, educational underachievement, 
unemployment, and early parenthood (Fergusson & Woodward, 2002).  
The etiology of depression is still not fully understood. Genetic factors confer risk 
for the disorder with heritability of MDD estimated to be around 40%; but genetic 
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variants explain only a small proportion of heritability (for reviews of GWAS depression 
studies see Dunn et al., 2015; Tsang et al., 2017). Research has also shown that stressful 
life events also confer risk for depression above and beyond heritability (Kendler, 
Thornton, & Gardner, 2001; Kendler, Karkowski, & Prescott, 1999). Recent work 
utilizing the UK BioBank (N = 126, 522) found that the SNP-based heritability of MDD 
stratified by reported trauma exposure (24%) was much greater than MDD without 
reported trauma exposure (12%) suggesting a complex relationship between genetic risk, 
stressful life events, and MDD (Coleman et al., 2020).  
Epigenetic research sits at the intersection between biological and environmental 
explanations for the development of depression. Although the human genome is static, 
the epigenome is dynamic and highly responsive to environmental input. The epigenome 
describes the chemical switches that sit on top of genes and modulate gene expression by 
either silencing or activating certain genes. Stress-induced epigenetic modifications are 
typically measured by examining DNA methylation, where methyl groups are added to 
cytosine-guanine-phosphate (CpG) sites (Jaenisch & Bird, 2003). Because the epigenome 
is highly responsive to stress signals from the environment, modifications that produce 
enduring changes in gene expression are a possible biological mechanism by which 
stressful life events increase risk for depression. Our study aims to examine the etiology 
of depression using epigenetic mechanisms through a developmental lens focusing on 
two sensitive periods: in utero and adolescence.  
Heterogeneity in Depression 
Major Depressive Disorder is a heterogenous phenotype across many domains. 
There is heterogeneity in presenting symptoms, both in terms of the type and 
combination. For example, researchers found over a 1,000 unique depression symptom 
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profiles in individuals diagnosed with MDD (N = 3707), representing only 3.6 patients 
per profile (Fried & Nesse, 2015). Depression is also heterogenous in severity and is 
better understood as a dimension ranging from normative response to life stress to a 
severe disorder (Beach & Amir, 2003; Ruscio & Ruscio, 2000). Finally, depression is 
also heterogeneous in clinical prognosis over time. Research has shown that depression 
can be both a time-limited, single episode phenomenon and a recurring and chronic 
lifetime disorder (Lorenzo-Luaces, 2015). It is clear that depression is better understood 
as a heterogenous symptom cluster rather than a discrete, underlying condition with 
demarcated boundaries and a homogeneous group of patients (Monroe & Anderson, 
2015). However, in the search for biological vulnerabilities to MDD, research has largely 
relied on a categorical, disease model when operationalizing depression. As a result, 
despite decades of genetic, neurological, and biological research, slow progress has been 
made in identifying reliable biomarkers for MDD. In an effort to take this phenotypic 
heterogeneity into account, our study is the first to utilize a more dynamic measure of 
depression using trajectories that reflect severity and course over time.  
Sensitive Periods of Development 
Adolescence. Although depression in childhood is rare (less than 3% prevalence 
rate), there is a dramatic surge in depression rates during ages 13-17, with 17% of 
individuals experiencing a depressive episode before the age of 18 (Ge et al., 1994; 
Merikangas et al., 2010). There is a strong continuity of depression from adolescence into 
adulthood, while most depressed pre-pubertal children do not grow up to be depressed 
adults (Hankin et al., 2015a; Pine et al., 1999; Rutter et al., 2006). Therefore, adolescence 
represents a particularly significant developmental stage in which to study biological 
mechanisms underlying the development of depression.  
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In utero. Researchers have long posited that the risk for psychopathology can be 
embedded as early as the uterine period of development. With regards to depression 
research, a consistent finding is that maternal depression during pregnancy significantly 
increases risk for depression in offspring above and beyond postnatal maternal 
depression, contextual factors, and overall postnatal environment (Barker et al., 2011; 
Pawlby et al., 2009; Pearson et al., 2013; Plant et al., 2015) suggesting that the risk for 
depression could be traced back to prenatal development.  
Our study is able to assess the biological programming of depression risk through 
a more developmentally relevant framework by examining epigenetic changes in 
sensitive periods of development (in utero and adolescence) that have the biggest 
potential to help us understand the causes of depression.  
Literature Review of Epigenetics and Depression.  
 In the past ten years, there has been an explosion of DNA methylation studies 
examining the depression phenotype. In the nascent stages of behavioral epigenetics as a 
field, candidate gene approaches were most common. However, as the need for less 
biased and more comprehensive approaches grew, epigenome-wide studies have become 
more frequent, especially in the last five years. There are a number of reviews that 
describe this vast literature. For a comprehensive systematic review of approximately 70 
depression EWAS and candidate gene studies published before 2018 see Li and 
colleagues (2019). For a systematic review more focused on work stress, burnout, and 
depression see Bakusic and colleagues (2017). For a narrative review focusing on seven 
specific candidate genes of depression see Chen and colleagues (2017). Finally, for a 
more focused systematic review of monozygotic twin DNA methylation studies see 
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Palma-Gudiel and colleagues (2020). Findings from some of these studies are broadly 
summarized below.  
Candidate Gene Studies. For candidate-gene approaches, using case-control 
designs, the most frequently studied genes include brain derived neurotrophic factor 
(BDNF), the glucocorticoid receptor gene (NR3C1), and the serotonin transporter gene 
(SL6A4). The most robust candidate gene has been the BDNF with the majority of 
studies finding hypermethylation of BDNF to be associated with depression (e.g. 
Chagnon, Potvin, Hudon, & Préville, 2015; Choi et al., 2015; Fuchikami et al., 2011; Na 
et al., 2016; Roy et al., 2017).. The BDNF gene provides the instructions for making 
proteins often in the brain and spinal cord and are involved in promoting the growth, 
maturation, and maintenance of neurons as well as regulating synaptic plasticity. There 
have also been consistent associations of hypermethylation of SLC6A4 (e.g. Bayles et al., 
2013; Philibert et al., 2008; Shi et al., 2017; Zhao, Goldberg, Bremner, & Vaccarino, 
2013) and NR3C1 (e.g. Roy, Shelton, & Dwivedi, 2017; Bustamante et al., 2016; Na et 
al., 2014; Nantharat, Wanitchanon, Amesbutr, Tammachote, & Praphanphoj, 2015) and 
depression. SLC6A4 codes for a protein that is involved in the regulation of serotonergic 
signaling and NR3C1 is the receptor to which cortisol and glucocorticoids bind; both 
have been implicated in mood and anxiety disorders. Other, less typically studied 
candidate genes have also shown differences in DNA methylation in depressed 
individuals including oxytocin receptor (OXTR; Chagnon et al., 2015; Reiner et al., 
2015), monoamine oxidase A (MAOA; Melas & Forsell, 2015), tescalin (TESC; Han et 
al., 2017), and synapsin II (SYN2; Cruceanu et al., 2016). 
Epigenome-wide Association Studies (EWAS). In the past few years, there has 
been a substantial increase in EWAS depression studies. The majority of studies are 
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cross-sectional, use the case-control design, and study populations in Western developed 
countries. Most studies use whole blood sampling (Byrne et al., 2013; Davies et al., 2014; 
Córdova-Palomera et al., 2015; Numata et al., 2015; Uddin et al., 2011), while a small 
handful examined brain tissue from deceased individuals (Kaut et al., 2015; Nagy et al., 
2015; Sabunciyan et al., 2012). Sample sizes range from N = 12 to 473. The number of 
significant hits varies widely based on methodology from zero to 115; there are no 
specific genes that stand out as frequent replications. This lack of overlap may be due to 
the complexity of the depression phenotype as well as methodological differences in 
study design, technology platforms, type and timing of tissue sampling, assessment of 
depression symptoms including different measures at different stages in the lifespan, and 
small sample sizes. 
Almost all epigenome-wide studies utilize convenience sampling of adults, most 
often in middle to late adulthood, making it difficult to disentangle DNA methylation 
changes as causes or consequences of depression. Only two cross-sectional studies 
conducted an EWAS in an adolescent sample (Boström et al., 2017; Dempster et al., 
2014). Dempster and colleagues (2014) utilized 18 pairs of monozygotic twins discordant 
for depression and did not find any differentially methylated regions (DMR) that survived 
corrections for multiple testing. However, in a recent study, Bostrom and colleagues 
(2017) found that hypomethylation of a CpG site located on the promoter region of micro 
RNA 4646 (MIR4646) was related to an increased risk of depression. This finding was 
replicated in a validation sample and in a sample of post-mortem frontal cortex tissue in 
deceased subjects with a history of major depression. Genes related to MIR4646 play a 
major role in the conversion of omega-3 fatty acids, which have been previously 
associated with MDD (for a meta-analytic review see Lin & Su, 2007). 
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There has been one small longitudinal analysis examining DNA methylation in 
adolescence (N=23 cases and N=36 controls, Mage = 18.6) that attempted to identify 
epigenome-wide associations between changes in depression risk and changes in DNA 
methylation levels from baseline to 1 year follow up (Ciuculete et al., 2019). After FDR 
correction, no significant CpG probes were identified; however, there were 9 nominally 
significant probes. The largest methylation difference was detected at cg24627299 within 
the hepatocyte growth factor receptor (MET) gene, a gene involved in sending signals 
within cells and in cell growth and survival.  
Fetal Programming Studies. There are a handful of longitudinal studies of DNA 
methylation assessed at birth predicting outcomes later in childhood that typically focus 
on externalizing disorders including ADHD (Neumann et al., 2019; van Mil et al., 2014), 
ODD (E. D. Barker et al., 2018), conduct problems (Cecil et al., 2018) and substance use 
(Cecil et al., 2016); these studies typically show robust DNA methylation differences. 
Although there is evidence that prenatal stress predicts internalizing outcomes later in 
childhood, less is known about the role of DNA methylation in this pathway. A small 
handful of studies have examined more proximal infant behavioral phenotypes in the 
context of prenatal stress and DNA methylation including cortisol reactivity (Oberlander 
et al., 2008) and aspects of neurobehavior such as self-regulation, hypotonia, lethargy, 
habituation, and reflexes (Appleton et al., 2015; Conradt et al., 2013b; Monk et al., 2016) 
but none have assessed more specific depression symptomatology later in life. To our 
knowledge, this is the first study (candidate gene or EWAS) to examine DNA 
methylation at birth and a depression phenotype later in childhood. 
Current Study 
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We build upon previous epigenome-wide studies of depression in the following 
ways: (1) Studies in behavioral epigenetics continue to operationalize depression as a 
categorical construct assessed at a single time point. Researchers typically create two 
comparison groups based on a clinically significant cut-off point of a sum score of 
symptoms. We were able to utilize repeated measures of depression symptoms from early 
to late adolescence to identify groups that are homogenous in terms of their initial levels 
of symptomatology at the beginning of adolescence and the slope of their symptoms over 
time. In addition to providing novel insights into the biological mechanisms of depression 
over time, the ability to reduce heterogeneity in the depression phenotype may boost 
power to detect epigenetic changes. (2) We examine depression in early to late 
adolescence at a time that is developmentally relevant in understanding the causative 
mechanisms in the onset of depression. Most studies examine depression in mid to late 
adulthood, where it is unclear whether DNA methylation changes reflect a causal 
mechanism or instead represent the “wear and tear” that chronic depression and its 
accompanying sequela including substance use and health problems has on the 
epigenome throughout the lifespan. (3) The longitudinal nature of this study allows us to 
also examine depression through the fetal programming framework where we are able to 
examine whether epigenetic changes present at birth can set developmental trajectories 
that confer risk for depression later in adolescence. Moreover, the design allows us to test 
whether the same genes or genetic networks are implicated in depression at different 
sensitive periods potentially pointing to distinct pathways by which epigenetic 
modifications at different points in development increase risk for depression. (4) We 




 The ARIES subsample of ALSPAC was used. Final analytic samples for analyses 
included only participants who had both depression and methylation data available (N = 
830 for prenatal analyses and N= 893 for adolescent analyses). Analyses at birth and 
adolescence largely included the same participants (90% match across data sets, N = 801 
participants present in both sets of analyses). DNA methylation in adolescence was 
measured either at age 15 (n = 222, 25% of the participants) or at age 17 (n = 671, 75% 
of the participants). See Figure 5 for descriptive flowchart of sample.  
Measures 
 Depression Trajectories. Depression was assessed using The Short Moods and 
Feelings Questionnaire (SMFQ; Angold, Costello, Messer, & Pickles, 1995), a 13-item 
child self-report questionnaire that enquired about the occurrence of depressive 
symptoms over the past 2 weeks. Scores range from 0-26. A cut-off of 11 and above has 
been used to describe clinically significant symptoms (Joinson et al., 2012). The SMFQ 
has been validated as a tool for assessing depressive symptoms in adolescence (Turner et 
al., 2014) and distinguishes children with depression from those who are not depressed in 
general population samples (Sharp et al., 2006). Previous studies done with ALSPAC 
data have shown that the mean SMFQ score and variability increase from childhood to 
adolescence (Niarchou, Zammit, & Lewis, 2015; Sequeira, Lewis, Bonilla, Smith, & 
Joinson, 2017). By the age of 18, 8% of the sample meets ICD-10 criteria for depression 
(Niarchou et al., 2015). This study uses SMFQ data collected at mean ages 12.5, 13.5, 16, 
and 17.5.  
DNA Methylation. DNA methylation was assayed according to standard protocol 
described in the Introduction to the thesis (p. 19-22). In an attempt to reduce non-
 47 
biological differences between probes, samples were functional normalized using 10 
principal components derived from control probes using the “meffil” package in R.  
Covariates for DNA Methylation at Birth. Research has shown that a number 
of prenatal environmental factors impact differential DNA methylation in newborns 
including infant birthweight (Filiberto et al., 2011), infant gestational age or pre-term 
birth (H. Lee et al., 2012; Schroeder et al., 2011), and maternal age (Adkins et al., 2011). 
In addition to these covariates, we also controlled for maternal substance use including 
smoking cigarettes, marijuana use, and alcohol use. Mothers were asked about substance 
use at different time points throughout pregnancy.  
Cigarette Use. Smoking is considered one of the most powerful environmental 
modifiers of DNA methylation across the lifespan. Research has shown that mother’s 
prenatal smoking has large effects on infant DNA methylation in cord blood (Küpers et 
al., 2015; Lee et al., 2015). Mothers were asked how many times per day did they smoke 
cigarettes at three time points (first, second, and third trimester). Data from each time 
point was entered into the model as a separate continuous covariate. 
Alcohol Use. Chronic alcohol use in pregnancy has a number of deleterious 
developmental effects on the fetus, often culminating in fetal alcohol syndrome (FAS). 
Some research has shown differential methylation profiles in infants who were born with 
FAS (Laufer et al., 2015; Portales-Casamar et al., 2016). However, research has shown 
that there are no consistent adverse developmental consequences of low to moderate 
alcohol use during pregnancy (see for review Henderson, Gray, & Brocklehurst, 2007). 
Mothers were asked to rate on a 6-point scale, how often they used alcohol ranging from 
“none” to “greater than 9 glasses daily” during the first and third trimesesters of 
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pregnancy. Data from each time point was entered into the model as a separate 
continuous covariate. 
Marijuana Use. To our knowledge there is no research examining the effects of 
marijuana use on epigenetic changes in human offspring. However, numerous animal 
models have shown that chronic prenatal exposure to cannabinoids triggers epigenetic 
changes that have suppressive immunological effects on offspring (see Zumbrun, Sido, 
Nagarkatti, & Nagarkatti, 2015 for a review). Therefore, as a precaution, we included 
marijuana use as a covariate in our analyses due to its potential influence on 
development. Mothers were asked to rate on a 6-point scale, how often they used 
marijuana or any cannabis products ranging from “none” to “every day” at the same time 
points they were asked about cigarette smoking. Data from each time point was entered 
into the model as a separate continuous covariate. 
Data were available regarding illicit drug use during pregnancy (e.g. cocaine, 
heroin). However, none of the mothers in our analytic sample indicated any illicit drug 
use during pregnancy. Tables 4 and 5 show descriptive statistics for EWAS analyses at 
birth and in adolescence, respectively broken down by depression trajectories.  
 Covariates for DNA Methylation in Adolescence  
Substance Use. Research has shown a robust link between depression and 
substance use in adolescence (Armstrong & Costello, 2002; Kandel et al., 1999). 
Research has also shown that chronic substance use is related to individual differences in 
DNA methylation patterns (Parira, Laverde, & Agudelo, 2017; Rotter et al., 2013). 
Therefore, we included cigarette smoking and marijuana use as covariates. Covariate 
time points were matched with available DNA methylation time points. For example, 
adolescents with methylation data collected at age 15 had corresponding covariates 
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measured at age 14.5 years, while adolescents with DNA methylation data collected at 
age 17 had corresponding covariates measured at 16.5 years. At age 14.5 and 16.5, 
adolescents were asked about the frequency of their cigarette smoking ranging from “I 
have only ever tried smoking cigarettes once or twice” to “I usually smoke one or more 
cigarettes every day.” At the same time points, adolescents were asked about the 
frequency of their marijuana use similarly ranging from “I have only ever tried cannabis 
once or twice” to “I usually use or take cannabis every day.” 
 Data regarding illicit drug use was available but was focused on whether or not an 
adolescent had experimented with drugs and did not reflect problematic or chronic use. 
Data regarding alcohol use was only measured at age 14.5 years and not at 16.5 years. 
Because the majority of our sample had DNA methylation data at age 17, alcohol use was 
not included as a covariate.  
Data Analysis Plan 
The subsequent three chapters will describe the methods, results, and discussion points 
for (1) latent class growth curve modeling of depression trajecotries in MPLUS (2) 
epigenome-wide analyses of depression trajectories and gene annotation, and (3) follow-
up regional and gene network analyses. 
CHAPTER  6: A Longitudinal Epigenome-wide Analysis of Depression Trajectories 
in Adolescence (Part 2) 
Latent Class Growth Curve Modeling of Depression Trajectories 
Methods 
  Due to the heterogeneous nature of the course of depression over time, we 
utilized a latent class growth curve model in MPLUS to extract homogenous subgroups 
of adolescents with distinct developmental trajectories of depressive symptoms. We 
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utilized the full ALSPAC sample (N = 15,445) to retain power and controlled for sex. It 
is well-known that females are at twice the risk for developing depression compared to 
males. Therefore, it is likely that sex has significant effects on the growth factors of the 
model including the intercept and slope as well as trajectory classification (i.e. 
classification into one trajectory class over another may be due to sex and not depression 
score). Only participants who had depression data available from at least one time point 
were included in the analysis (N = 8,360). Mplus handles missing data by the standard 
approach of Missing At Random (MAR) under Maximum Likelihood (ML). This means 
that it uses all the data that is available to estimate the model using full information 
maximum likelihood where each parameter is estimated directly without filling in 
missing data values for each individual (Muthén & Muthén, 1998). Previous research 
deriving depression trajectories from the ALSPAC cohort has demonstrated little 
difference on the shape of trajectories, distribution of trajectory membership, or 
associations of trajectories with outcomes when comparing individuals with at least 1 
measurement of depression symptoms with participants with at least 3 or more measures 
(Kwong et al., 2019). 
 Following guidelines in the field based on simulation studies (Nylund et al., 
2007), number of classes were determined by the following fit indices: Lo-Mendell-
Rubin adjusted likelihood ratio test (LMR-LRT) and the bootstrap likelihood ratio test 
(BLRT), where significant p-values prompt the rejection of the k-1 model in favor of the 
K-class model. Other considerations also included model convergence, lower Bayesian 
Information Criterion values, higher entropy values (near 1.0), no less than 1-2% of 
participants in a class, and higher posterior probabilities (values > 70% indicating good 
model fit) (Jung & Wickrama, 2008).  
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Extracting Depression Class Trajectories  
  Class solutions were examined in a sequential order starting from a two-class 
structure.  The two-class model indicated a “low” (N = 7087; 85%) and a “high” (N = 
1273; 15%) depression group (LMR-LRT, p = 0.000; BLRT, p = 0.000; Entropy = 0.83; 
BIC=296434.645). Because significant LMR-LRT and BLRT values prompt the rejection 
of the k-1 model in favor of the k model, this meant that a two-class solution was a better 
model fit than a one-class solution. The three-class model indicated a “low” (N = 6732; 
77%), “increasing” (N = 949; 14%), and “moderate/decreasing” (N = 679; 9%) group 
(LMR-LRT, p = 0.000; BLRT, p = 0.000; Entropy = 0.80; BIC = 248937.648). Again, 
significant p-values indicated that a three-class solution was a better model fit that a two-
class solution. The four-class model yielded a “low” (N = 6350; 76%), “increasing” (N = 
775; 9%), “moderate/decreasing” (N = 978; 12%), and always high (N = “257”; 3%) 
group (LMR-LRT, p = 0.000; BLRT, p = 0.000; Entropy = 0.79; BIC = 294141.890). 
Although the four-class model converged and p-values were significant, the results were 
unreliable due to solutions being local maxima that did not resolve with increased 
random starts. In MPLUS, the estimation algorithm attempts to converge on the globally 
best solution with the largest loglikelihood – one set of parameter values. However, 
sometimes it converges on a local maximum solution, which is the best solution around 
the parameter, but not the best one. This coupled with increased BIC value, decreased 
entropy, only 3% of participants in one class, and posterior probabilities dropping to 
70%, the three-class solution was chosen as the most reliable model fit for the analyses. 
Depression trajectories were classified on the entire ALSPAC sample. See Figure 6 for 
visual representation of depression trajectories. When applied to the ARIES DNA 
methylation subset, the final analytic sample retained similar class proportions. In the 
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birth EWAS, 80% of participants were classified in the low trajectory (n = 662), 11% in 
the increasing trajectory (n = 94), and 9% in the moderate/decreasing trajectory (n = 74). 
In the adolescent EWAS, 80% of participants were classified in the low trajectory (n = 
720), 11% in the increasing trajectory (n = 77), and 9% in the moderate/decreasing 
trajectory (n = 64).   
 There is a vast literature examining longitudinal depression trajectories in 
adolescence. Using various trajectory modeling techniques, the number of unique class 
trajectories range from 3 to 6 with usually a consistent “low” group and variations of 
“increasing”, “high”, “moderate”, and “decreasing” groups (for a review see Schubert et 
al., 2017). In a recent meta-analysis examining 20 longitudinal studies published in the 
past 20 years, a random pooled effect estimate identified a consistent “no or low” group 
(56% of the sampled study populations), a consistent “moderate” group (26%) and a 
variations of “high”, “increasing” or “decreasing” groups (12%) (Shore et al., 2017). 
Regarding the ALSPAC cohort specifically, the number and types of depression class 
trajectories has also varied. Using 7543 adolescents with data between 10.5 years and 
18.5 years of age, 3 trajectory classes were identified using a dichotomous depression 
score (i.e. using the SMFQ clinical cut-point of 11): “persistently low” (74%), “later-
adolescent onset” or “increasing” group (17%) and an “early-adolescence onset” or 
“stably moderate/high” group (9%) (Frances Rice et al., 2002). These trajectory groups 
closely match our classifications. On the other hand, using a sample of 3525 ALSPAC 
individuals with measurements extending into adulthood (i.e. mean age 24), 5 trajectories 
were identified: “low” (71%), “early-adult-onset” (11%), individuals who started with 
low depression symptoms that increased during adolescence and young adulthood, 
“adolescent-limited” (9%),  individuals who experienced elevated levels of depression 
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symptoms only during adolescence, “childhood-limited” (6%), individuals who started 
with elevated levels of depression symptoms in childhood that decreased. and 
“childhood-persistent” (3%) individuals with moderate levels of depression symptoms 
that continued to increase and stay high during adolescence and into young adulthood 
(Kwong et al., 2019). Although there are differences likely due to the result of extending 
measurements well into young adulthood, Kwong and colleagues’ results are still broadly 
comparable to the three-class solutions.  
Describing the Depression Class Trajectories.  
 Descriptive statistics for the depression trajectories for the analytic sample for the 
birth EWAS and for the adolescence EWAS sample were near identical and are discussed 
here more broadly. See Tables 4 and 5 for more specific descriptive statistics of 
depression trajectories separated by EWAS analytic sample. The majority of the 
increasing trajectory (70%) and the moderate/decreasing trajectory (around 65%) was 
made up of females. Females made up less than half of the low trajectory group (around 
48%). For the low depression trajectory, mean depression scores (i.e. SMFQ; total 26, 
clinical cut-off 11) stayed in the 2-6 range across all 4 times points. For the increasing 
trajectory, mean depression scores started low (M = ~ 5), increased by age 13 (M = ~10), 
and continued to increase into late adolescence (M= ~15). For the moderate trajectory, 
mean depression scores were clinically significant at age 12 (M= ~13) and slightly 
decreased in later adolescence to be below the clinical cut-point (M= ~9). 
 An ANOVA with Tukey HSD was used to assess any potential mean differences 
in covariates across the three trajectory groups. For the birth analytic sample, the three 
trajectories did not significantly differ on most covariates including gestation length, 
maternal age at birth, birth weight, mother’s alcohol use and mother’s smoking during 
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pregnancy. Individuals in the increasing trajectory had mothers with increased use of 
marijuana, though this was only a significant difference compared to the low group and 
only in the 3rd trimester.  
 For the adolescent analytic sample, individuals in the increasing and moderate 
trajectories had significantly higher levels of adolescent cigarette smoking compared to 
the low group. Individuals in the increasing and moderate trajectories had higher levels of 
adolescent marijuana use compared with the low group, though differences were only 
significant in the moderate vs. low group. Results regarding cigarette smoking are 
consistent with a robust literature describing increased smoking by depressed adolescents 
and adults (see reviews e.g. Chaiton et al., 2009; Fluharty et al., 2017; Lee & Pausova, 
2013; Weinberger et al., 2017) with less robust results describing increased marijuana use 
(Brook et al., 2011; Passarotti et al., 2015) 
CHAPTER 7: A Longitudinal Epigenome-wide Analysis of Depression Trajectories 
in Adolescence (Part 3) 
Epigenome-Wide Analyses (EWAS) of Depression Trajectories 
EWAS Methods 
For our EWAS analyses, we were particularly interested in the increasing trajectory as 
those individuals show a dramatic increase in depression symptoms from very low during 
pre-adolescence to more severe levels by age 18. In order to test whether youth whose 
symptoms of depression increased across adolescence were biologically distinct from 
those with stable low or moderate symptoms, we compared patterns of DNA methylation 
(1) at birth and (2) in adolescence for the increasing versus low trajectories and for the 
increasing versus moderate trajectories. In order to increase power in our EWAS 
analyses, we also combined the increasing and moderate/decreasing trajectories to form a 
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high group and compared patterns of DNA methylation to the low group. Thus, we 
conducted 6 EWAS in total. In addition, as supplementary analyses, we also ran a more 
“traditional” case-control design EWAS using depression at a fixed time point (age 17.5). 
We used the clinically significant SMFQ cut point of 11 to categorize participants into 
depressed (N = 173) and non-depressed groups (N = 567) and compared patterns of DNA 
methylation at birth and in adolescence.  
 Due to the large size and subsequent processing burden of the data (i.e. 485,000 
data points per individual for 1,000 individuals across 2 time points), initial data cleaning 
and variable derivation was conducted using the University of Pennsylvania School of 
Arts and Sciences high performance computing cluster in which “jobs” were submitted 
using Linux code to run on multiple computers simultaneously. Once data were cleaned 
and processed, EWAS analyses were able to run on a personal computer. EWAS analyses 
were performed using a general linear model using the ‘CpG assoc’ package 
implemented in R. All analyses controlled for sex, cell type proportion (as described in 
the Introduction), and sample ID for additional batch effect controls. As described in the 
Introduction, probes known to be polymorphic or cross-reactive were removed prior to 
analysis. In addition, participants with non-Caucasian or missing ethnicity (based on self-
reports, n = 28) were removed prior to the analysis to control for race/ethnicity effects on 
DNA methylation. Analyses using DNA methylation at birth included the following 
covariates that potentially have effects on DNA methylation levels in cord blood: infant 
birthweight, mother’s age, infant gestation length, mother’s alcohol, marijuana, and 
cigarette use during pregnancy. Analyses using DNA methylation in adolescence 
included the following covariates: adolescent marijuana and cigarette use.  
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  An EWAS essentially entails conducting hundreds of thousands of linear 
regressions at one time. If 485,000 CpG sites are being interrogated, around 1/20 or 
20,000 can be false positives (i.e. significant hits that are significant by chance and not 
due to underlying biological differences) due to Type 1 error if using traditional α = 0.05 
thresholds. The multiple comparison problem in epigenome-wide analyses is most often 
addressed through Benjamini & Hochberg’s (1995) false discovery rate (FDR) 
correction, which estimates and controls for the proportion of false positives in an 
analysis. We utilized the FDR correction in all our analyses (q <.05). Because DNA 
methylation analyses yield very small effect sizes, statistical power to detect those small 
effects is always a concern. It is likely that low statistical power results in some number 
of relevant CpG hits that do not cross the threshold of significance after FDR correction. 
Therefore, many researchers report hits that are approaching significance. We used the 
most liberal genome-wide threshold proposed in the literature ( ) to identify hits 
we label as nominal (Rakyan et al., 2011). Hits below this liberal threshold are less likely 
to be true hits not detected due to power concerns. Once FDR-corrected differentially 
methylated CpG sites or “hits” are identified, individual linear regressions are performed 
comparing mean methylation levels on that CpG site between trajectory groups to extract 
more specific regression statistics including standardized betas, standard error, and 
adjusted R values. CpG hits are then mapped to their respective gene sites through 
extensive probe annotation available from Illumina that includes probe location within 
genes (annotated by University of California, Santa Cruz (UCSC) Genome Browser 
(http://genome.ucsc.edu; UCSC Genome Bio- informatics, Santa Cruz, CA, USA), CpG 
islands and shores, and regulatory features.  
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 As with genome-wide association studies, epigenome-wide statistical inflation 
resulting in increased rates of false positive is also of concern. High genomic inflation is 
thought to be caused by population stratification, technical batch effects, sample quality, 
and unknown relatedness between samples (Devlin & Roeder, 1999). Usually, the 
inflation is quantified using the genomic inflation factor (λ), which is defined as the ratio 
of the median of the empirically observed distribution of the test statistic to the expected 
median. Therefore, the lambda is used to calculate the deviation of a distribution of 
residuals from a null distribution. A genomic inflation factor of 1.0 or lower reflects no 
evidence of inflation while increasing values reflect inflation. Researchers also often 
visually inspect quantile-quantile (QQ) plots that are able to graph the deviations of the 
observed distribution from the expected null distribution.  
Results: DNA Methylation at Birth.  
High Versus Low Trajectories. At birth, no probes were differentially 
methylated 
between the high (increasing + moderate) versus low trajectories after FDR correction, 
nor were any probes approaching significance.  
 Increasing Versus Low Trajectories. At birth, no probes were differentially 
methylated between the increasing and low trajectories after FDR correction when 
controlling for smoking, alcohol, and marijuana use during pregnancy as well as birth 
characteristics, sex, cell type, and plate number. One probe, cg08214693 was 
approaching significance but still did not meet nominal significance cut-offs. 
Cg08214693 was hypomethylated in the increasing trajectory and was annotated to 
SCRIB (scribbled planar cell polarity protein). See Table 6 for more details. Absolute 
mean percentage methylation between the increasing and low trajectory groups was 
 58 
1.3%. Inspection of the QQ plot (Supplementary Figure 4) and a lambda statistic of 0.79 
provided little evidence of inflation of test statistics. See Figure 7 for manhattan plot of 
EWAS. 
 Increasing Versus Moderate Trajectories. At birth, no probes were 
differentially methylated between the increasing versus moderate trajectories after FDR 
correction, nor were any probes approaching significance. 
Supplementary Analyses. When examining depression at a single time point at 
age 17.5, there were no probes differentially methylated between the depressed and non-
depressed groups after FDR correction, nor were any probes approaching significance. 
Results: DNA Methylation at Adolescence 
 High Versus Low Trajectories. In adolescence, one probe was differentially 
methylated between the high (increasing + moderate) and low trajectories after FDR 
correction when controlling for covariates (See Table 7 for more details). Cg06758781 
was hypomethylated in the high group (q = 0.02) and was annotated to AACS (Activates 
acetoacetate to acetoacetyl-CoA). Inspection of the QQ plot (Supplementary Figure 5) 
and a lambda statistic of 0.856 provided little evidence of inflation of test statistics. See 
Figure 8 for Manhattan graph of results. 
 Increasing Versus Low Trajectories. In adolescence, one probe was 
differentially methylated between the increasing and low trajectories after FDR 
correction when controlling for smoking, marijuana use, cell type, sex, and plate number 
while 6 probes were approaching significance (See Table 8 for more details). 
Cg06460328 was hypermethylated in the increasing group (q = 0.030) and was annotated 
to CBFA2T3 (CBFA2/RUNX1 translocation partner 3). Absolute mean percentage 
methylation between the increasing and low trajectory groups was 2%. All 6 nominal hits 
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were also hypermethylated in the increasing group with methylation differences ranging 
from 1% - 2.5%. See Table 8 for further details. Inspection of the QQ plots 
(Supplementary Figure 6) and lambda statistic of 1.09 provided evidence of some mild 
inflation of test statistics. See Figure 9 for Manhattan graph of results.  
 Increasing Versus Moderate Trajectories. In adolescence, no probes were 
differentially methylated between the increasing versus moderate trajectories after FDR 
correction.  
 Supplementary Analyses. When examining depression at a single time point at 
age 17.5, there were no probes differentially methylated between the depressed and non-
depressed groups after FDR correction, nor were any probes approaching significance. 
Follow-up Regional Analyses 
Data Analysis Plan 
EWAS studies typically interrogate DNA methylation at the individual CpG level. 
Although this is very informative, it does not take into account the broader context of the 
DNA methylation status of its neighboring CpG sites, as sometimes a gene is not turned 
on and off by the action of a single CpG site but rather a cluster of CpG sites in close 
proximity to one another through co-methylation. Results have shown moderate levels of 
correlations (0.25-0.40) in proximal CpG sites up to a distance of 1kb apart and no 
significant correlations once inter-pair distances reach around 2kb (Saffari et al., 2018). 
Therefore, researchers have started to additionally interrogate differentially 
methylated regions (DMRs) as complementary analyses to EWAS. This region-based 
approach is statistically more powerful with a lower rate of false positive findings and has 
the potential to be more biologically informative than individual CpGs. Many 
bioinformatic packages to interrogate DMRs are available. We utilized the DMRcate 
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package in R (Peters et al., 2015), which identifies and ranks the most differentially 
methylated regions across the genome. It is a data-driven agnostic approach that does not 
favor known annotated genomic regions (i.e. known CpG islands) and has the ability to 
assess all 450k probes.  
First, estimates of differential methylation at individual CpG sites are derived 
using the limma package in R (this package is similar to CpGassoc used for the single 
CpG site EWAS). Identical covariates to the EWAS were used in all regional analyses. 
The corresponding t-statistic obtained with each probe’s beta value is utilized in the 
DMR-finding function to which a Gaussian kernel smoothing method is applied. A kernel 
smoother is a statistical technique used to estimate the real value of a function as the 
weighted average of neighboring observed data. The weight is defined by the kernel, 
meaning that closer points are given higher weights. A Gaussian kernel is a kernel with 
the shape of a Gaussian or normal distribution curve. The length of the nucleotide region 
can be user specific, though the authors of the package suggest a bandwidth of 1000 
nucleotides (lambda = 1000) and a scaling factor of 2 (C = 2; at least 2 CpG sites in a 
region). Significant p-values were again FDR-corrected for multiple testing. Data output 
consists of significant regions ranked by their corresponding p-values as well as genomic 
coordinates and gene associations.  
Results: Regional Analyses with DNA Methylation at Birth 
            Using DNA methylation analysed at birth, no regions were differentially 
methylated in either high (moderate + high) versus low, increasing versus low, or 
increasing versus moderate analyses.  
Results: Regional Analyses with DNA Methylation in Adolescence 
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 High Versus Low Trajectories. In adolescence, regional analyses identified 1 
differentially methylated region using the fully adjusted model (q <0.05). See Table 9. 
This region was mapped to the Small Nucleolar RNA (SnoRNA) family of non-coding 
RNAs.  
           Increasing Versus Low trajectories. In adolescence, regional analyses identified 
3 differentially methylated regions using the fully adjusted model (q <0.05). See Table 
10. These regions were mapped to Zinc Finger and BTB Domain Containing 44 
(ZBTB44), Bladder Cancer-Associate Protein (BLCAP), and the Small Nucleolar RNA 
(SnoRNA) family of non-coding RNAs. 
           Increasing Versus Moderate Trajectories. No regions were differentially 
methylated between the increasing and moderate trajectories.  
Discussion of Genes Implicated in EWAS and Regional Analyses  
Utilizing the ALSPAC longitudinal cohort to extract latent class trajectories of 
depression symptoms, we conducted EWAS analyses using DNA methylation obtained at 
birth and during mid-adolescence. To examine potential fetal programming effects, we 
assessed whether DNA methylation patterns present at birth differentiated the increasing 
trajectory class compared to the low and moderate/decreasing trajectory classes. In our 
birth EWAS analyses, the closest hit to significance (q = .074) was annotated to the 
SCRIB gene and hypomethylated in the increasing group compared to the low depression 
group. The SCRIB gene is a scaffold protein that is part of a pathway of genes called the 
Scribble complex that is involved in cell migration, cell polarity (i.e. spatial differences in 
shape, structure, and function of a cell), and cell proliferation in epithelial cells (Anastas 
et al., 2012). Loss of cell polarity is a hallmark of epithelial cancers and therefore 
regulators of polarity are hypothesized to play a major role in suppression of 
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tumorigenesis. Recent studies have shown that increased expression on SCRIB is related 
to adverse clinical outcomes in breast cancer and that reducing its expression reduced the 
growth of human breast cancer cells (Anastas et al., 2012). A recent EWAS of depression 
symptomatology measured in an elderly cohort of 742 monozygotic Danish twins, also 
identified 3 CpG sites mapped to the SCRIB gene in regional analyses that were 
differentially methylated in the depressed group (Starnawska et al., 2019). Interestingly, 
the SCRIB gene was not in our top 50 hits in our EWAS using DNA methylation in 
adolescence. Results of this hit are presented for informational purposes. However, this 
CpG site did not reach even more liberal nominal level of significance and therefore 
should be interpreted with caution.  
Although research on externalizing disorders such as ADHD, conduct problems, 
and ODD (Barker et al., 2018; Cecil et al., 2018; Neumann et al., 2019; van Mil et al., 
2014) have shown robust association with DNA methylation at birth, much less is known 
about fetal programming effects of internalizing disorders  To our knowledge, this was 
the first study to assess whether DNA methylation profiles at birth can predict depression 
outcomes later in development. Interestingly, our analyses did not show any potential 
fetal programming effects. It is possible that prenatal risks may be embedded more 
broadly as traits and predispositions (i.e. emotional reactivity) that may be exacerbated by 
the psychological, behavioral, and physiological consequences of the trait including 
emotion dysregulation, difficulty in social relationships, and unhealthy coping behaviors 
throughout childhood. This can culminate in development of depression in adolescence 
triggered by more specific developmental demands during this sensitive period, which 
includes a multitude of neural and hormonal changes. This is supported by the fact DNA 
methylation studies examining prenatal stress and more trait-like features in infancy find 
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robust results (Appleton et al., 2015; Conradt et al., 2013b; Monk et al., 2016), and the 
fact that the prevalence rates of depression in childhood is rare and increases dramatically 
in adolescence (Hankin et al., 2015b). In addition, disorders like ADHD and ODD 
manifest much earlier in childhood, while the incubation period for depression is much 
longer, and therefore may include more downstream cascading effects that are 
unmeasured. More research is needed to elucidate the potential fetal programming effects 
that underlie internalizing disorders via DNA methylation mechanisms. 
 Given the dearth of EWAS studies of depression occurring in adolescence, we 
also examined whether DNA methylation in mid-adolescence predicted depression 
trajectory groups. When collapsing the two clinically significant depression groups 
(increasing and moderate/decreasing) into one “high” category and comparing it to the 
low group for a more powerful analysis, one CpG hit annotated to the AACS gene was 
significant even after correction for multiple testing and hypermethylated in the “high” 
group. No other depression EWAS has identified this gene. AACS is hypothesized to be 
involved in utilizing ketone body (i.e. energy source that is mainly produced in the liver) 
for fatty acid-synthesis during adipose tissue development (Hasegawa et al., 2012). High-
fat diet obesity has been shown to induce unusual metabolism of ketone bodies through 
inflammatory mechanisms (Puchalska & Crawford, 2017). Research on the expression of 
AACS is scant and exclusively has been assessed in animal models. Interestingly, one 
study has shown increased expression of AACS as a result of inflammatory mechanisms 
due to a high fat diet (Yamasaki et al., 2016) 
 Our results did not show DNA methylation differences between the increasing 
and moderate trajectory. There was one CpG site that was nominally significant but not 
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annotated to a specific gene and therefore the function of this differential methylation in 
largely unknown.  
When comparing the increasing trajectory group to the low group, one CpG hit 
annotated to the CBFA2T3 gene was significant even after correction for multiple testing 
and was hypermethylated in the increasing group. No other depression EWAS has 
identified this gene. The CBFA2T3 gene is responsible for transcription repression. 
Research has shown that the expression of CBFA2T3 was significantly reduced in breast 
cancer cell lines and breast tumors and CBFA2T3 has emerged as a candidate gene of 
breast cancer tumor suppression (Kochetkova et al., 2002; Kumar et al., 2006).  
Additionally, there were 6 CpG hits that were nominally significant (p < 1 x 106) 
that were annotated to 6 genes: LRTOMT (Leucine Rich Transmembrane And O-
Methyltransferase Domain Containing), NUMA1 (Nuclear Mitotic Apparatus Protein 1), 
LDB1 (LIM Domain Binding 1), USF2 (Upstream Transcription Factor 2, C-Fos 
Interacting), HEY2 (Hes Related Family BHLH Transcription Factor With YRPW Motif 
2), and BLCAP (BLCAP Apoptosis Inducing Factor). Not much is known about the 
specific biological mechanism of LRTOMT except that it is an O - methyl transferase 
heavily implicated in the morphology and physiology of ear development and its 
mutation has been consistently studied as leading to autosomal recessive non-syndromic 
hearing loss (i.e. non-specific genetic hearing loss) (Charif et al., 2012; Taghizadeh et al., 
2013; Vanwesemael et al., 2011). NUMA1 is also an understudied gene that codes for the 
spindle protein NuMA; spindle fibers form a protein structure that divides the genetic 
material in a cell (Quintyne et al., 2005). Only one study has assessed expression of 
NUMA1 directly and linked increased expression to epithelial ovarian cancer due to its 
role in aneuploidy (i.e. presence of an abnormal number of chromosomes in a cell, as 
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often seen in cancer cells) (Brüning-Richardson et al., 2012). However, more research 
needs to be done to elucidate whether NUMA1 is consistently involved in carcinogenesis. 
LDB1 is a transcription cofactor (i.e. modulates the effects of transcription factors 
by recruiting other proteins for binding). It is part of a complex that maintains the 
function of erythroid cells (i.e. most common blood cell and principal means of 
delivering oxygen to the body tissues via blood flow through the circulatory system) 
through transcription activation (Matthews & Visvader, 2003). Due to its role in 
modulation of transcription factors it has been studied in the context of cancer 
progression. Studies have shown that overexpression of LDB1 is associated with negative 
prognosis factors in colorectal, head, and neck cancer (García et al., 2016; Simonik et al., 
2016).  
USF2 (and its counterpart USF1) are transcription factors (i.e. proteins that bind 
to the DNA sequences of their target genes and participate in the regulation of a large 
number of genes) and part of the basic helix-loop-helix (bHLH) class. USF2 in particular 
appears to be crucial for embryonic development, brain function, metabolism, iron 
homeostasis and fertility while USF1 has more specific roles in metabolism and immune 
system functioning (Horbach et al., 2015). Recent research suggests that deregulation of 
transcription factors can cause tissue damage and suggests a major role for transcription 
factors in the inappropriate growth of cancer cells. In fact, the USF genes seem to exhibit 
a tissue protective and tumor suppressive function in several cancer types (Horbach et al., 
2015). Most consistently, downregulation of USF2 has been linked to the proliferation of 
breast and prostate cancer (Chen et al., 2006; Ismail et al., 1999; Kivinen et al., 2004; Tan 
et al., 2019). Similarly to USF2, HEY2 is a bHLH transcription factor, involved primarily 
in the regulation of cell differentiation of the cardiovascular system and the heart itself 
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(Iso et al., 2002). Increased expression of HEY2 has been linked to the progression of 
prostate, liver, and pancreatic cancer (Cavard et al., 2009; Tradonsky et al., 2012; Wu et 
al., 2016). One 
EWAS comparing 20 medication free patients with MDD and 19 control subjects (Mage 
= 44) found 363 differentially methylated CpG sites after FDR correction for multiple 
testing, one of which was annotated to HEY2. However, it is important to note that the 
study did not correct for cigarette smoking and most importantly did not control for cell-
type heterogeneity which greatly limits our ability to identify this as a true replication.  
 Finally, the BLCAP gene encodes a protein that reduces cell growth by 
stimulating apoptosis (i.e. cell death) and is hypothesized to play a major role in the 
regulation of tumor cell proliferation and survival. Studies have shown that decreased 
expression of the BLCAP gene was associated with the progression of cervical, renal, 
bladder, and tongue cancer tissue, and conversely increased expression in breast cancer 
tissues (Gromova et al., 2012). This gene was also implicated in regional analyses (6 
CpG sites) comparing the increasing to low trajectory group suggesting that it may be the 
most consistent finding in our EWAS though it only reached nominal significance in the 
single CpG site analysis.  
In addition to BLCAP, two other differentially methylated regions were identified 
in regional analyses. Two CpG hits were identified on the ZBTB44 gene. Not much is 
known about the ZBTB44 gene, except that it is primarily involved in transcription 
regulation and nucleic acid binding (www.genecards.org). Four CpG sites were identified 
in a region composed of several small nucleolar RNAs (snoRNAs). snoRNAs are a type 
of non-coding RNA (i.e. RNA transcripts that never get translated to protein and 
consequently are never expressed). For a long time, non-coding RNA have been 
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considered as cellular housekeeping maintenance molecules or “junk DNA” due to their 
non-coding nature. However, recent research has demonstrated that in addition to DNA 
methylation and histone modification, non-coding RNAs are essential mechanisms of 
epigenetic changes and function as post-transcriptional modulators of gene expression, 
especially during development and disease progression (Peschansky & Wahlestedt, 2014; 
Watson et al., 2019; Wei et al., 2016). snoRNAs are crucial for ribosomal RNA (rRNA) 
maturation and functionality (Gaviraghi et al., 2019). Because hyperactive ribosomal 
biogenesis is widely observed in cancer, an increasing body of work has linked increased 
expression of snoRNAs to renal, colorectal, lung, prostate, and breast cancer (Baral et al., 
2018; Gao et al., 2015; Mannoor et al., 2014; Martens-Uzunova et al., 2015; Okugawa et 
al., 2017; su et al., 2013). 
CHAPTER 8: A Longitudinal Epigenome-wide Analysis of Depression Trajectories 
in Adolescence (Part 4) 
Gene Networks and Functional Enrichment Analyses 
Methods 
 After decades of genomic research, it is now best understood that genes often act 
in concert with each other rather than in isolation. It has been increasingly apparent that 
the function of a single gene cannot explain genetic liability for phenotypically complex 
biomedical and psychological disorders that are most likely the result of polygenic 
interactions. A list of differentially methylated genes or regions, although informative, 
does not describe how genes may be acting in unison with each other and other 
unidentified genes to confer risk. To assess whether the genes identified in our analyses 
are related to one another, we inputted them in a bioinformatic webserver called 
GeneMANIA (http://www. genemania.org). GeneMANIA mines all publicly available 
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biological datasets of all mapped genes in the human genome to create genetic networks. 
Researchers can input a list of genes into the server to examine any possible connections 
between genes using this comprehensive literature review. Gene networks are compiled 
based on several categories including: (1) co-expression; genes are linked if their 
expression levels are similar across conditions in gene expression studies, (2) physical 
interaction; genes are linked if their proteins are known to physically interact, (3) gene 
interaction; genes are linked if the expression of one gene depends on the 
presence/absence of another, (4) shared protein domains; genes are linked if they code for 
the same protein domain, (5) co-localization; genes are linked if they are both expressed 
in the same tissue or if their gene products are both identified in the same cellular 
location, (6) pathways; genes are linked if they participate in the same reaction within a 
pathway, and finally (7) predicted; genes are linked if they have similar functional 
mechanisms. Once a list of genes is inputted into the server, a network is created based 
on those seven categories. The weighting of connections between genes is chosen 
automatically using linear regression to make genes on the inputted list interact as much 
as possible with each other, and as little as possible with genes not in the inputted list. 
The network weighting prioritizes gene-ontology, where genes are connected based on 
similar biological functions. For more detailed description of network bioinformatics see 
Mostafavi et al., 2008 and Warde-Farley et al., 2010. 
In order to better understand the underlying biological processes of the gene 
network, GeneMANIA also provides functional enrichment analyses using Gene 
Ontology (GO) categories. Similarly, GeneMANIA mines the GO database, which is a 
bioinformatics initiative to categorize a vocabulary of known genes and their products 
into an organized graph structure describing what is known about the biological function 
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of known genes. GeneMANIA compares the functional profile (i.e. biological pathway 
describing the cellular or physiological role) of the inputted gene set to the functional 
profiles described by GO to examine whether the network is significantly enriched for 
particular functions. Functional enrichment analyses also use the FDR (q < .05) 
correction for multiple testing.  GO analyses provide the number of genes in the network 
that are implicated in a biological process out of the total number of genes identified in 
that process in the literature (i.e. coverage).  
The comparison of DNA methylation values in adolescence in the increasing 
versus low trajectories produced multiple hits that were annotated to multiple genes (1 
FDR corrected significant, 6 nominally significant). We ran gene network and functional 
enrichment analyses using genes obtained from these comparisons. snoRNAs are not 
genes and therefore were not inputted in the analysis. In exploratory analyses, we wanted 
to examine the addition of AACS, a significant hit in the combined “high” versus low 
trajectory groups to assess whether it is biologically connected to those genes annotated 
in the increasing versus low trajectory group analyses.  
Results: Description of the Gene Network 
Results of inputting annotated genes into the network analysis showed that rather 
than acting in isolation, these genes form a compact cluster network based on known 
genetic and physical interactions, shared pathways and protein domains as well as protein 
co-expression data. See Figure 10 for visual representation of the gene network. In gene 
ontology analyses, the most enriched gene ontology biological functions were related to 
sequencing specific DNA binding, bhlh transcription factor binding, and cardiac 
development, which corresponds to our literature review of annotated genes. See Table 
11 for comprehensive gene ontology descriptions.  
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Interestingly, ZBTB47, a gene identified in regional analysis but not the EWAS, 
emerged as part of this network though a physical reaction with CBFA2T3. LRTOMT 
and NUMA1 were only tangentially related to the network while CBFA2T3, HEY2, 
USF2, BLCAP, and LDB1 formed a tighter “cancer gene” cluster. This makes sense as 
the biological function of LRTOMT and NUMA1 is still largely unknown. Because 
network analyses use existing data to create connections between genes, this does not 
necessarily mean that LRTOMT and NUMA1 are unrelated to this cancer network, but 
rather more research is necessary to elucidate their function. LRTOMT and NUMA1 
were related through co-expression which is consistent with our data as a single CpG hit 
was annotated to both genes suggesting they are in close proximity. They are connected 
to the network through NUMA1 and LDB1 co-expression, which suggests that they are 
potentially biologically relevant to the cancer network. Interestingly CBFA2T3, the only 
FDR corrected significant hit, appeared to be central to the 5-gene cancer network and 
was connected to USF2, BLCAP, LDB1 through predicted connections. HEY2 is 
connected to the network through genetic interactions with BLCAP and USF2, which 
makes sense as HEY2 and USF2 both regulate transcription factors.  
In exploratory analysis, we assessed the role of AACS, the FDR corrected 
significant hit from analyses comparing the combined “high” group to the low trajectory 
group, in the gene network. AACS did not appear to be relevant to the cancer gene 
network and was only related to CBFA2T3 through a small genetic interaction (See 
Figure 11). The fact that AACS was not part of the cancer gene network associated with 
the increasing trajectory could suggest that epigenetic correlates of depression that 
increases throughout adolescence are distinct from epigenetic correlates of symptoms of 
depression that are moderately high throughout adolescence (as seen in the combined 
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increasing and moderate/decreasing groups). On the other hand, there is much less 
research on the biological function of AACS compared to other genes in the network and 
AACS may be more centrally implicated than these analyses show.  
Broader Discussion of EWAS, Regional, and Gene Network Analyses 
 Overall, our results demonstrated a link between genes implicated in cancer 
genesis and progression and individuals who demonstrated increasing levels of 
depression symptoms as they progressed through adolescence. The prevalence of 
depression in patients with various types of cancer exceeds that observed in the general 
population and is associated with a poorer prognosis and higher mortality rate Pasquini & 
Biondi, 2007). This of course makes intuitive sense; individuals faced with a life-
threatening illness and painful treatment would be more likely to develop depression as a 
result. However, there is a body of research that suggests that increased depression 
prevalence is not solely a reaction to the socioemotional and physical stress after a cancer 
diagnosis and posits that there may be a bi-directional relationship between depression 
and cancer with common underlying pathophysiology.  
Whether depression earlier in life can be conceptualized as a risk factor for 
developing cancer later on has long been debated. Several large-scale longitudinal 
epidemiologic studies have reported significant associations between depression 
symptoms and subsequent development of cancer (Dalton et al., 2002; Penninx et al., 
1998), and some have not (Kaplan & Reynolds, 1988; Zonderman et al., 1989). A meta-
analysis using eight longitudinal, population-based studies found a small but significant 
increased risk for cancer among depressed individuals (relative risk = 1.19) (Oerlemans 
et al., 2007). The most dominant theory of shared underlying pathophysiology is chronic 
inflammation, followed by lesser studied hypotheses of malfunctions in DNA repair.  
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 Chronic inflammation propagates increased wear and tear on several biological 
systems in the body impairing their functions. In terms of cancer, impaired functioning of 
immune cells, most specifically, natural killer (NK) cells creates a immunosuppressive 
environment that promotes tumor growth; it has now been evident that an inflammatory 
microenvironment is an essential component of all types of tumors (Baniyash et al., 2014; 
Grivennikov et al., 2010). Because pro-inflammatory responses over-activate the HPA, 
the main mechanism through which cortisol shuts down and inflammatory response, 
chronic inflammation has been widely studied as both a result of and precursor to 
depression (Miller et al., 2009; Moriarity et al., 2020; Raison & Miller, 2011, 2013; Su, 
2012). For example, one meta-analysis found that chronic inflammation preceded the 
development of depression even after controlling for a wide range of factors associated 
with risk for depression (Valkanova et al., 2013).  
 It has also been hypothesized that psychosocial stress may have a negative impact 
on DNA repair and cell apoptosis which leads to the initiation and production of 
abnormal cells, a primary drive of induction of tumor growth and spread (Kiecolt-Glaser 
et al., 2002). Stress may decrease the ability of DNA repair enzymes, like 
methyltransferase, in carrying out maintenance tasks of tumor suppression.  
 Our pattern of results potentially supports both of these two theorized biological 
mechanisms in different ways. The implication of the AACS gene (with a theorized 
critical function in adipose tissue development and consequently obesity) when 
comparing individuals with any depression in adolescence compared to individuals with 
none suggests that underlying inflammatory mechanisms may differentiate the two 
groups broadly. This is supported by a vast literature demonstrating the link between 
obesity and depression (for several reviews and meta-analyses see: (Atlantis & Baker, 
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2008; Blaine, 2008; de Wit et al., 2010; Luppino et al., 2010). This pattern of results may 
be due to the addition of the moderate/decreasing group whose sustained high levels of 
depression even pre-adolescence may better predict or reflect more chronic activation of 
the immune system. However, it is important to note that no other genes directly related 
to the immune system were implicated suggesting more research needs to be done on the 
function of AACS in the context of depression.  
When examining the increasing group specifically, no genes directly implicated in 
inflammatory processes were identified and instead a cluster of genes heavily implicated 
in cancer genesis emerged. Many of the biological function of those genes were DNA 
repair and apoptosis and several have been identified as tumor suppressing genes. 
However, these results should not serve as a definite evidence for the implication of 
cancer related processes underlying the development of depression. The relationships 
between inflammation, DNA repair processes, depression, and cancer are likely to be 
infinitely complex as both disorders involve the maladaptive disruption of multiple 
biological systems and can reflect a wide range of risk factors. In addition, our analyses 
used peripheral blood to obtain DNA methylation levels and most studies assessing 
expression of our identified genes used target tissues (colon, pancreas, breast). DNA 
methylation patterns are tissue-specific (see broader discussion on page 78) and therefore 
we cannot make definitive conclusions on the concordance of DNA methylation and 
expression of these genes in the blood versus in target tissue during tumor growth. 
However, based on review of gene databases (e.g. genecards), all genes annotated in our 
analyses are as expressed in the blood as in other tissues and are hypothesized to have 
immune system functioning roles. Most importantly, gene annotations are only as 
comprehensive as the research that informs them. Cancer research dominates the research 
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on the functional role of thousands of genes including the ones identified in our analyses. 
It is possible that annotated genes have other functions that many be related to 
psychological phenotypes in different ways. More research on the functional role of 
genes beyond the context of cancer is necessary for more comprehensive understanding 
of novel hits in EWAS.  
Limitations 
There are several additional limitations of the EWAS design that should be noted. 
EWAS is frequently underpowered due to a combination of very small effect sizes (see 
more in-depth discussion on page 80), punitive multiple test corrections, and small 
sample sizes due to data availability and the cost of microarray assays. No formal power 
analyses for EWAS exist, however, some studies have tried to estimate sufficient sample 
size for adequate power using data stimulations. Tsai and Bell (2015) found that in a 
case-control design, N = 1,000 (or 500 pairs) was necessary to detect DNA methylation 
differences between 0-5% in terms of genome-wide significance at 80% power; N = 200 
was necessary in monozygotic twin designs. Our sample size is one of the largest seen in 
EWAS (birth EWAS: low = 662, increasing = 94, moderate/decreasing = 74; adolescent 
EWAS: low = 720, increasing = 77, moderate = 64). However, group membership was 
heavily skewed towards the low depression trajectory and therefore, our analyses might 
not have been adequately powered. Issues of power likely contribute to EWAS 
replication difficulties similar to those seen in GWAS.  
There are also several limitations of our specific study in particular. First, we 
were unable to control for antidepressant use in our study. Research has shown that 
antidepressants may affect DNA methylation of certain sites in candidate genes such as 
BDNF, SLC6A4, HTR1A and HTR1B (Serotonin receptor 5HT1A subtype variants), 
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IL11 (interleuken-11), as well as more global whole genome changes (for recent 
systematic review see Webb et al., 2020). It is possible that individuals in the increasing 
group trajectory were more likely to use antidepressants throughout adolescence. 
Therefore, DNA methylation differences found in the increasing symptom trajectory may 
be confounded by anti-depressant effects on DNA methylation. Second, we measured 
DNA methylation at age 15.5 and did not have DNA methylation data available at 
baseline at age 12.5. This may be especially important for the increasing trajectory group, 
where individuals were not experiencing clinical symptoms of depression at ages 12.5 
and 13.5. Although it can be argued that we may be tapping into an epigenetic pathway 
that has already been calibrated earlier on, we could not completely rule out issue of 
reverse-causation. Third, depression is a heterogenous disorder that is often co-morbid 
with other psychological disorders. Because we did not assess for co-morbidity, it is 
unclear if our trajectory groups differed on prevalence of related psychopathology further 
obscuring DNA methylation results. Future epigenetic research should focus less on 
specific psychiatric diagnoses and instead emphasize broad trait-level vulnerabilities, 
such as emotion dysregulation or impulsivity. Further discussion on clinical phenotypes 
in behavioral epigenetic research is on page 81. Fourth, we did not control for the 
presence of other biomedical disorders especially those related to inflammatory processes 
including cancer, Type II diabetes, or cardiovascular disorder, though prevalence rates of 
diseases associated with aging in adolescence is very low. Finally, due to issues of power, 
we were not able to stratify our sample by gender though it was controlled for at every 
level of analysis. Given the 2:1 depression gender ratio that emerges in adolescence and 
the differential hormonal changes related to puberty for teenage girls, it is highly likely 
that underlying epigenetic mechanisms for depression may be gender-specific, especially 
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for those girls with increasing depression symptoms over time. The need for higher-
powered gender specific EWAS for depression is compounded by the fact that our most 
significant hit, that was also central to the cancer gene network, has been consistently 
identified as a breast cancer tumor suppressor.  
CHAPTER 9: Thesis Discussion 
The Tissue Issue 
One of the most salient debates in the viability of using DNA methylation to 
understand complex psychological phenotypes is the “tissue issue.’ DNA methylation 
profiles are tissue-specific, which means that each tissue (e.g. blood, brain, skin) has its 
own unique DNA methylation profile as part of normative tissue differentiation. Since 
most behavioral epigenetic studies utilize peripheral tissue, most commonly blood, a 
major debate is whether peripheral tissue samples have utility for the study of disorders 
that are thought to be primarily manifest in the brain. Simply put, does DNA methylation 
that we observe in the blood, have anything to do with what is going on in the brain? One 
study sought to characterize intra- and inter-individual methylome variation across whole 
blood and multiple regions of the brain (Davies et al., 2012). They found that DNA 
methylation at CpG island around promoter sites was largely conserved between blood 
and brain regions, while CpG shores and intragenic regions showed tissue-specific DNA 
methylation differences. Most strikingly, inter-individual DNA methylation differences 
found in the blood were correlated (p < 0.001) with inter-individual differences in the 
brain (correlation = 0.76 in the cerebellum and 0.66 in the cortex). This means that 
differential DNA methylation patterns between two individuals that are detected in 
peripheral blood are also present in the brain suggesting that peripheral tissues are still 
relevant despite tissue-specific DNA methylation patterns. Similarly, another study found 
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that interindividual variation in DNA methylation are highly correlated between whole 
blood and brain when probes are in CpG promoter regions (Hannon et al., 2015). 
However, they found that interindividual variation in DNA methylation between blood 
and brain exists in 1-3% of 450k probes and warned against using blood DNA 
methylation patterns as proxies for DNA methylation in the brain. It is important to note 
that DNA methylation differences as assessed by candidate gene studies are often 
substantiated with similar patterns in post-mortem brain samples, albeit not within the 
same individual (e.g. Keller et al., 2010; Labonte et al., 2012; McGowan et al., 2009; 
Stenz et al., 2015) 
Although DNA methylation patterns in the blood may not always be aligned with 
DNA methylation patterns in the brain, we argue that peripheral tissues can still provide 
useful information about etiology of psychopathology. Peripheral tissue types may seem 
irrelevant under the assumption that psychological disorders are primarily disorders of 
the brain and are the result of dysfunction of neural circuitry. However, there has recently 
been an explosion of research exploring the connection between the immune system, 
chronic inflammation, and psychological disorders beyond depression (for various 
reviews see Mitchell & Goldstein, 2014; Renna et al., 2018, 2018; Su, 2012; Monica 
Uddin & Diwadkar, 2014). Similarly, a new research base focusing on the 
gastrointestinal system has linked altered gut microbiome functioning to psychological 
disorders as well (for reviews see Groen et al., 2018; Mayer & Hsiao, 2017; Nguyen et 
al., 2018). Perhaps psychological disorders are caused by disruptions in multiple body 
systems in addition to the brain and the traditional dichotomy between mind and body 
should be reconceptualized when thinking about disease etiology. Peripheral tissue may 
not be an exact proxy for brain processes but can instead be thought of as a window to 
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disrupted pathways in other body systems that interact with, are a consequence to, or a 
precursor to processes in the brain.  
Furthermore, even if large scale access to post-mortem brain tissue was easier and 
sample size was not an issue, there are other considerations to take into account about the 
limitations of brain tissue sampling. First, one cannot rule out the profound effects that 
death can have on DNA methylation patterns in the brain, especially if death was 
traumatic or due to illness. Second, post-mortem samples will not tell us anything about 
the etiology of psychological disorders and how they unfold over time during sensitive 
periods of development. Third, if the hope is that DNA methylation will one day be a 
biomarker for either the onset of psychological disorders or as evidence of wear and tear, 
it must be easily and reliably accessed. It is likely that blood-based epigenetic studies will 
continue, and emerging evidence suggests that limitations to this approach can be 
surmountable, though confirmation in brain tissue remains important.  
Effect Size 
 While epigenetic studies in cancer and other disorders typically manifest DNA 
methylation differences of ~20% when comparing cases and controls, studies in 
behavioral epigenetics examining psychological phenotypes often have effect sizes 
ranging from 1-10% and sometimes even smaller differences are reported. Similarly, our 
studies reported mean DNA methylation differences in the range of 1-2%. It has been 
posited that large changes in DNA methylation as a result of stress would hinder any 
possible social-emotional development in the same way that DNA methylation leading to 
cancer renders the tissue completely lost of its normative function and as a result, large 
effect sizes are not to be expected when assessing stress and psychopathology (Breton et 
al., 2017).  
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Furthermore, is important to note that there is usually a strong statistical 
significance reported with these small differences, suggesting that even though the effects 
are small, there is little variability in the measured values. An important example of this 
is the robust literature linking maternal smoking during pregnancy and DNA methylation 
in infant blood where effect sizes range from 1-13% (Breton et al., 2017). It is perhaps 
also useful to recategorize what we see as small effects. Very small changes in DNA 
methylation can have large effects on transcriptional activity. For example, one study 
analyzing the DNA methylation of the imprinted insulin-like growth factor II (IGF2) 
gene in umbilical cord blood, found that for every 1% difference observed in DNA 
methylation, there was a doubling or halving of IGF2 transcription (Murphy et al., 2012). 
Effect sizes are also isolated to DNA methylation differences in one CpG site and the 
collective effect of multiple CpG sites on one gene or across many genes is largely 
unmeasured (to our knowledge, there is no capacity to estimate regional effect sizes. 
Though it is always imperative to question the clinical significance of effect sizes, 
researchers must take into account the context in which they are being examined to truly 
determine if they are relevant. The best way to assess the implications of a difference in 
methylation is to further examine downstream processes such as level of gene expression; 
though this was not available in the ALSPAC cohort.  
Psychological Phenotypes in Behavioral Epigenetics  
Difficulties with EWAS replication have historically been discussed in terms of 
issues with power, technology, and statistical analysis. Less discussed is the likelihood 
that the lack of replication and consequently, any meaningful biological understanding of 
epigenetic pathways that underlie mental health disorders is due to the manner in which 
psychological phenotypes are conceptualized in behavioral epigenetic studies. 
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Psychological constructs are typically treated as categorical disease categories in the 
same vein as biomedical disorders like cancer, but there is little evidence to suggest that 
the actual underlying structure of psychological phenotypes matches that 
conceptualization. In fact, this has been an important debate in the field of clinical 
psychology where the current DSM-5 (Diagnostic and Statistical Manual of Mental 
Disorders – 5) classification of psychological disorders in terms of a categorical disease 
model has been vehemently criticized as ultimately failing to “carve nature at its joints”. 
Extensive heterogeneity and comorbidity demonstrate that diagnoses are more like 
heterogeneous constellations of features in multidimensional space within the context of 
normative human experience and processes (Lilienfeld, 2014). Limiting samples to 
individuals who only meet criteria for one particular psychological disorder or other ways 
to methodologically obtain a “cleaner” experimental phenotype is not reflective of the 
true nature of psychopathology where individuals often meet criteria for multiple 
disorders at one time or have a lifetime history of multiple diagnoses. Our current 
classification of psychological phenotypes may have utility in terms of reliable 
identification and treatment, but it is severely limiting in its ability to study biological 
pathology and etiology and should not be used as the default operationalization of 
phenotypes in behavioral epigenetic studies. If psychological research in epigenetics is to 
be elucidating and fruitful, as much care is to be taken in understanding and 
conceptualizing the phenotype as has been taken to understand epigenetic methodology. 
In these two studies we have attempted to remedy this somewhat by moving 
beyond a case-control design. In study 1, we conceptualized psychopathology using 
confirmatory factor analysis to extract conduct, hyperactivity, emotion problems factors 
as well as a global psychopathology score. In study 2, we conceptualized depression 
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using longitudinal trajectories that take into account change in symptoms over time. 
There are many ways in which the psychological phenotype can be refined in future 
studies for an increased possibility in finding underlying biological pathways. First, as we 
attempted in our first study, psychological phenotypes can be broadened to get at more 
meaningful underlying factors. Research in clinical psychology has found that the 
structure of mental disorders can be potentially summarized by three core 
psychopathological dimensions: internalizing (i.e. liability towards mood disorders like 
depression and anxiety), externalizing (i.e. liability towards impulse and behavioral 
control disorders like ADHD and substance use), and thought disorders (i.e. liability 
towards disordered and disorganized thinking and symptoms of psychosis like 
schizophrenia and bipolar disorder) (Caspi et al., 2014). In behavioral epigenetics, 
psychological phenotypes may be expanded upon into these dimensions with the additive 
bonus of increased sample size and statistical power.  
Disorders can also be grouped in other meaningful ways, for example, 
neurodevelopmental disorders such as autism, ADHD, and schizophrenia may have 
similar underlying epigenetic mechanisms as research has already identified overlap in 
genetic risk among these disorders (Owen et al., 2011). It would also be interesting to 
examine DNA methylation variation on an even broader scale of those who have 
psychopathology and those who have less or not at all. Researchers have posited some 
evidence pointing to one general underlying dimension dubbed the “p factor” that 
described an individual’s propensity to develop psychopathology period, where 
individuals are classified on a low to high psychopathology dimension (Caspi et al., 
2014). It is plausible that epigenetic changes confer risk for psychopathology on a 
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broader scale and lack of replicability may be due to the mistaken assumption that 
different psychological disorders emerge from different epigenetic underpinnings.  
On the other hand, psychological phenotypes could also be narrowed into 
transdiagnostic endophenotypes that are “closer” to underlying epigenetic vulnerability in 
the lengthy pathway between DNA methylation and complex behavioral and emotional 
phenotypes. Endophenotypes can be described as constructs that provide the means for 
identifying the downstream trait or facets of more complex observable behaviors as well 
as the upstream consequences of genetic and epigenetic processes (Gottesman & Gould, 
2003). Although endophenotypes have been more traditionally thought of as simpler 
underlying biological processes (e.g. cortisol reactivity, sensory motor gazing, eye-
tracking, reward learning), that definition has been expanded to include transdiagnostic 
personality traits that underpin psychopathology (e.g. neuroticism, impulsivity). 
Endophenotypes are particularly useful due to the recurring nature of psychopathology in 
a lifespan perspective as they are not state dependent and are more stably manifested in 
the individual whether the psychological disorder is currently present or not (Gottesman 
& Gould, 2003). The endophenotype concept fits within the Research Domain Criteria 
(RDoC) framework, which was developed as an alternative to the DSM classification 
system as a way to organize psychological disorders on transdiagnostic dimensional 
domains (e.g. arousal and regulatory systems, cognitive processes) that focus on 
pathophysiology across several units of analysis (e.g. genetics, physiology, behavior) 
(Insel & Cuthbert, 2009). As discussed previously, studies examining prenatal stress, 
DNA methylation, and infant neurobehavioral outcomes have utilized endophenotypes 
such as cortisol reactivity (e.g. Houtepen et al., 2016; Oberlander et al., 2008; Tf et al., 
2008). There are a few studies who have also examined DNA methylation and its relation 
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to cortisol reactivity later in development (Alexander et al., 2014, 2014; Ouellet-Morin et 
al., 2013). For example, in one EWAS, researchers found that the methylation of one 
locus in the Kit ligand gene (KITTLG) in adults mediated the relationship between 
childhood trauma and cortisol stress reactivity (Houtepen et al., 2016). Although 
endophenotype outcomes in behavioral epigenetic should also be expanded to include 
other measures of cognitive, physiological, and biological functioning, it would also be 
interesting for DNA methylation studies to examine transdiagnostic trait-like 
endophenotypes such as neuroticism (i.e. the tendency to exhibit frequent and intense 
negative emotions) or impulsivity instead of traditional disease model approaches.  
Another consequence of overreliance on the disease model in studying 
psychological phenotypes, is the lack of research on epigenetic pathways that promote 
resilience as well as risk. It is likely that epigenetic mechanisms such as DNA 
methylation play a major role not only in elucidating why some individuals go on to 
develop psychopathology as a result of environmental stress but also why some do not. 
Study 1 of this thesis is an attempt to begin to understand the biological underpinnings of 
resilience to psychopathology in a sensitive period of development, but much more work 
needs to be done in this area. Contrast to the thousands of EWAS and candidate gene 
studies focusing on risk for negative outcomes, there is a lack of a substantial literature in 
understanding the epigenetics of protective factors and resilience to psychopathology. 
There have been a few studies examining the role of DNA methylation to resilience to 
acute stress in animal models (Elliott et al., 2010; Taff et al., 2019; Uchida et al., 2011; 
Wang et al., 2018), but very few exist in humans. There is some preliminary work 
examining resilience to PTSD in combat soldiers. For example, one study found that in 
soldiers with a diagnosis of PTSD, resilience, as measured by a range of coping 
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strategies, was associated with DNA methylation age acceleration suggesting that aspects 
of resilience may come at a biological cost (Mehta et al., 2018). To our knowledge, no 
studies have examined epigenetic mechanisms of resilience to psychopathology in 
childhood and much more work is needed to be done in this area. It would also be 
interesting to examine how protective factors such as social support and maternal warmth 
may alter epigenetic signaling pathways to promote resilience, especially early on in 
development.  
Future Research Directions  
 In addition to more refined clinical phenotypes as outcomes measures and a 
greater focus of resilience and protective factors, more developmentally relevant 
longitudinal designs are needed to push the field forward. However, this is easier said 
than done as most longitudinal cohorts established decades ago could not have foreseen 
the need for more frequent extractions of blood samples to assess temporal timing of 
DNA methylation. Research utilizing longitudinal designs, including the ALSPAC cohort 
in this thesis, is greatly limited by needing to make do with what existing data is 
available. Future launches of longitudinal cohorts may have the benefit of establishing 
designs and timing of assessments that may be more conducive to hypotheses of 
underlying biological mechanisms. Studies with more frequent sampling of DNA 
methylation across a period of time are greatly needed, not only to better establish 
temporal order, but to gain better understanding the timing of epigenetic changes. How 
quickly after stressors can DNA methylation changes be identified? Are they temporary 
fluctuations or more permanent cellular reprogramming phenomena?  
 Additionally, innovated epigenetic designs beyond the traditional candidate gene 
and EWAS case-control samples are necessary. Epigenetic research will be most robust 
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when integrating multiple levels of analysis. The distance between DNA methylation and 
a complex behavioral phenotype is vast and in between lies a number of cascading 
processes. Future research should continue to include multi-omics measures including 
genomics, transcriptomics, metabolomics, proteomics, and imaging data (Lin & Tsai, 
2019).  Furthermore, the polygenic risk score approach that has been utilized in 
application of GWAS data should also be adapted to epigenetic research, given that 
multiple CpG sites of multiple genomic regions are likely acting and interacting in 
accordance with one another.  
 Finally, the interpretation of EWAS is often limited by how little is actually 
known about the biological functioning of newly identified genes as much of what is 
known about gene function is through cancer research. In theory, EWAS are hypothesis 
generating analyses where novel genes implicated in psychological phenotypes are 
discovered. However, there is very little if any follow-up (for example, candidate gene 
analyses) on novel hits in the field of behavioral epigenetics. There are a large number of 
novel genes in many EWAS that have not been more closesly examined. If the field is to 
continue to grow, researchers must conduct more in-depth follow-up analyses on how 
these genes are related to psychological phenotypes.  
Clinical Implications  
The seminal study conducted by Weaver and colleagues (2004), demonstrated in 
an animal model that early life experience became embedded through DNA methylation 
of the GR gene to propagate an anxious phenotype later in life. Perhaps the most striking 
result of this study was that the epigenetic changes were reversible. Central infusion of a 
histone deacetylase inhibitor into the brain effectively removed the methyl tags on the 
GR gene and removed group differences in DNA methylation, GR transcription and 
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expression, hypothalamic-pituitary adrenal (HPA) responses to stress, and most 
importantly, the actual anxious phenotype. Previously anxious mice were now not 
distinguishable from their non-anxious control counterparts. While epigenetic 
pharmacotherapy is an exciting concept in treatment of mental illness, these results 
demonstrate more of a proof of principle rather than possible reality in human 
psychopathology. Current epigenome-editing technology uses DNA methyltransferase 
(DNMT) inhibitors acting on DNA methylation and histone deacetylase (HDAC) 
inhibitors targeting histone post-translational modification (i.e. another mechanism of 
epigenetic mechanisms not discussed in this thesis) (Kular & Kular, 2018). However, in 
humans these modifiers affect DNA methylation globally, exerting broad effects on the 
epigenome, and current technology cannot target individual loci. And even if that 
technology comes to fruition, it would be unclear which loci to safely target and in what 
tissue without adverse pleiotropic side-effects. Unlike in cancers where malignant tumors 
can be localized and targeted with global methylation changes, it remains to be seen how 
this would be possible in complex psychological phenotypes that have social, emotional, 
cognitive, and behavioral components.  
Although direct biological intervention may not be possible, epigenetic research 
has the potential to inform the classification and treatment of mental health disorders in 
other ways. The most obvious utility is the central aim of this thesis: to better understand 
the etiology and mechanisms of psychopathology. In addition, DNA methylation changes 
can also serve as potential biomarkers that can predict and track clinical outcomes as well 
as potentially classify particular subtypes of a disorder. For example, one longitudinal 
study assessing postpartum depression identified 116 transcripts, related to estrogen 
signaling, that were differentially expressed between cases and controls during the 3rd 
 87 
trimester that then predicted with 88% accuracy who went on to develop postpartum 
depression in two separate sample cohorts (Mehta et al., 2014). Similarly, another study 
posited the predictive utility of DNA methylation of HP1BP3 and TTC9B, both of which 
are regulated by estrogen with 80% accuracy (Guintivano et al., 2014). Another study 
using an epigenome-wide approach examined DNA methylation in the context of 
treatment response to antidepressant medication. Results identified differential DNA 
methylation in two genes, CHN2 and JAK2, that distinguished responders from non-
responders with CHN2 being replicated in an independent sample (Ju et al., 2019). 
The future of behavioral epigenetics, aided by strides in technological advances, 
improved bioinformatic methods, more meaningful and developmentally relevant 
phenotypes, and innovative research designs, looks bright. However, the field is still in its 
infancy and researchers must use caution in overinterpreting new discoveries. The more 
that novel discoveries of the epigenome are uncovered, the more of our ignorance of the 
complexities in relationships between genes and environments is revealed. It is unlikely 
that epigenetics, like genetics before it, will be the final piece of the puzzle in solving the 
disease burden of mental illness. However, it continues to hold enormous potential for 
better understanding of the etiology of psychopathology and for better, more precise 
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Table and Figures from Study 1: Variation in DNA Methylation of the Oxytocin 























Figure 2. Confirmatory factor analysis of Strengths and Weaknesses Questionnaire 




















































Figure 3. Linear Regression models used to classify resilient and non-resilient groups to global, conduct, hyperactivity, and 
emotional problems. Red (top half) dots represent the non-resilient group while the blue (bottom half) represent the resilient 
group. 
Table 1. Multiple Linear Regression Predicting Factor 1 Methylation and Individual Probes at Birth by Types of 
Resilience  
        Global       Conduct      Hyperactivity        Emotional 
Parameter β    95% CI      β   95% 
CI 
    β    95% CI     β 95% CI 




































Note:  β = Beta Weights; CI = Bootstrapped Confidence Intervals; Analyses controlled for sex and cell type 
*p < .05, **p < .01, ***p < .001.
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Figure 4. This figure shows mean methylation percentages at each individual probe that makes up Factor 1 controlling for sex 
and estimated cell–type composition. *p < .05, **p < .01, ***p < .001. 
Resilient 
(N = 44) 
Non-
Resilient 
     (N = 47) 
Probes % M SD M SD 
Average 2.2 .19 .04 .17 .06 
    Probe 1 2.5 .18 .05 .15 .04 
    Probe 5 2.3 .14 .04 .12 .03 
    Probe 10 1.7      .17 .04   .15 .02 
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Table 2. Descriptive Statistics of Resilient and Non-Resilient groups in Conduct Problems 
      Resilient 
       (N = 44) 
Non-Resilient 
(N = 47) 
    N (%) N (%) 
Gender 
     Male     20 (46.5) 23 (53.5) 
     Female 24 (50.0) 24 (50.0) 
      M (SD) M (SD) T-test
 Environmental Risk 
     Prenatal 0.54 (0.46) .047 (.429) -0.750
     Ages 0-7 5.96 (4.46) 6.58 (5.80) 0.564
     Ages 8-9 0.85 (1.81) 0.99 (1.76) 0.387
      M (SD) M (SD) F-test
Psychopathology 
     Hyperactivity -0.55 (1.10) 0.45 (1.22)     16.56*** 
     Emotional Problems 0.00 (0.67) 0.31 (0.70)  4.90* 
     Peer Problems -0.10 (0.67) 0.17 (0.63) 3.72t 
     Prosocial Behavior 0.61 (0.64) -0.40 (1.03)         31.18*** 
     Social Cognition (Age 7) 2.24 (2.33) 5.16 (3.65)      18.14*** 
     Callous-Unemotional Traits (Age 13) 1.79 (0.54) 2.33 (0.61)      16.87*** 
*p < .05, Note: All psychopathology outcomes controlled for sex
*p < .05, **p < .01, ***p < .001.
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Table 3. OXTR Single Nucleotide Polymorphism (SNP) effects on Probe 1 and Probe 10 
Timepoint SNP SNP chr SNP pos A1 A2 CpG site 
CpG 
chr CpG pos Beta T-stat 
Effec
t Size
Birth (Probe 1) rs62243375 3 8810462 T C cg00078085 3 8810592 0.613 0.00 0.008 
Birth (Probe 10) rs237900 3 8808696 A G cg12695586 3 8810077 -0.328 0.00 0.004 
Note: chr = chromosome, pos = position  
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Table and Figures from Study 2: A Longitudinal Epigenome-wide Analysis of Depression Trajectories in Adolescence 
Figure 5. Flowchart of sample selection from ALSPAC cohort 
96 
Figure 6. Depression trajectories (measured with Short Moods and Feelings Questionnaire; SMFQ) obtained through latent 
class growth curve modeling using the full ALSPAC sample (N = 8,360).   
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Table 4. Descriptive Statistics for EWAS analyses at birth broken down by depression 
trajectories. 
Low Increasing    Moderate/   Decreasing 
Birth EWAS (N = 830) 
N (%)  662 (80) 94 (11) 74 (9) 
N (%) female 311 (47) 66 (70) 48 (65) 
Birth covariates  M (SD) M (SD) M (SD) 
Maternal smoking freq 
   1st trimester  0.93 (3.46)    1.71 (5.04)   1.32 (4.49) 
   2nd trimester  0.60 (2.69)    1.04 (3.65)  1.16 (3.87) 
   3rd trimester  0.70 (2.98)    1.55 (4.75)  1.28 (4.69)  
Maternal marijuana freq 
   1st trimester  0.02 (0.19)    0.05 (0.43)   0.01 (0.12) 
   2nd trimester  0.01 (0.16)    0.05 (0.43)   0.03 (0.17) 
   3rd trimester   0.02 (0.22)a     0.10 (0.62)ab   0.03 (0.17)b
Maternal alcohol use freq 
   1st trimester  0.77 (0.81)   0.84 (0.86)   0.64 (0.69) 
   3rd trimester  0.80 (0.79)   0.79 (0.88)   0.81 (0.81) 
Child gestation length (weeks)    39.60 (1.48) 39.33 (1.56) 39.68 (1.45) 
Maternal age at birth (years)    29.65 (4.27) 29.49 (4.71) 29.88 (5.17) 
Child birthweight (grams) 
      3509.50 





Adolescent Dep (age 12.5) 2.94 (2.34)    5.31 (2.56)  12.80 (3.64) 
   N (%) clin sig dep   2 (.03) 2 (2) 57 (77) 
Adolescent Dep (age 13.5) 3.59 (2.93)    9.34 (5.19)  11.64 (4.53) 
   N (%) clin sig dep 20 (3) 34 (36) 39 (53) 
Adolescent Dep (age 16) 5.40 (3.22) 15.49 (5.78)  10.15 (5.72) 
   N (%) clin sig dep 53 (8) 73 (78) 30 (41) 
Adolescent Dep (age 17.5) 5.06 (3.85) 14.41 (5.11)    8.75 (4.66) 
   N (%) clin sig dep 73 (11) 73 (78) 25 (34) 
Note: M = Mean, SD = Standard Deviation; ANOVA with Tukey HSD was used to assess mean 
differences in covariates, columns with different superscripts are significantly different from each 
other; Dep = SMFQ Depression score; freq = frequency; clin sig dep = clinically significant 
depression;  Range of values for smoking, marijuana, and alcohol use are 0 (none) to 6 (frequent daily 
use) 
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Table 5. Descriptive Statistics for EWAS analyses at adolescence broken down by 
depression trajectories. 
Low Increasing    Moderate/   Decreasing 
Adolescent EWAS (N = 893) 
N (%) 720 (80) 77 (11) 96 (9) 
N (%) female 346 (48)  54 (70) 61 (64) 
M (SD) M (SD) M (SD) 
Adolescent Age 17.14 (1.03) 17.15 (1.06) 17.10 (1.08) 
Adolescent Smoking    0.85 (1.46)a   1.68 (1.99)b     1.62 (1.80)b
Adolescent Marijuana  0.42 (0.97)a   0.75 (1.37)ab     0.93 (1.48)b
Adolescent Dep (age 12.5) 2.86 (2.30)   5.27 (2.52) 12.69 (3.47)
N (%) clin sig dep (SMFQ > 11) 2 (.03) 2 (2) 56 (77) 
Adolescent Dep (age 13.5) 3.53 (2.89)   9.49 (5.20) 11.73 (4.56) 
   N (%) clin sig dep 20 (3) 32 (39) 39 (53) 
Adolescent Dep (age 16) 5.35 (3.21) 14.88 (5.89)   9.87 (5.39) 
   N (%) clin sig dep 43 (8) 53 (73) 21 (39) 
Adolescent Dep (age 17.5) 4.99 (3.77) 14.83 (5.22)   8.93 (4.79) 
   N (%) clin sig dep 72 (10) 58 (82) 35 (36) 
Note: M = Mean, SD = Standard Deviation; ANOVA with Tukey HSD was used to assess mean 
differences in covariates, columns with different superscripts are significantly different from each 
other; Dep = SMFQ Depression score; freq = frequency; clin sig dep = clinically significant 




Table 6. EWAS comparing increasing (N = 94) to low (N = 662) groups using DNA methylation obtained at birth 
CpG Gene Chr Position 
Location 


























Note: Chr = chromosome; b = unstandardized beta; SE = standard error, q = adjusted FDR value; Adj = 





Figure 7. Manhattan plot of EWAS comparing increasing (N = 94) to low (N = 662) groups using DNA methylation obtained 





Table 7. EWAS comparing combined high (N = 173) to low (N = 720) groups using DNA methylation obtained at 
adolescence 
CpG Gene Chr Position 
Location 


























Note: Chr = chromosome; b = unstandardized beta; SE = standard error, q = adjusted FDR value; Adj = Adjusted; M 
= mean; SD = standard deviation; Location details = location in genomic space, location on the gene, and whether 





Figure 8. Manhattan plot of EWAS comparing combined high (N = 173) to low (N = 720) groups using DNA methylation 





Table 8. EWAS comparing increasing (N = 96) to low (N = 720) groups using DNA methylation obtained at 
adolescence 
CpG Gene Chr 
Location 
Details 






































































































Note: Chr = chromosome; b = unstandardized beta; SE = standard error, q = adjusted FDR value; Adj = 
Adjusted; M = mean; SD = standard deviation; inc = increasing; Meth diff = percentage methylation 
difference.  Location details = location in genomic space, location on the gene, and whether CpG is near the 





Figure 9. Manhattan plot of EWAS comparing increasing (N = 96) to low (N = 720) groups using DNA methylation obtained 





Table 9. Regional analyses comparing combined high (N = 173) to low (N = 720) groups using DNA 
methylation obtained at adolescence 
DMR position (hg19) Number of probes in the 
DMR 
        DMR p-value                Gene 
Chr3:127347876-
127347978 










Table 10. Regional analyses comparing increasing (N = 96) to low (N = 720) groups using DNA 
methylation obtained at adolescence 
DMR position (hg19) Number of probes in the 
DMR 
        DMR p-value Gene 
Chr3:127347876-
127347978 







2 0.000 ZBTB44 
Chr20:36155925-
36156146 
6 0.000 BLCAP 





Figure 10. GeneMANIA gene network analysis using significant and nominal hits from increasing versus low groups EWAS 
using DNA methylation in adolescence. Striped black circles represent genes associated with the probes found to be related to 
depression trajectories in the EWAS. Solid black circles represent additional genes predicted by GeneMANIA based on genetic 
and physical interactions, shared pathways and protein domains as well as protein co-expression data.
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Table 11. Gene ontology analyses from GeneMANIA gene network analysis using significant and 
nominal hits from increasing versus low groups EWAS using DNA methylation in adolescence. 
Function FDR Coverage 
sequence-specific DNA binding 1.60e-8 10/255 
bHLH transcription factor binding 2.79e-7 5/18 
cardiac septum morphogenesis 0.000002 5/27 
cardiac septum development 0.000007 5/37 
cardiac ventricle development 0.00005 5/56 
cardiac chamber morphogenesis 0.00006 5/60 
muscle structure development 0.00009 7/244 
cardiac chamber development 0.00009 5/70 
regulatory region DNA binding 0.0001 7/268 
transcription regulatory region DNA binding 0.0001 7/267 
regulatory region nucleic acid binding 0.0001 7/268 
RNA polymerase II transcription factor binding 0.0001 5/74 
sequence-specific DNA binding RNA polymerase 
II transcription factor activity 
0.0004 6/200 
cardiac right ventricle morphogenesis 0.0004 3/10 
cardiac ventricle morphogenesis 0.0006 4/47 
heart morphogenesis 0.0007 5/120 
histone deacetylase binding 0.0007 4/51 
chordate embryonic development 0.0007 5/125 
embryo development ending in birth or egg 
hatching 
0.0007 5/125 
aorta morphogenesis 0.0008 3/14 
ventricular septum morphogenesis 0.0008 3/14 
aorta development 0.0009 3/15 
embryonic organ development 0.001 5/144` 
transcription factor complex 0.002 5/155 
mesenchymal cell differentiation 0.002 4/68 
smooth muscle cell differentiation 0.002 3/19 
ventricular septum development 0.002 3/21 
mesenchyme development 0.003 4/80 
regulation of neuron differentiation 0.004 5/188 
E-box binding 0.004 3/27 
heart development 0.005 5/203 
artery morphogenesis 0.006 3/30 
RNA polymerase II activating transcription factor
binding
0.007 3/32 
outflow tract morphogenesis 0.007 3/33 
artery development 0.007 3/33 
regulation of neurogenesis 0.007 5/228 
regulation of nervous system development 0.01 5/256 
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regulation of binding 0.01 4/127 
regulation of DNA binding 0.02 3/46 
in utero embryonic development 0.02 3/47 
activating transcription factor binding 0.02 3/48 
muscle cell differentiation 0.02 4/151 
mesenchymal cell development 0.03 3/60 
negative regulation of binding 0.04 3/61 
blood vessel morphogenesis 0.04 4/170 
regulation of vasculogenesis 0.04 2/10 
stem cell differentiation 0.04 4/171 
cardiocyte differentiation 0.04 3/64 
cardiac epithelial to mesenchymal transition 0.05 2/12 
endocardial cushion morphogenesis 0.05 2/12 
cardiac left ventricle morphogenesis 0.05 2/12 
protein heterodimerization activity 0.05 4/191 
blood vessel development 0.05 4/193 
Note: Coverage = how many genes in this network/how many genes identified in this process 





Figure 11. GeneMANIA gene network analysis using significant and nominal hits from increasing versus low groups EWAS 
using DNA methylation in adolescence with the addition of AACS from high versus low groups EWAS. Striped black circles 
represent genes associated with the probes found to be related to depression trajectories in the EWAS. Solid black circles 
represent additional genes predicted by GeneMANIA based on genetic and physical interactions, shared pathways and protein 






SI 1. Factor analysis procedure for reducing OXTR methylation data and results obtained from Cecil and colleagues (2014) 
for study 1. 
Procedure: 
We used exploratory factor analysis (EFA) to examine associations between the 12 OXTR probes at birth. EFA is a data 
reduction technique that groups correlated probes into a smaller set of factors which account for shared variance between them 
– an advantageous method when the pattern of relationships between variables (i.e. probes) is not known. The optimal number
of factors was determined by comparing fit statistics between models estimating 1 to 5 factors. Model fit was first established
using the chi-square statistic, which tests the difference between observed and expected covariance matrices, producing a non-
significant value if this difference is close to zero .  In the event of a significant chi-square value, we examined additional
relative fit indices , including the mean square error of approximation (RMSEA; acceptable fit =< .08), the Comparative Fit
Index and Tucker-Lewis Index (CFI & TLI; acceptable fit => .90). As a next step, confirmatory factor analysis (CFA) was run
to validate the factor structure identified by the EFA. Once methylation factors at birth were confirmed, we tested whether they
remained consistent from birth onwards (i.e. birth vs age 7; age 7 vs age 9), by examining correlations between probes in each
factor, and mean levels of DNA methylation in probes within each factor.
Results:  
Correlations between the 12 OXTR probes at birth can be found in SI3. Using EFA, we identified 3 methylation factors at birth 
(containing 3 probes each), which showed the best model fit: X2 (33) = 41.15, p = .16. We then used CFA to validate the 3-
factor model and extract factor scores (i.e. containing shared variance between probes in each factor). Model fit was 
satisfactory (X2 (24) = 70.03 p <.01; CFI = .91; TLI = .86; RMSEA = .08, 90% CIs = .06, .10). See SI4 for probe descriptive 
statistics, standardized loadings and factor correlations. Probe correlations for each factor remained consistent between birth 
and age 7, as well as between age 7 and age 9, but mean levels varied across time (see SI5). We present findings relating to 
Factor 2 as it associated with both the environment and CU. Of note, all probes included in this factor were physically located 










SI 3. Intercorrelations between environmental risk domains across developmental periods and confirmatory factor models 




















Adkins, R. M., Thomas, F., Tylavsky, F. A., & Krushkal, J. (2011). Parental ages and levels of 
DNA methylation in the newborn are correlated. BMC Medical Genetics, 12(1), 47. 
https://doi.org/10.1186/1471-2350-12-47 
Alexander, N., Wankerl, M., Hennig, J., Miller, R., Zänkert, S., Steudte-Schmiedgen, S., Stalder, 
T., & Kirschbaum, C. (2014). DNA methylation profiles within the serotonin transporter 
gene moderate the association of 5-HTTLPR and cortisol stress reactivity. Translational 
Psychiatry, 4(9), e443–e443. https://doi.org/10.1038/tp.2014.88 
Anastas, J. N., Biechele, T. L., Robitaille, M., Muster, J., Allison, K. H., Angers, S., & Moon, R. 
T. (2012). A protein complex of SCRIB, NOS1AP and VANGL1 regulates cell polarity
and migration, and is associated with breast cancer progression. Oncogene, 31(32), 3696–
3708. https://doi.org/10.1038/onc.2011.528 
Anderson, O. S., Sant, K. E., & Dolinoy, D. C. (2012). Nutrition and epigenetics: An interplay of 
dietary methyl donors, one-carbon metabolism, and DNA methylation. The Journal of 
Nutritional Biochemistry, 23(8), 853–859. https://doi.org/10.1016/j.jnutbio.2012.03.003 
Angold, A., Costello, E. J., Messer, S. C., & Pickles, A. (1995). Development of a short 
questionnaire for use in epidemiological studies of depression in children and 
adolescents. International Journal of Methods in Psychiatric Research, 5(4), 237–249. 
Appleton, A. A., Lester, B. M., Armstrong, D. A., Lesseur, C., & Marsit, C. J. (2015). 
Examining the joint contribution of placental NR3C1 and HSD11B2 methylation for 
infant neurobehavior. Psychoneuroendocrinology, 52, 32–42. 
https://doi.org/10.1016/j.psyneuen.2014.11.004 
119 
Armstrong, T. D., & Costello, E. J. (2002). Community studies on adolescent substance use, 
abuse, or dependence and psychiatric comorbidity. Journal of Consulting and Clinical 
Psychology, 70(6), 1224–1239. https://doi.org/10.1037/0022-006X.70.6.1224 
Atlantis, E., & Baker, M. (2008). Obesity effects on depression: Systematic review of 
epidemiological studies. International Journal of Obesity, 32(6), 881–891. 
https://doi.org/10.1038/ijo.2008.54 
Bakulski, K. M., Feinberg, J. I., Andrews, S. V., Yang, J., Brown, S., McKenney, S. L., Witter, 
F., Walston, J., Feinberg, A. P., & Fallin, M. D. (2016). DNA methylation of cord blood 
cell types: Applications for mixed cell birth studies. Epigenetics, 11(5), 354–362. 
https://doi.org/10.1080/15592294.2016.1161875 
Bakusic, J., Schaufeli, W., Claes, S., & Godderis, L. (2017). Stress, burnout and depression: A 
systematic review on DNA methylation mechanisms. Journal of Psychosomatic 
Research, 92, 34–44. https://doi.org/10.1016/j.jpsychores.2016.11.005 
Baniyash, M., Sade-Feldman, M., & Kanterman, J. (2014). Chronic inflammation and cancer: 
Suppressing the suppressors. Cancer Immunology, Immunotherapy, 63(1), 11–20. 
https://doi.org/10.1007/s00262-013-1468-9 
Baral, D., Wu, L., Katwal, G., Yan, X., Wang, Y., & Ye, Q. (2018). Clinical significance and 
biological roles of small nucleolar RNAs in hepatocellular carcinoma (Review). 
Biomedical Reports, 8(4), 319–324. https://doi.org/10.3892/br.2018.1063 
Barker, D. J. (1995). Fetal origins of coronary heart disease. BMJ : British Medical Journal, 
311(6998), 171–174. 
120 
Barker, E. D., Jaffee, S. R., Uher, R., & Maughan, B. (2011). The contribution of prenatal and 
postnatal maternal anxiety and depression to child maladjustment. Depression and 
Anxiety, 28(8), 696–702. https://doi.org/10.1002/da.20856 
Barker, E. D., & Maughan, B. (2009). Differentiating Early-Onset Persistent Versus Childhood-
Limited Conduct Problem Youth. American Journal of Psychiatry, 166(8), 900–908. 
https://doi.org/10.1176/appi.ajp.2009.08121770 
Barker, E. D., Oliver, B. R., & Maughan, B. (2010). Co-occurring problems of early onset 
persistent, childhood limited, and adolescent onset conduct problem youth. Journal of 
Child Psychology and Psychiatry, 51(11), 1217–1226. https://doi.org/10.1111/j.1469-
7610.2010.02240.x 
Barker, E. D., Walton, E., Cecil, C. A. M., Rowe, R., Jaffee, S. R., Maughan, B., O’Connor, T. 
G., Stringaris, A., Meehan, A. J., McArdle, W., Relton, C. L., & Gaunt, T. R. (2018). A 
Methylome-Wide Association Study of Trajectories of Oppositional Defiant Behaviors 
and Biological Overlap With Attention Deficit Hyperactivity Disorder. Child 
Development, 89(5), 1839–1855. https://doi.org/10.1111/cdev.12957 
Bayles, R., Baker, E. K., Jowett, J. B. M., Barton, D., Esler, M., El-Osta, A., & Lambert, G. 
(2013). Methylation of the SLC6a2 Gene Promoter in Major Depression and Panic 
Disorder. PLoS ONE, 8(12). https://doi.org/10.1371/journal.pone.0083223 
Beach, S. R. H., & Amir, N. (2003). Is depression taxonic, dimensional, or both? Journal of 
Abnormal Psychology, 112(2), 228–236. 
Bergman, K., Sarkar, P., Glover, V., & O’Connor, T. g. (2008). Quality of child–parent 
attachment moderates the impact of antenatal stress on child fearfulness. Journal of Child 
121 
Psychology and Psychiatry, 49(10), 1089–1098. https://doi.org/10.1111/j.1469-
7610.2008.01987.x 
Bergman, Kristin, Sarkar, P., Glover, V., & O’Connor, T. G. (2010). Maternal Prenatal Cortisol 
and Infant Cognitive Development: Moderation by Infant–Mother Attachment. 
Biological Psychiatry, 67(11), 1026–1032. 
https://doi.org/10.1016/j.biopsych.2010.01.002 
Bibikova, M., Barnes, B., Tsan, C., Ho, V., Klotzle, B., Le, J. M., Delano, D., Zhang, L., 
Schroth, G. P., Gunderson, K. L., Fan, J.-B., & Shen, R. (2011a). High density DNA 
methylation array with single CpG site resolution. Genomics, 98(4), 288–295. 
https://doi.org/10.1016/j.ygeno.2011.07.007 
Bibikova, M., Barnes, B., Tsan, C., Ho, V., Klotzle, B., Le, J. M., Delano, D., Zhang, L., 
Schroth, G. P., Gunderson, K. L., Fan, J.-B., & Shen, R. (2011b). High density DNA 
methylation array with single CpG site resolution. Genomics, 98(4), 288–295. 
https://doi.org/10.1016/j.ygeno.2011.07.007 
BICK, J., NAUMOVA, O., HUNTER, S., BARBOT, B., LEE, M., LUTHAR, S. S., RAEFSKI, 
A., & GRIGORENKO, E. L. (2012). Childhood adversity and DNA methylation of genes 
involved in the hypothalamus–pituitary–adrenal axis and immune system: Whole-genome 
and candidate-gene associations. Development and Psychopathology, 24(4), 1417–1425. 
https://doi.org/10.1017/S0954579412000806 
Billack, B., Serio, R., Silva, I., & Kinsley, C. H. (2012). Epigenetic changes brought about by 
perinatal stressors: A brief review of the literature. Journal of Pharmacological and 
Toxicological Methods, 66(3), 221–231. https://doi.org/10.1016/j.vascn.2012.08.169 
122 
Bird, A. (2002). DNA methylation patterns and epigenetic memory. Genes & Development, 
16(1), 6–21. https://doi.org/10.1101/gad.947102 
Blaine, B. (2008). Does Depression Cause Obesity?: A Meta-analysis of Longitudinal Studies of 
Depression and Weight Control. Journal of Health Psychology, 13(8), 1190–1197. 
https://doi.org/10.1177/1359105308095977 
Boström, A. E., Ciuculete, D.-M., Attwood, M., Krattinger, R., Nikontovic, L., Titova, O. E., 
Kullak-Ublick, G. A., Mwinyi, J., & Schiöth, H. B. (2017). A MIR4646 associated 
methylation locus is hypomethylated in adolescent depression. Journal of Affective 
Disorders, 220, 117–128. https://doi.org/10.1016/j.jad.2017.05.017 
Boyd, A., Golding, J., Macleod, J., Lawlor, D. A., Fraser, A., Henderson, J., Molloy, L., Ness, 
A., Ring, S., & Davey Smith, G. (2013). Cohort Profile: The ’children of the 90s’--the 
index offspring of the Avon Longitudinal Study of Parents and Children. International 
Journal of Epidemiology, 42(1), 111–127. https://doi.org/10.1093/ije/dys064 
Braithwaite, E. C., Murphy, S. E., & Ramchandani, P. G. (2014). Prenatal risk factors for 
depression: A critical review of the evidence and potential mechanisms. Journal of 
Developmental Origins of Health and Disease, 5(5), 339–350. 
https://doi.org/10.1017/S2040174414000324 
Breton Carrie V., Marsit Carmen J., Faustman Elaine, Nadeau Kari, Goodrich Jaclyn M., 
Dolinoy Dana C., Herbstman Julie, Holland Nina, LaSalle Janine M., Schmidt Rebecca, 
Yousefi Paul, Perera Frederica, Joubert Bonnie R., Wiemels Joseph, Taylor Michele, 
Yang Ivana V., Chen Rui, Hew Kinjal M., Freeland Deborah M. Hussey, … Murphy 
Susan K. (2017). Small-Magnitude Effect Sizes in Epigenetic End Points are Important in 
Children’s Environmental Health Studies: The Children’s Environmental Health and 
123 
Disease Prevention Research Center’s Epigenetics Working Group. Environmental 
Health Perspectives, 125(4), 511–526. https://doi.org/10.1289/EHP595 
Brook, J. S., Zhang, C., & Brook, D. W. (2011). Developmental Trajectories of Marijuana Use 
From Adolescence to Adulthood: Personal Predictors. Archives of Pediatrics & 
Adolescent Medicine, 165(1), 55–60. https://doi.org/10.1001/archpediatrics.2010.248 
Brown, G. W., & Harris, T. O. (2008). Depression and the serotonin transporter 5-HTTLPR 
polymorphism: A review and a hypothesis concerning gene–environment interaction. 
Journal of Affective Disorders, 111(1), 1–12. https://doi.org/10.1016/j.jad.2008.04.009 
Brüning-Richardson, A., Bond, J., Alsiary, R., Richardson, J., Cairns, D. A., McCormac, L., 
Hutson, R., Burns, P. A., Wilkinson, N., Hall, G. D., Morrison, E. E., & Bell, S. M. 
(2012). NuMA Overexpression in Epithelial Ovarian Cancer. PLoS ONE, 7(6). 
https://doi.org/10.1371/journal.pone.0038945 
Bustamante, A. C., Aiello, A. E., Galea, S., Ratanatharathorn, A., Noronha, C., Wildman, D. E., 
& Uddin, M. (2016). Glucocorticoid receptor DNA methylation, childhood maltreatment 
and major depression. Journal of Affective Disorders, 206, 181–188. 
https://doi.org/10.1016/j.jad.2016.07.038 
Byrne, E. M., Carrillo-Roa, T., Henders, A. K., Bowdler, L., McRae, A. F., Heath, A. C., Martin, 
N. G., Montgomery, G. W., Krause, L., & Wray, N. R. (2013). Monozygotic twins
affected with major depressive disorder have greater variance in methylation than their 
unaffected co-twin. Translational Psychiatry, 3(6), e269. 
https://doi.org/10.1038/tp.2013.45 
Carr, C. P., Martins, C. M. S., Stingel, A. M., Lemgruber, V. B., & Juruena, M. F. (2013). The 
Role of Early Life Stress in Adult Psychiatric Disorders: A Systematic Review According 
124 
to Childhood Trauma Subtypes. The Journal of Nervous and Mental Disease, 201(12), 
1007–1020. https://doi.org/10.1097/NMD.0000000000000049 
Caspi, A., Houts, R. M., Belsky, D. W., Goldman-Mellor, S. J., Harrington, H., Israel, S., Meier, 
M. H., Ramrakha, S., Shalev, I., Poulton, R., & Moffitt, T. E. (2014). The p Factor: One
General Psychopathology Factor in the Structure of Psychiatric Disorders? Clinical 
Psychological Science : A Journal of the Association for Psychological Science, 2(2), 
119–137. https://doi.org/10.1177/2167702613497473 
Cavard, C., Audebourg, A., Letourneur, F., Audard, V., Beuvon, F., Cagnard, N., Radenen, B., 
Varlet, P., Vacher‐Lavenu, M.-C., Perret, C., & Terris, B. (2009). Gene expression 
profiling provides insights into the pathways involved in solid pseudopapillary neoplasm 
of the pancreas. The Journal of Pathology, 218(2), 201–209. 
https://doi.org/10.1002/path.2524 
Cecil, C. A., Lysenko, L. J., Jaffee, S. R., Pingault, J.-B., Smith, R. G., Relton, C. L., Woodward, 
G., McArdle, W., Mill, J., & Barker, E. D. (2014). Environmental risk, Oxytocin 
Receptor Gene (OXTR) methylation and youth callous-unemotional traits: A 13-year 
longitudinal study. Molecular Psychiatry, 19(10), 1071–1077. 
https://doi.org/10.1038/mp.2014.95 
Cecil, C. A. M., Walton, E., Jaffee, S. R., O’Connor, T., Maughan, B., Relton, C. L., Smith, R. 
G., McArdle, W., Gaunt, T. R., Ouellet-Morin, I., & Barker, E. D. (2018). Neonatal DNA 
methylation and early-onset conduct problems: A genome-wide, prospective study. 
Development and Psychopathology, 30(2), 383–397. 
https://doi.org/10.1017/S095457941700092X 
125 
Cecil, C. a. M., Walton, E., Smith, R. G., Viding, E., McCrory, E. J., Relton, C. L., Suderman, 
M., Pingault, J.-B., McArdle, W., Gaunt, T. R., Mill, J., & Barker, E. D. (2016). DNA 
methylation and substance-use risk: A prospective, genome-wide study spanning 
gestation to adolescence. Translational Psychiatry, 6(12), e976–e976. 
https://doi.org/10.1038/tp.2016.247 
Chagnon, Y. C., Potvin, O., Hudon, C., & Préville, M. (2015). DNA methylation and single 
nucleotide variants in the brain-derived neurotrophic factor (BDNF) and oxytocin 
receptor (OXTR) genes are associated with anxiety/depression in older women. Frontiers 
in Genetics, 6. https://doi.org/10.3389/fgene.2015.00230 
Chaiton, M. O., Cohen, J. E., O’Loughlin, J., & Rehm, J. (2009). A systematic review of 
longitudinal studies on the association between depression and smoking in adolescents. 
BMC Public Health, 9(1), 356. https://doi.org/10.1186/1471-2458-9-356 
Charif, M., Bounaceur, S., Abidi, O., Nahili, H., Rouba, H., Kandil, M., Boulouiz, R., & Barakat, 
A. (2012). The c.242G>A mutation in LRTOMT gene is responsible for a high
prevalence of deafness in the Moroccan population. Molecular Biology Reports, 39(12), 
11011–11016. https://doi.org/10.1007/s11033-012-2003-3 
Chen, D., Meng, L., Pei, F., Zheng, Y., & Leng, J. (2017). A review of DNA methylation in 
depression. Journal of Clinical Neuroscience, 43, 39–46. 
https://doi.org/10.1016/j.jocn.2017.05.022 
Chen, N., Szentirmay, M. N., Pawar, S. A., Sirito, M., Wang, J., Wang, Z., Zhai, Q., Yang, H.-
X., Peehl, D. M., Ware, J. L., & Sawadogo, M. (2006). Tumor-suppression function of 
transcription factor USF2 in prostate carcinogenesis. Oncogene, 25(4), 579–587. 
https://doi.org/10.1038/sj.onc.1209079 
126 
Chen, Y., Lemire, M., Choufani, S., Butcher, D. T., Grafodatskaya, D., Zanke, B. W., Gallinger, 
S., Hudson, T. J., & Weksberg, R. (2013). Discovery of cross-reactive probes and 
polymorphic CpGs in the Illumina Infinium HumanMethylation450 microarray. 
Epigenetics, 8(2), 203–209. https://doi.org/10.4161/epi.23470 
Choi, S., Han, K.-M., Won, E., Yoon, B.-J., Lee, M.-S., & Ham, B.-J. (2015). Association of 
brain-derived neurotrophic factor DNA methylation and reduced white matter integrity in 
the anterior corona radiata in major depression. Journal of Affective Disorders, 172, 74–
80. https://doi.org/10.1016/j.jad.2014.09.042
Ciuculete, D. M., Voisin, S., Kular, L., Welihinda, N., Jonsson, J., Jagodic, M., Mwinyi, J., & 
Schiöth, H. B. (2019). Longitudinal DNA methylation changes at MET may alter HGF/c-
MET signalling in adolescents at risk for depression. Epigenetics, 0(0), 1–18. 
https://doi.org/10.1080/15592294.2019.1700628 
Coleman, J. R. I., Peyrot, W. J., Purves, K. L., Davis, K. A. S., Rayner, C., Choi, S. W., Hübel, 
C., Gaspar, H. A., Kan, C., Van der Auwera, S., Adams, M. J., Lyall, D. M., Choi, K. W., 
on the behalf of Major Depressive Disorder Working Group of the Psychiatric Genomics 
Consortium, Dunn, E. C., Vassos, E., Danese, A., Maughan, B., Grabe, H. J., … Breen, 
G. (2020). Genome-wide gene-environment analyses of major depressive disorder and
reported lifetime traumatic experiences in UK Biobank. Molecular Psychiatry. 
https://doi.org/10.1038/s41380-019-0546-6 
Conradt, E., Lester, B. M., Appleton, A. A., Armstrong, D. A., & Marsit, C. J. (2013a). The roles 
of DNA methylation of NR3C1 and 11β-HSD2 and exposure to maternal mood disorder 
in utero on newborn neurobehavior. Epigenetics, 8(12), 1321–1329. 
https://doi.org/10.4161/epi.26634 
127 
Conradt, E., Lester, B. M., Appleton, A. A., Armstrong, D. A., & Marsit, C. J. (2013b). The roles 
of DNA methylation of NR3C1 and 11β-HSD2 and exposure to maternal mood disorder 
in utero on newborn neurobehavior. Epigenetics, 8(12), 1321–1329. 
https://doi.org/10.4161/epi.26634 
Córdova-Palomera, A., Fatjó-Vilas, M., Gastó, C., Navarro, V., Krebs, M.-O., & Fañanás, L. 
(2015). Genome-wide methylation study on depression: Differential methylation and 
variable methylation in monozygotic twins. Translational Psychiatry, 5(4), e557. 
https://doi.org/10.1038/tp.2015.49 
Cruceanu, C., Kutsarova, E., Chen, E. S., Checknita, D. R., Nagy, C., Lopez, J. P., Alda, M., 
Rouleau, G. A., & Turecki, G. (2016). DNA hypomethylation of Synapsin II CpG islands 
associates with increased gene expression in bipolar disorder and major depression. BMC 
Psychiatry, 16(1), 286. https://doi.org/10.1186/s12888-016-0989-0 
Dadds, M. R., Moul, C., Cauchi, A., Dobson-Stone, C., Hawes, D. J., Brennan, J., & Ebstein, R. 
E. (2014). Methylation of the oxytocin receptor gene and oxytocin blood levels in the
development of psychopathy. Development and Psychopathology, 26(01), 33–40. 
https://doi.org/10.1017/S0954579413000497 
Dalton, S. O., Mellemkjaer, L., Olsen, J. H., Mortensen, P. B., & Johansen, C. (2002). 
Depression and cancer risk: A register-based study of patients hospitalized with affective 
disorders, Denmark, 1969-1993. American Journal of Epidemiology, 155(12), 1088–
1095. https://doi.org/10.1093/aje/155.12.1088 
Daskalakis, N. P., Bagot, R. C., Parker, K. J., Vinkers, C. H., & de Kloet, E. R. (2013). The 
three-hit concept of vulnerability and resilience: Toward understanding adaptation to 
128 
early-life adversity outcome. Psychoneuroendocrinology, 38(9), 1858–1873. 
https://doi.org/10.1016/j.psyneuen.2013.06.008 
Davies, M. N., Krause, L., Bell, J. T., Gao, F., Ward, K. J., Wu, H., Lu, H., Liu, Y., Tsai, P.-C., 
Collier, D. A., Murphy, T., Dempster, E., Mill, J., Battle, A., Mostafavi, S., Zhu, X., 
Henders, A., Byrne, E., Wray, N. R., … Wang, J. (2014). Hypermethylation in the 
ZBTB20 gene is associated with major depressive disorder. Genome Biology, 15(4), R56. 
https://doi.org/10.1186/gb-2014-15-4-r56 
Davies, M. N., Volta, M., Pidsley, R., Lunnon, K., Dixit, A., Lovestone, S., Coarfa, C., Harris, R. 
A., Milosavljevic, A., Troakes, C., Al-Sarraj, S., Dobson, R., Schalkwyk, L. C., & Mill, J. 
(2012). Functional annotation of the human brain methylome identifies tissue-specific 
epigenetic variation across brain and blood. Genome Biology, 13(6), R43. 
https://doi.org/10.1186/gb-2012-13-6-r43 
de Wit, L., Luppino, F., van Straten, A., Penninx, B., Zitman, F., & Cuijpers, P. (2010). 
Depression and obesity: A meta-analysis of community-based studies. Psychiatry 
Research, 178(2), 230–235. https://doi.org/10.1016/j.psychres.2009.04.015 
Deaton, A. M., & Bird, A. (2011). CpG islands and the regulation of transcription. Genes & 
Development, 25(10), 1010–1022. https://doi.org/10.1101/gad.2037511 
Dedeurwaerder, S., Defrance, M., Bizet, M., Calonne, E., Bontempi, G., & Fuks, F. (2014). A 
comprehensive overview of Infinium HumanMethylation450 data processing. Briefings 
in Bioinformatics, 15(6), 929–941. https://doi.org/10.1093/bib/bbt054 
Dempster, E. L., Wong, C. C. Y., Lester, K. J., Burrage, J., Gregory, A. M., Mill, J., & Eley, T. 
C. (2014). Genome-wide Methylomic Analysis of Monozygotic Twins Discordant for
129 
Adolescent Depression. Biological Psychiatry, 76(12), 977–983. 
https://doi.org/10.1016/j.biopsych.2014.04.013 
Devlin, B., & Roeder, K. (1999). Genomic Control for Association Studies. Biometrics, 55(4), 
997–1004. https://doi.org/10.1111/j.0006-341X.1999.00997.x 
Dolinoy, D. C., Weidman, J. R., & Jirtle, R. L. (2007). Epigenetic gene regulation: Linking early 
developmental environment to adult disease. Reproductive Toxicology (Elmsford, N.Y.), 
23(3), 297–307. https://doi.org/10.1016/j.reprotox.2006.08.012 
Dunn, E. C., Brown, R. C., Dai, Y., Rosand, J., Nugent, N. R., Amstadter, A. B., & Smoller, J. 
W. (2015). Genetic determinants of depression: Recent findings and future directions.
Harvard Review of Psychiatry, 23(1), 1–18. 
https://doi.org/10.1097/HRP.0000000000000054 
Eckhardt, F., Lewin, J., Cortese, R., Rakyan, V. K., Attwood, J., Burger, M., Burton, J., Cox, T. 
V., Davies, R., Down, T. A., Haefliger, C., Horton, R., Howe, K., Jackson, D. K., Kunde, 
J., Koenig, C., Liddle, J., Niblett, D., Otto, T., … Beck, S. (2006). DNA methylation 
profiling of human chromosomes 6, 20 and 22. Nature Genetics, 38(12), 1378–1385. 
https://doi.org/10.1038/ng1909 
Elliott, E., Ezra-Nevo, G., Regev, L., Neufeld-Cohen, A., & Chen, A. (2010). Resilience to 
social stress coincides with functional DNA methylation of the Crf gene in adult mice. 
Nature Neuroscience, 13(11), 1351–1353. https://doi.org/10.1038/nn.2642 
Fergusson, D. M., & Woodward, L. J. (2002). Mental health, educational, and social role 
outcomes of adolescents with depression. Archives of General Psychiatry, 59(3), 225–
231.
130 
Filiberto, A. C., Maccani, M. A., Koestler, D. C., Wilhelm-Benartzi, C., Avissar-Whiting, M., 
Banister, C. E., Gagne, L. A., & Marsit, C. J. (2011). Birthweight is associated with DNA 
promoter methylation of the glucocorticoid receptor in human placenta. Epigenetics, 6(5), 
566–572. https://doi.org/10.4161/epi.6.5.15236 
Fluharty, M., Taylor, A. E., Grabski, M., & Munafò, M. R. (2017). The Association of Cigarette 
Smoking With Depression and Anxiety: A Systematic Review. Nicotine & Tobacco 
Research, 19(1), 3–13. https://doi.org/10.1093/ntr/ntw140 
Fraser, A., Macdonald-Wallis, C., Tilling, K., Boyd, A., Golding, J., Davey Smith, G., 
Henderson, J., Macleod, J., Molloy, L., Ness, A., Ring, S., Nelson, S. M., & Lawlor, D. 
A. (2013). Cohort Profile: The Avon Longitudinal Study of Parents and Children:
ALSPAC mothers cohort. International Journal of Epidemiology, 42(1), 97–110. 
https://doi.org/10.1093/ije/dys066 
Fried, E. I., & Nesse, R. M. (2015). Depression is not a consistent syndrome: An investigation of 
unique symptom patterns in the STAR*D study. Journal of Affective Disorders, 172, 96–
102. https://doi.org/10.1016/j.jad.2014.10.010
Fuchikami, M., Morinobu, S., Segawa, M., Okamoto, Y., Yamawaki, S., Ozaki, N., Inoue, T., 
Kusumi, I., Koyama, T., Tsuchiyama, K., & Terao, T. (2011). DNA Methylation Profiles 
of the Brain-Derived Neurotrophic Factor (BDNF) Gene as a Potent Diagnostic 
Biomarker in Major Depression. PLOS ONE, 6(8), e23881. 
https://doi.org/10.1371/journal.pone.0023881 
Gao, L., Ma, J., Mannoor, K., Guarnera, M. A., Shetty, A., Zhan, M., Xing, L., Stass, S. A., & 
Jiang, F. (2015). Genome-wide small nucleolar RNA expression analysis of lung cancer 
131 
by next-generation deep sequencing. International Journal of Cancer, 136(6), E623–
E629. https://doi.org/10.1002/ijc.29169 
García, S. A., Swiersy, A., Radhakrishnan, P., Branchi, V., Nanduri, L. K., Győrffy, B., Betzler, 
A. M., Bork, U., Kahlert, C., Reißfelder, C., Rahbari, N. N., Weitz, J., & Schölch, S.
(2016). LDB1 overexpression is a negative prognostic factor in colorectal cancer. 
Oncotarget, 7(51), 84258–84270. https://doi.org/10.18632/oncotarget.12481 
Gaunt, T. R., Shihab, H. A., Hemani, G., Min, J. L., Woodward, G., Lyttleton, O., Zheng, J., 
Duggirala, A., McArdle, W. L., Ho, K., Ring, S. M., Evans, D. M., Davey Smith, G., & 
Relton, C. L. (2016). Systematic identification of genetic influences on methylation 
across the human life course. Genome Biology, 17, 61. https://doi.org/10.1186/s13059-
016-0926-z
Gaviraghi, M., Vivori, C., & Tonon, G. (2019). How Cancer Exploits Ribosomal RNA 
Biogenesis: A Journey beyond the Boundaries of rRNA Transcription. Cells, 8(9). 
https://doi.org/10.3390/cells8091098 
Ge, X., & And Others. (1994). Trajectories of Stressful Life Events and Depressive Symptoms 
during Adolescence. Developmental Psychology, 30(4), 467–483. 
Glover, V. (2015). Prenatal stress and its effects on the fetus and the child: Possible underlying 
biological mechanisms. Advances in Neurobiology, 10, 269–283. 
https://doi.org/10.1007/978-1-4939-1372-5_13 
Gluckman, P. D., Hanson, M. A., Cooper, C., & Thornburg, K. L. (2008a). Effect of In Utero 
and Early-Life Conditions on Adult Health and Disease. The New England Journal of 
Medicine, 359(1), 61–73. https://doi.org/10.1056/NEJMra0708473 
132 
Gluckman, P. D., Hanson, M. A., Cooper, C., & Thornburg, K. L. (2008b). Effect of in utero and 
early-life conditions on adult health and disease. The New England Journal of Medicine, 
359(1), 61–73. https://doi.org/10.1056/NEJMra0708473 
Goodman, R. (1997). The Strengths and Difficulties Questionnaire: A Research Note. Journal of 
Child Psychology and Psychiatry, 38(5), 581–586. https://doi.org/10.1111/j.1469-
7610.1997.tb01545.x 
GOODMAN, R. (2001). Psychometric Properties of the Strengths and Difficulties Questionnaire. 
Journal of the American Academy of Child & Adolescent Psychiatry, 40(11), 1337–1345. 
https://doi.org/10.1097/00004583-200111000-00015 
Gottesman, I. I., & Gould, T. D. (2003). The endophenotype concept in psychiatry: Etymology 
and strategic intentions. The American Journal of Psychiatry, 160(4), 636–645. 
https://doi.org/10.1176/appi.ajp.160.4.636 
Gregory, S. G., Connelly, J. J., Towers, A. J., Johnson, J., Biscocho, D., Markunas, C. A., Lintas, 
C., Abramson, R. K., Wright, H. H., Ellis, P., Langford, C. F., Worley, G., Delong, G. R., 
Murphy, S. K., Cuccaro, M. L., Persico, A., & Pericak-Vance, M. A. (2009). Genomic 
and epigenetic evidence for oxytocin receptor deficiency in autism. BMC Medicine, 7(1), 
62. https://doi.org/10.1186/1741-7015-7-62
Grivennikov, S. I., Greten, F. R., & Karin, M. (2010). Immunity, Inflammation, and Cancer. 
Cell, 140(6), 883–899. https://doi.org/10.1016/j.cell.2010.01.025 
Groen, R. N., Clercq, N. C. de, Nieuwdorp, M., Hoenders, H. J. R., & Groen, A. K. (2018). Gut 
microbiota, metabolism and psychopathology: A critical review and novel perspectives. 
Critical Reviews in Clinical Laboratory Sciences, 55(4), 283–293. 
https://doi.org/10.1080/10408363.2018.1463507 
133 
Gromova, I., Gromov, P., Kroman, N., Wielenga, V. T., Simon, R., Sauter, G., & Moreira, J. M. 
A. (2012). Immunoexpression Analysis and Prognostic Value of BLCAP in Breast
Cancer. PLoS ONE, 7(9). https://doi.org/10.1371/journal.pone.0045967 
Guintivano, J., Arad, M., Gould, T. D., Payne, J. L., & Kaminsky, Z. A. (2014). Antenatal 
prediction of postpartum depression with blood DNA methylation biomarkers. Molecular 
Psychiatry, 19(5), 560–567. https://doi.org/10.1038/mp.2013.62 
Han, K.-M., Won, E., Kang, J., Choi, S., Kim, A., Lee, M.-S., Tae, W.-S., & Ham, B.-J. (2017). 
TESC gene-regulating genetic variant (rs7294919) affects hippocampal subfield volumes 
and parahippocampal cingulum white matter integrity in major depressive disorder. 
Journal of Psychiatric Research, 93, 20–29. 
https://doi.org/10.1016/j.jpsychires.2017.05.010 
Handy, D. E., Castro, R., & Loscalzo, J. (2011). Epigenetic Modifications: Basic Mechanisms 
and Role in Cardiovascular Disease. Circulation, 123(19), 2145–2156. 
https://doi.org/10.1161/CIRCULATIONAHA.110.956839 
Hankin, B. L., Young, J. F., Abela, J. R. Z., Smolen, A., Jenness, J. L., Gulley, L. D., Technow, 
J. R., Gottlieb, A. B., Cohen, J. R., & Oppenheimer, C. W. (2015a). Depression from
childhood into late adolescence: Influence of gender, development, genetic susceptibility, 
and peer stress. Journal of Abnormal Psychology, 124(4), 803–816. 
https://doi.org/10.1037/abn0000089 
Hankin, B. L., Young, J. F., Abela, J. R. Z., Smolen, A., Jenness, J. L., Gulley, L. D., Technow, 
J. R., Gottlieb, A. B., Cohen, J. R., & Oppenheimer, C. W. (2015b). Depression from
childhood into late adolescence: Influence of gender, development, genetic susceptibility, 
134 
and peer stress. Journal of Abnormal Psychology, 124(4), 803–816. 
https://doi.org/10.1037/abn0000089 
Hannon, E., Lunnon, K., Schalkwyk, L., & Mill, J. (2015). Interindividual methylomic variation 
across blood, cortex, and cerebellum: Implications for epigenetic studies of neurological 
and neuropsychiatric phenotypes. Epigenetics, 10(11), 1024–1032. 
https://doi.org/10.1080/15592294.2015.1100786 
Hasegawa, S., Noda, K., Maeda, A., Matsuoka, M., Yamasaki, M., & Fukui, T. (2012). 
Acetoacetyl-CoA synthetase, a ketone body-utilizing enzyme, is controlled by SREBP-2 
and affects serum cholesterol levels. Molecular Genetics and Metabolism, 107(3), 553–
560. https://doi.org/10.1016/j.ymgme.2012.08.017
Heijmans, B. T., Tobi, E. W., Stein, A. D., Putter, H., Blauw, G. J., Susser, E. S., Slagboom, P. 
E., & Lumey, L. H. (2008). Persistent epigenetic differences associated with prenatal 
exposure to famine in humans. Proceedings of the National Academy of Sciences, 
105(44), 17046–17049. https://doi.org/10.1073/pnas.0806560105 
Heinrichs, M., von Dawans, B., & Domes, G. (2009). Oxytocin, vasopressin, and human social 
behavior. Frontiers in Neuroendocrinology, 30(4), 548–557. 
https://doi.org/10.1016/j.yfrne.2009.05.005 
Henderson, J., Gray, R., & Brocklehurst, P. (2007). Systematic review of effects of low–
moderate prenatal alcohol exposure on pregnancy outcome. BJOG: An International 
Journal of Obstetrics & Gynaecology, 114(3), 243–252. https://doi.org/10.1111/j.1471-
0528.2006.01163.x 
135 
Ho, S.-M., Johnson, A., Tarapore, P., Janakiram, V., Zhang, X., & Leung, Y.-K. (2012). 
Environmental Epigenetics and Its Implication on Disease Risk and Health Outcomes. 
ILAR Journal, 53(3–4), 289–305. https://doi.org/10.1093/ilar.53.3-4.289 
Hompes, T., Izzi, B., Gellens, E., Morreels, M., Fieuws, S., Pexsters, A., Schops, G., Dom, M., 
Van Bree, R., Freson, K., Verhaeghe, J., Spitz, B., Demyttenaere, K., Glover, V., Van 
den Bergh, B., Allegaert, K., & Claes, S. (2013). Investigating the influence of maternal 
cortisol and emotional state during pregnancy on the DNA methylation status of the 
glucocorticoid receptor gene (NR3C1) promoter region in cord blood. Journal of 
Psychiatric Research, 47(7), 880–891. https://doi.org/10.1016/j.jpsychires.2013.03.009 
Horbach, T., Götz, C., Kietzmann, T., & Dimova, E. Y. (2015). Protein kinases as switches for 
the function of upstream stimulatory factors: Implications for tissue injury and cancer. 
Frontiers in Pharmacology, 6. https://doi.org/10.3389/fphar.2015.00003 
Houseman, E. A., Kile, M. L., Christiani, D. C., Ince, T. A., Kelsey, K. T., & Marsit, C. J. 
(2016). Reference-free deconvolution of DNA methylation data and mediation by cell 
composition effects. BMC Bioinformatics, 17(1), 259. https://doi.org/10.1186/s12859-
016-1140-4
Houtepen, L. C., Vinkers, C. H., Carrillo-Roa, T., Hiemstra, M., van Lier, P. A., Meeus, W., 
Branje, S., Heim, C. M., Nemeroff, C. B., Mill, J., Schalkwyk, L. C., Creyghton, M. P., 
Kahn, R. S., Joëls, M., Binder, E. B., & Boks, M. P. M. (2016). Genome-wide DNA 
methylation levels and altered cortisol stress reactivity following childhood trauma in 
humans. Nature Communications, 7(1), 10967. https://doi.org/10.1038/ncomms10967 
136 
Insel, T. R., & Cuthbert, B. N. (2009). Endophenotypes: Bridging genomic complexity and 
disorder heterogeneity. Biological Psychiatry, 66(11), 988–989. 
https://doi.org/10.1016/j.biopsych.2009.10.008 
Irizarry, R. A., Ladd-Acosta, C., Wen, B., Wu, Z., Montano, C., Onyango, P., Cui, H., Gabo, K., 
Rongione, M., Webster, M., Ji, H., Potash, J. B., Sabunciyan, S., & Feinberg, A. P. 
(2009). The human colon cancer methylome shows similar hypo- and hypermethylation 
at conserved tissue-specific CpG island shores. Nature Genetics, 41(2), 178–186. 
https://doi.org/10.1038/ng.298 
Ismail, P. M., Lu, T., & Sawadogo, M. (1999). Loss of USF transcriptional activity in breast 
cancer cell lines. Oncogene, 18(40), 5582–5591. https://doi.org/10.1038/sj.onc.1202932 
Iso, T., Chung, G., Hamamori, Y., & Kedes, L. (2002). HERP1 Is a Cell Type-specific Primary 
Target of Notch. Journal of Biological Chemistry, 277(8), 6598–6607. 
https://doi.org/10.1074/jbc.M110495200 
Jack, A., Connelly, J. J., & Morris, J. P. (2012). DNA methylation of the oxytocin receptor gene 
predicts neural response to ambiguous social stimuli. Frontiers in Human Neuroscience, 
6. https://doi.org/10.3389/fnhum.2012.00280
Jaenisch, R., & Bird, A. (2003). Epigenetic regulation of gene expression: How the genome 
integrates intrinsic and environmental signals. Nature Genetics, 33 Suppl, 245–254. 
https://doi.org/10.1038/ng1089 
Jaffee, S. R., Caspi, A., Moffitt, T. E., Polo-Tomás, M., & Taylor, A. (2007). Individual, family, 
and neighborhood factors distinguish resilient from non-resilient maltreated children: A 
cumulative stressors model. Child Abuse & Neglect, 31(3), 231–253. 
https://doi.org/10.1016/j.chiabu.2006.03.011 
137 
Johnson, W. E., Li, C., & Rabinovic, A. (2007). Adjusting batch effects in microarray expression 
data using empirical Bayes methods. Biostatistics, 8(1), 118–127. 
https://doi.org/10.1093/biostatistics/kxj037 
Joinson, C., Heron, J., Araya, R., Paus, T., Croudace, T., Rubin, C., Marcus, M., & Lewis, G. 
(2012). Association between pubertal development and depressive symptoms in girls 
from a UK cohort. Psychological Medicine, 42(12), 2579–2589. 
https://doi.org/10.1017/S003329171200061X 
Jones, P. A. (2012). Functions of DNA methylation: Islands, start sites, gene bodies and beyond. 
Nature Reviews Genetics, 13(7), 484–492. https://doi.org/10.1038/nrg3230 
Ju, C., Fiori, L. M., Belzeaux, R., Theroux, J.-F., Chen, G. G., Aouabed, Z., Blier, P., Farzan, F., 
Frey, B. N., Giacobbe, P., Lam, R. W., Leri, F., MacQueen, G. M., Milev, R., Müller, D. 
J., Parikh, S. V., Rotzinger, S., Soares, C. N., Uher, R., … Turecki, G. (2019). Integrated 
genome-wide methylation and expression analyses reveal functional predictors of 
response to antidepressants. Translational Psychiatry, 9(1), 254. 
https://doi.org/10.1038/s41398-019-0589-0 
Jung, T., & Wickrama, K. a. S. (2008). An Introduction to Latent Class Growth Analysis and 
Growth Mixture Modeling. Social and Personality Psychology Compass, 2(1), 302–317. 
https://doi.org/10.1111/j.1751-9004.2007.00054.x 
Kandel, D. B., Johnson, J. G., Bird, H. R., Weissman, M. M., Goodman, S. H., Lahey, B. B., 
Regier, D. A., & Schwab-stone, M. E. (1999). Psychiatric Comorbidity Among 
Adolescents With Substance Use Disorders: Findings From the MECA Study. Journal of 
the American Academy of Child & Adolescent Psychiatry, 38(6), 693–699. 
https://doi.org/10.1097/00004583-199906000-00016 
138 
Kaplan, G. A., & Reynolds, P. (1988). Depression and cancer mortality and morbidity: 
Prospective evidence from the Alameda County study. Journal of Behavioral Medicine, 
11(1), 1–13. https://doi.org/10.1007/BF00846165 
Kaut, O., Schmitt, I., Hofmann, A., Hoffmann, P., Schlaepfer, T. E., Wüllner, U., & Hurlemann, 
R. (2015). Aberrant NMDA receptor DNA methylation detected by epigenome-wide
analysis of hippocampus and prefrontal cortex in major depression. European Archives of 
Psychiatry and Clinical Neuroscience, 265(4), 331–341. https://doi.org/10.1007/s00406-
014-0572-y
Keller, S., Sarchiapone, M., Zarrilli, F., Videtič, A., Ferraro, A., Carli, V., Sacchetti, S., Lembo, 
F., Angiolillo, A., Jovanovic, N., Pisanti, F., Tomaiuolo, R., Monticelli, A., Balazic, J., 
Roy, A., Marusic, A., Cocozza, S., Fusco, A., Bruni, C. B., … Chiariotti, L. (2010). 
Increased BDNF Promoter Methylation in the Wernicke Area of Suicide Subjects. 
Archives of General Psychiatry, 67(3), 258–267. 
https://doi.org/10.1001/archgenpsychiatry.2010.9 
Kendler, K. S., Karkowski, L. M., & Prescott, C. A. (1999). Causal relationship between 
stressful life events and the onset of major depression. The American Journal of 
Psychiatry, 156(6), 837–841. https://doi.org/10.1176/ajp.156.6.837 
Kendler, K. S., Thornton, L. M., & Gardner, C. O. (2001). Genetic risk, number of previous 
depressive episodes, and stressful life events in predicting onset of major depression. The 
American Journal of Psychiatry, 158(4), 582–586. 
https://doi.org/10.1176/appi.ajp.158.4.582 
Kessler, R. C., Berglund, P., Demler, O., Jin, R., Merikangas, K. R., & Walters, E. E. (2005). 
Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National 
139 
Comorbidity Survey Replication. Archives of General Psychiatry, 62(6), 593–602. 
https://doi.org/10.1001/archpsyc.62.6.593 
Kiecolt-Glaser, J. K., Robles, T. F., Heffner, K. L., Loving, T. J., & Glaser, R. (2002). Psycho-
oncology and cancer: Psychoneuroimmunology and cancer. Annals of Oncology: Official 
Journal of the European Society for Medical Oncology, 13 Suppl 4, 165–169. 
https://doi.org/10.1093/annonc/mdf655 
Kim, J. K., Samaranayake, M., & Pradhan, S. (2008). Epigenetic mechanisms in mammals. 
Cellular and Molecular Life Sciences, 66(4), 596. https://doi.org/10.1007/s00018-008-
8432-4 
Kim-Cohen, J., Moffitt, T. E., Caspi, A., & Taylor, A. (2004). Genetic and Environmental 
Processes in Young Children’s Resilience and Vulnerability to Socioeconomic 
Deprivation. Child Development, 75(3), 651–668. https://doi.org/10.1111/j.1467-
8624.2004.00699.x 
Kivinen, A., Patrikainen, L., Kurkela, R., Porvari, K., & Vihko, P. (2004). USF2 is connected to 
GAAAATATGATA element and associates with androgen receptor-dependent 
transcriptional regulation in prostate. The Prostate, 59(2), 190–202. 
https://doi.org/10.1002/pros.20015 
Klengel, T., Mehta, D., Anacker, C., Rex-Haffner, M., Pruessner, J. C., Pariante, C. M., Pace, T. 
W. W., Mercer, K. B., Mayberg, H. S., Bradley, B., Nemeroff, C. B., Holsboer, F., Heim,
C. M., Ressler, K. J., Rein, T., & Binder, E. B. (2013). Allele-specific FKBP5 DNA
demethylation mediates gene–childhood trauma interactions. Nature Neuroscience, 16(1), 
33–41. https://doi.org/10.1038/nn.3275 
140 
Klose, R. J., & Bird, A. P. (2006). Genomic DNA methylation: The mark and its mediators. 
Trends in Biochemical Sciences, 31(2), 89–97. https://doi.org/10.1016/j.tibs.2005.12.008 
Kochetkova, M., McKenzie, O. L. D., Bais, A. J., Martin, J. M., Secker, G. A., Seshadri, R., 
Powell, J. A., Hinze, S. J., Gardner, A. E., Spendlove, H. E., O’Callaghan, N. J., Cleton-
Jansen, A.-M., Cornelisse, C., Whitmore, S. A., Crawford, J., Kremmidiotis, G., 
Sutherland, G. R., & Callen, D. F. (2002). CBFA2T3 (MTG16) Is a Putative Breast 
Tumor Suppressor Gene from the Breast Cancer Loss of Heterozygosity Region at 
16q24.3. Cancer Research, 62(16), 4599–4604. 
Koenen, K. C., Nugent, N. R., & Amstadter, A. B. (2008). Gene-environment interaction in 
posttraumatic stress disorder. European Archives of Psychiatry and Clinical 
Neuroscience, 258(2), 82–96. https://doi.org/10.1007/s00406-007-0787-2 
Kular, L., & Kular, S. (2018). Epigenetics applied to psychiatry: Clinical opportunities and 
future challenges. Psychiatry and Clinical Neurosciences, 72(4), 195–211. 
https://doi.org/10.1111/pcn.12634 
Kumar, R., Manning, J., Spendlove, H. E., Kremmidiotis, G., McKirdy, R., Lee, J., Millband, D. 
N., Cheney, K. M., Stampfer, M. R., Dwivedi, P. P., Morris, H. A., & Callen, D. F. 
(2006). ZNF652, A Novel Zinc Finger Protein, Interacts with the Putative Breast Tumor 
Suppressor CBFA2T3 to Repress Transcription. Molecular Cancer Research, 4(9), 655–
665. https://doi.org/10.1158/1541-7786.MCR-05-0249
Kumsta, R., Hummel, E., Chen, F. S., & Heinrichs, M. (2013). Epigenetic regulation of the 
oxytocin receptor gene: Implications for behavioral neuroscience. Frontiers in 
Neuroscience, 7. https://doi.org/10.3389/fnins.2013.00083 
141 
Küpers, L. K., Xu, X., Jankipersadsing, S. A., Vaez, A., la Bastide-van Gemert, S., Scholtens, S., 
Nolte, I. M., Richmond, R. C., Relton, C. L., Felix, J. F., Duijts, L., van Meurs, J. B., 
Tiemeier, H., Jaddoe, V. W., Wang, X., Corpeleijn, E., & Snieder, H. (2015). DNA 
methylation mediates the effect of maternal smoking during pregnancy on birthweight of 
the offspring. International Journal of Epidemiology, 44(4), 1224–1237. 
https://doi.org/10.1093/ije/dyv048 
Kusui, C., Kimura, T., Ogita, K., Nakamura, H., Matsumura, Y., Koyama, M., Azuma, C., & 
Murata, Y. (2001). DNA Methylation of the Human Oxytocin Receptor Gene Promoter 
Regulates Tissue-Specific Gene Suppression. Biochemical and Biophysical Research 
Communications, 289(3), 681–686. https://doi.org/10.1006/bbrc.2001.6024 
Kwong, A. S. F., López-López, J. A., Hammerton, G., Manley, D., Timpson, N. J., Leckie, G., & 
Pearson, R. M. (2019). Genetic and Environmental Risk Factors Associated With 
Trajectories of Depression Symptoms From Adolescence to Young Adulthood. JAMA 
Network Open, 2(6). https://doi.org/10.1001/jamanetworkopen.2019.6587 
Labonte, B., Yerko, V., Gross, J., Mechawar, N., Meaney, M. J., Szyf, M., & Turecki, G. (2012). 
Differential glucocorticoid receptor exon 1(B), 1(C), and 1(H) expression and 
methylation in suicide completers with a history of childhood abuse. Biological 
Psychiatry, 72(1), 41–48. https://doi.org/10.1016/j.biopsych.2012.01.034 
Lam, L. L., Emberly, E., Fraser, H. B., Neumann, S. M., Chen, E., Miller, G. E., & Kobor, M. S. 
(2012). Factors underlying variable DNA methylation in a human community cohort. 
Proceedings of the National Academy of Sciences, 109(Supplement 2), 17253–17260. 
https://doi.org/10.1073/pnas.1121249109 
142 
Larsson, H., Chang, Z., D’Onofrio, B. M., & Lichtenstein, P. (2014). The heritability of 
clinically diagnosed attention deficit hyperactivity disorder across the lifespan. 
Psychological Medicine, 44(10), 2223–2229. 
https://doi.org/10.1017/S0033291713002493 
Lau, J. Y. F., Gregory, A. M., Goldwin, M. A., Pine, D. S., & Eley, T. C. (2007). Assessing 
gene–environment interactions on anxiety symptom subtypes across childhood and 
adolescence. Development and Psychopathology, 19(4), 1129–1146. 
https://doi.org/10.1017/S0954579407000582 
LAUCHT, M., ESSER, G., BAVING, L., GERHOLD, M., HOESCH, I., IHLE, W., 
STEIGLEIDER, P., STOCK, B., STOEHR, R. M., WEINDRICH, D., & SCHMIDT, M. 
H. (2000). Behavioral Sequelae of Perinatal Insults and Early Family Adversity at 8
Years of Age. Journal of the American Academy of Child & Adolescent Psychiatry, 
39(10), 1229–1237. https://doi.org/10.1097/00004583-200010000-00009 
Laufer, B. I., Kapalanga, J., Castellani, C. A., Diehl, E. J., Yan, L., & Singh, S. M. (2015). 
Associative DNA methylation changes in children with prenatal alcohol exposure. 
Epigenomics, 7(8), 1259–1274. https://doi.org/10.2217/epi.15.60 
Lee, H., Jaffe, A. E., Feinberg, J. I., Tryggvadottir, R., Brown, S., Montano, C., Aryee, M. J., 
Irizarry, R. A., Herbstman, J., Witter, F. R., Goldman, L. R., Feinberg, A. P., & Fallin, 
M. D. (2012). DNA methylation shows genome-wide association of NFIX, RAPGEF2
and MSRB3 with gestational age at birth. International Journal of Epidemiology, 41(1), 
188–199. https://doi.org/10.1093/ije/dyr237 
Lee, K. W. K., & Pausova, Z. (2013). Cigarette smoking and DNA methylation. Frontiers in 
Genetics, 4. https://doi.org/10.3389/fgene.2013.00132 
143 
Lee Ken W.K., Richmond Rebecca, Hu Pingzhao, French Leon, Shin Jean, Bourdon Celine, 
Reischl Eva, Waldenberger Melanie, Zeilinger Sonja, Gaunt Tom, McArdle Wendy, Ring 
Susan, Woodward Geoff, Bouchard Luigi, Gaudet Daniel, Smith George Davey, Relton 
Caroline, Paus Tomas, & Pausova Zdenka. (2015). Prenatal Exposure to Maternal 
Cigarette Smoking and DNA Methylation: Epigenome-Wide Association in a Discovery 
Sample of Adolescents and Replication in an Independent Cohort at Birth through 17 
Years of Age. Environmental Health Perspectives, 123(2), 193–199. 
https://doi.org/10.1289/ehp.1408614 
Li, M., D’Arcy, C., Li, X., Zhang, T., Joober, R., & Meng, X. (2019). What do DNA methylation 
studies tell us about depression? A systematic review. Translational Psychiatry, 9(1), 1–
14. https://doi.org/10.1038/s41398-019-0412-y
Lilienfeld, S. O. (2014). The Research Domain Criteria (RDoC): An analysis of methodological 
and conceptual challenges. Behaviour Research and Therapy, 62, 129–139. 
https://doi.org/10.1016/j.brat.2014.07.019 
Lin, E., & Tsai, S.-J. (2019). Epigenetics and Depression: An Update. Psychiatry Investigation, 
16(9), 654–661. https://doi.org/10.30773/pi.2019.07.17.2 
Lin, P.-Y., & Su, K.-P. (2007). A meta-analytic review of double-blind, placebo-controlled trials 
of antidepressant efficacy of omega-3 fatty acids. The Journal of Clinical Psychiatry, 
68(7), 1056–1061. 
Lohoff, F. W. (2010). Overview of the Genetics of Major Depressive Disorder. Current 
Psychiatry Reports, 12(6), 539–546. https://doi.org/10.1007/s11920-010-0150-6 
144 
Lorenzo-Luaces, L. (2015). Heterogeneity in the prognosis of major depression: From the 
common cold to a highly debilitating and recurrent illness. Epidemiology and Psychiatric 
Sciences, 24(6), 466–472. https://doi.org/10.1017/S2045796015000542 
Luppino, F. S., Wit, L. M. de, Bouvy, P. F., Stijnen, T., Cuijpers, P., Penninx, B. W. J. H., & 
Zitman, F. G. (2010). Overweight, Obesity, and Depression: A Systematic Review and 
Meta-analysis of Longitudinal Studies. Archives of General Psychiatry, 67(3), 220–229. 
https://doi.org/10.1001/archgenpsychiatry.2010.2 
Luthar, S. S., Cicchetti, D., & Becker, B. (2000). The Construct of Resilience: A Critical 
Evaluation and Guidelines for Future Work. Child Development, 71(3), 543–562. 
Luthar, S. S., Crossman, E. J., & Small, P. J. (n.d.). Resilience and adversity. Handbook of Child 
Psychology and Developmental Science. Retrieved September 4, 2015, from 
http://onlinelibrary.wiley.com/doi/10.1002/9781118963418.childpsy307/full 
Lutz, P.-E., & Turecki, G. (2014). DNA methylation and childhood maltreatment: From animal 
models to human studies. Neuroscience, 264, 142–156. 
https://doi.org/10.1016/j.neuroscience.2013.07.069 
Mamrut, S., Harony, H., Sood, R., Shahar-Gold, H., Gainer, H., Shi, Y.-J., Barki-Harrington, L., 
& Wagner, S. (2013). DNA Methylation of Specific CpG Sites in the Promoter Region 
Regulates the Transcription of the Mouse Oxytocin Receptor. PLoS ONE, 8(2), e56869. 
https://doi.org/10.1371/journal.pone.0056869 
Mannoor, K., Shen, J., Liao, J., Liu, Z., & Jiang, F. (2014). Small nucleolar RNA signatures of 
lung tumor-initiating cells. Molecular Cancer, 13(1), 104. https://doi.org/10.1186/1476-
4598-13-104 
145 
Martens-Uzunova, E. S., Hoogstrate, Y., Kalsbeek, A., Pigmans, B., Vredenbregt-van den Berg, 
M., Dits, N., Nielsen, S. J., Baker, A., Visakorpi, T., Bangma, C., & Jenster, G. (2015). 
C/D-box snoRNA-derived RNA production is associated with malignant transformation 
and metastatic progression in prostate cancer. Oncotarget, 6(19), 17430–17444. 
Martinez-Torteya, C., Anne Bogat, G., Von Eye, A., & Levendosky, A. A. (2009). Resilience 
Among Children Exposed to Domestic Violence: The Role of Risk and Protective 
Factors. Child Development, 80(2), 562–577. https://doi.org/10.1111/j.1467-
8624.2009.01279.x 
Masten, A. S. (2013). Risk and Resilience in Development. 
https://doi.org/10.1093/oxfordhb/9780199958474.013.0023 
Matthews, J. M., & Visvader, J. E. (2003). LIM-domain-binding protein 1: A multifunctional 
cofactor that interacts with diverse proteins. EMBO Reports, 4(12), 1132–1137. 
https://doi.org/10.1038/sj.embor.7400030 
Maunakea, A. K., Nagarajan, R. P., Bilenky, M., Ballinger, T. J., D’Souza, C., Fouse, S. D., 
Johnson, B. E., Hong, C., Nielsen, C., Zhao, Y., Turecki, G., Delaney, A., Varhol, R., 
Thiessen, N., Shchors, K., Heine, V. M., Rowitch, D. H., Xing, X., Fiore, C., … Costello, 
J. F. (2010). Conserved role of intragenic DNA methylation in regulating alternative 
promoters. Nature, 466(7303), 253–257. https://doi.org/10.1038/nature09165 
Mayer, E. A., & Hsiao, E. Y. (2017). The gut and its microbiome as related to central nervous 
system functioning and psychological wellbeing: Introduction to the Special Issue of 
Psychosomatic Medicine. Psychosomatic Medicine, 79(8), 844–846. 
https://doi.org/10.1097/PSY.0000000000000525 
146 
McCrory, E., De Brito, S. A., & Viding, E. (2012). The link between child abuse and 
psychopathology: A review of neurobiological and genetic research. Journal of the Royal 
Society of Medicine, 105(4), 151–156. https://doi.org/10.1258/jrsm.2011.110222 
McGowan, P. O., Sasaki, A., D’Alessio, A. C., Dymov, S., Labonté, B., Szyf, M., Turecki, G., & 
Meaney, M. J. (2009). Epigenetic regulation of the glucocorticoid receptor in human 
brain associates with childhood abuse. Nature Neuroscience, 12(3), 342. 
https://doi.org/10.1038/nn.2270 
McLaughlin, K. A., & Lambert, H. K. (2017). Child trauma exposure and psychopathology: 
Mechanisms of risk and resilience. Current Opinion in Psychology, 14, 29–34. 
https://doi.org/10.1016/j.copsyc.2016.10.004 
Mehta, D., Newport, D. J., Frishman, G., Kraus, L., Rex-Haffner, M., Ritchie, J. C., Lori, A., 
Knight, B. T., Stagnaro, E., Ruepp, A., Stowe, Z. N., & Binder, E. B. (2014). Early 
predictive biomarkers for postpartum depression point to a role for estrogen receptor 
signaling. Psychological Medicine, 44(11), 2309–2322. 
https://doi.org/10.1017/S0033291713003231 
Mehta, Divya, Bruenig, D., Lawford, B., Harvey, W., Carrillo-Roa, T., Morris, C. P., Jovanovic, 
T., Young, R. McD., Binder, E. B., & Voisey, J. (2018). Accelerated DNA methylation 
aging and increased resilience in veterans: The biological cost for soldiering on. 
Neurobiology of Stress, 8, 112–119. https://doi.org/10.1016/j.ynstr.2018.04.001 
Melas, P. A., & Forsell, Y. (2015). Hypomethylation of MAOA’s first exon region in depression: 
A replication study. Psychiatry Research, 226(1), 389–391. 
https://doi.org/10.1016/j.psychres.2015.01.003 
147 
Merikangas, K. R., He, J., Burstein, M., Swanson, S. A., Avenevoli, S., Cui, L., Benjet, C., 
Georgiades, K., & Swendsen, J. (2010a). Lifetime Prevalence of Mental Disorders in US 
Adolescents: Results from the National Comorbidity Study-Adolescent Supplement 
(NCS-A). Journal of the American Academy of Child and Adolescent Psychiatry, 49(10), 
980–989. https://doi.org/10.1016/j.jaac.2010.05.017 
Merikangas, K. R., He, J., Burstein, M., Swanson, S. A., Avenevoli, S., Cui, L., Benjet, C., 
Georgiades, K., & Swendsen, J. (2010b). Lifetime Prevalence of Mental Disorders in 
U.S. Adolescents: Results from the National Comorbidity Survey Replication–
Adolescent Supplement (NCS-A). Journal of the American Academy of Child & 
Adolescent Psychiatry, 49(10), 980–989. https://doi.org/10.1016/j.jaac.2010.05.017 
Miller, A. H., Maletic, V., & Raison, C. L. (2009). Inflammation and Its Discontents: The Role 
of Cytokines in the Pathophysiology of Major Depression. Biological Psychiatry, 65(9), 
732–741. https://doi.org/10.1016/j.biopsych.2008.11.029 
Mitchell, R. H. B., & Goldstein, B. I. (2014). Inflammation in Children and Adolescents With 
Neuropsychiatric Disorders: A Systematic Review. Journal of the American Academy of 
Child & Adolescent Psychiatry, 53(3), 274–296. 
https://doi.org/10.1016/j.jaac.2013.11.013 
Monk, C., Feng, T., Lee, S., Krupska, I., Champagne, F. A., & Tycko, B. (2016). Distress During 
Pregnancy: Epigenetic Regulation of Placenta Glucocorticoid-Related Genes and Fetal 
Neurobehavior. American Journal of Psychiatry, 173(7), 705–713. 
https://doi.org/10.1176/appi.ajp.2015.15091171 
148 
Monroe, S. M., & Anderson, S. F. (2015). Depression: The Shroud of Heterogeneity. Current 
Directions in Psychological Science, 24(3), 227–231. 
https://doi.org/10.1177/0963721414568342 
Moran, P., Ford, T., Butler, G., & Goodman, R. (2008). Callous and unemotional traits in 
children and adolescents living in Great Britain. The British Journal of Psychiatry, 
192(1), 65–66. https://doi.org/10.1192/bjp.bp.106.034876 
Mostafavi, S., Ray, D., Warde-Farley, D., Grouios, C., & Morris, Q. (2008). GeneMANIA: A 
real-time multiple association network integration algorithm for predicting gene function. 
Genome Biology, 9(1), S4. https://doi.org/10.1186/gb-2008-9-s1-s4 
Mulligan, C., D’Errico, N., Stees, J., & Hughes, D. (2012). Methylation changes at NR3C1 in 
newborns associate with maternal prenatal stress exposure and newborn birth weight. 
Epigenetics, 7(8), 853–857. https://doi.org/10.4161/epi.21180 
Murphy, S. K., Adigun, A., Huang, Z., Overcash, F., Wang, F., Jirtle, R. L., Schildkraut, J. M., 
Murtha, A. P., Iversen, E. S., & Hoyo, C. (2012). Gender-specific methylation 
differences in relation to prenatal exposure to cigarette smoke. Gene, 494(1), 36–43. 
https://doi.org/10.1016/j.gene.2011.11.062 
Muthén, L. K., & Muthén, B. O. (1998). Mplus: User’s manual. Los Angeles: Muthen and 
Muthen. 
Na, K.-S., Chang, H. S., Won, E., Han, K.-M., Choi, S., Tae, W. S., Yoon, H.-K., Kim, Y.-K., 
Joe, S.-H., Jung, I.-K., Lee, M.-S., & Ham, B.-J. (2014). Association between 
Glucocorticoid Receptor Methylation and Hippocampal Subfields in Major Depressive 
Disorder. PLoS ONE, 9(1). https://doi.org/10.1371/journal.pone.0085425 
149 
Na, K.-S., Won, E., Kang, J., Chang, H. S., Yoon, H.-K., Tae, W. S., Kim, Y.-K., Lee, M.-S., 
Joe, S.-H., Kim, H., & Ham, B.-J. (2016). Brain-derived neurotrophic factor promoter 
methylation and cortical thickness in recurrent major depressive disorder. Scientific 
Reports, 6. https://doi.org/10.1038/srep21089 
Nagy, C., Suderman, M., Yang, J., Szyf, M., Mechawar, N., Ernst, C., & Turecki, G. (2015). 
Astrocytic abnormalities and global DNA methylation patterns in depression and suicide. 
Molecular Psychiatry, 20(3), 320–328. https://doi.org/10.1038/mp.2014.21 
Nantharat, M., Wanitchanon, T., Amesbutr, M., Tammachote, R., & Praphanphoj, V. (2015). 
Glucocorticoid receptor gene (NR3C1) promoter is hypermethylated in Thai females with 
major depressive disorder. Genetics and Molecular Research: GMR, 14(4), 19071–
19079. https://doi.org/10.4238/2015.December.29.15 
Neumann, A., Walton, E., Alemany, S., Cecil, C., González, J. R., Jima, D. D., Lahti, J., 
Tuominen, S. T., Barker, E. D., Binder, E., Caramaschi, D., Carracedo, Á., Czamara, D., 
Evandt, J., Felix, J. F., Fuemmeler, B. F., Gutzkow, K. B., Hoyo, C., Julvez, J., … 
Tiemeier, H. (2019). Association between DNA methylation and ADHD symptoms from 
birth to school age: A prospective meta-analysis. BioRxiv, 806844. 
https://doi.org/10.1101/806844 
Nguyen, T. T., Kosciolek, T., Eyler, L. T., Knight, R., & Jeste, D. V. (2018). Overview and 
Systematic Review of Studies of Microbiome in Schizophrenia and Bipolar Disorder. 
Journal of Psychiatric Research, 99, 50–61. 
https://doi.org/10.1016/j.jpsychires.2018.01.013 
Niarchou, M., Zammit, S., & Lewis, G. (2015). The Avon Longitudinal Study of Parents and 
Children (ALSPAC) birth cohort as a resource for studying psychopathology in 
150 
childhood and adolescence: A summary of findings for depression and psychosis. Social 
Psychiatry and Psychiatric Epidemiology, 50(7), 1017–1027. 
https://doi.org/10.1007/s00127-015-1072-8 
Nugent, N. R., Tyrka, A. R., Carpenter, L. L., & Price, L. H. (2011). Gene–environment 
interactions: Early life stress and risk for depressive and anxiety disorders. 
Psychopharmacology, 214(1), 175–196. https://doi.org/10.1007/s00213-010-2151-x 
Numata, S., Ishii, K., Tajima, A., Iga, J., Kinoshita, M., Watanabe, S., Umehara, H., Fuchikami, 
M., Okada, S., Boku, S., Hishimoto, A., Shimodera, S., Imoto, I., Morinobu, S., & 
Ohmori, T. (2015). Blood diagnostic biomarkers for major depressive disorder using 
multiplex DNA methylation profiles: Discovery and validation. Epigenetics, 10(2), 135–
141. https://doi.org/10.1080/15592294.2014.1003743
Nylund, K. L., Asparouhov, T., & Muthén, B. O. (2007). Deciding on the Number of Classes in 
Latent Class Analysis and Growth Mixture Modeling: A Monte Carlo Simulation Study. 
Structural Equation Modeling: A Multidisciplinary Journal, 14(4), 535–569. 
https://doi.org/10.1080/10705510701575396 
Oberlander, T. F., Papsdorf, M., Brain, U. M., Misri, S., Ross, C., & Grunau, R. E. (2010). 
Prenatal Effects of Selective Serotonin Reuptake Inhibitor Antidepressants, Serotonin 
Transporter Promoter Genotype (SLC6A4), and Maternal Mood on Child Behavior at 3 
Years of Age. Archives of Pediatrics & Adolescent Medicine, 164(5), 444–451. 
https://doi.org/10.1001/archpediatrics.2010.51 
Oberlander, T. F., Weinberg, J., Papsdorf, M., Grunau, R., Misri, S., & Devlin, A. M. (2008). 
Prenatal exposure to maternal depression, neonatal methylation of human glucocorticoid 
151 
receptor gene (NR3C1) and infant cortisol stress responses. Epigenetics, 3(2), 97–106. 
https://doi.org/10.4161/epi.3.2.6034 
O’Connor, T. G., Heron, J., Golding, J., Beveridge, M., & Glover, V. (2002). Maternal antenatal 
anxiety and children’s behavioural/emotional problems at 4 years. Report from the Avon 
Longitudinal Study of Parents and Children. The British Journal of Psychiatry: The 
Journal of Mental Science, 180, 502–508. https://doi.org/10.1192/bjp.180.6.502 
O’Donnell, K. J., Glover, V., Barker, E. D., & O’Connor, T. G. (2014). The persisting effect of 
maternal mood in pregnancy on childhood psychopathology. Development and 
Psychopathology, 26(02), 393–403. https://doi.org/10.1017/S0954579414000029 
O’Donnell, K. J., & Meaney, M. J. (2020). Epigenetics, Development, and Psychopathology. 
Annual Review of Clinical Psychology, 16, 327–350. https://doi.org/10.1146/annurev-
clinpsy-050718-095530 
Oerlemans, M. E., van den Akker, M., Schuurman, A. G., Kellen, E., & Buntinx, F. (2007). A 
meta-analysis on depression and subsequent cancer risk. Clinical Practice and 
Epidemiology in Mental Health, 3(1), 29. https://doi.org/10.1186/1745-0179-3-29 
Okugawa, Y., Toiyama, Y., Toden, S., Mitoma, H., Nagasaka, T., Tanaka, K., Inoue, Y., 
Kusunoki, M., Boland, C. R., & Goel, A. (2017). Clinical significance of SNORA42 as 
an oncogene and a prognostic biomarker in colorectal cancer. Gut, 66(1), 107–117. 
https://doi.org/10.1136/gutjnl-2015-309359 
Oland, A. A., & Shaw, D. S. (2005). Pure Versus Co-occurring Externalizing and Internalizing 
Symptoms in Children: The Potential Role of Socio-Developmental Milestones. Clinical 
Child and Family Psychology Review, 8(4), 247–270. https://doi.org/10.1007/s10567-
005-8808-z
152 
Ouellet-Morin, I., Wong, C. C. Y., Danese, A., Pariante, C. M., Papadopoulos, A. S., Mill, J., & 
Arseneault, L. (2013). Increased serotonin transporter gene (SERT) DNA methylation is 
associated with bullying victimization and blunted cortisol response to stress in 
childhood: A longitudinal study of discordant monozygotic twins. Psychological 
Medicine, 43(9), 1813–1823. https://doi.org/10.1017/S0033291712002784 
Owen, M. J., O’Donovan, M. C., Thapar, A., & Craddock, N. (2011). Neurodevelopmental 
hypothesis of schizophrenia. The British Journal of Psychiatry, 198(3), 173–175. 
https://doi.org/10.1192/bjp.bp.110.084384 
Palma-Gudiel, H., Córdova-Palomera, A., Navarro, V., & Fañanás, L. (2020). Twin study 
designs as a tool to identify new candidate genes for depression: A systematic review of 
DNA methylation studies. Neuroscience & Biobehavioral Reviews, 112, 345–352. 
https://doi.org/10.1016/j.neubiorev.2020.02.017 
Parira, T., Laverde, A., & Agudelo, M. (2017). Epigenetic Interactions between Alcohol and 
Cannabinergic Effects: Focus on Histone Modification and DNA Methylation. Journal of 
Alcoholism and Drug Dependence, 5(2). https://doi.org/10.4172/2329-6488.1000259 
Passarotti, A. M., Crane, N. A., Hedeker, D., & Mermelstein, R. J. (2015). Longitudinal 
Trajectories of Marijuana Use from Adolescence to Young Adulthood. Addictive 
Behaviors, 45, 301–308. https://doi.org/10.1016/j.addbeh.2015.02.008 
Patterson, G. R., DeBaryshe, B. D., & Ramsey, E. (1989). A developmental perspective on 
antisocial behavior. The American Psychologist, 44(2), 329–335. 
Pawlby, S., Hay, D. F., Sharp, D., Waters, C. S., & O’Keane, V. (2009). Antenatal depression 
predicts depression in adolescent offspring: Prospective longitudinal community-based 
153 
study. Journal of Affective Disorders, 113(3), 236–243. 
https://doi.org/10.1016/j.jad.2008.05.018 
Pearson, R. M., Evans, J., Kounali, D., Lewis, G., Heron, J., Ramchandani, P. G., O’Connor, T. 
G., & Stein, A. (2013). Maternal Depression During Pregnancy and the Postnatal Period: 
Risks and Possible Mechanisms for Offspring Depression at Age 18 Years. JAMA 
Psychiatry, 70(12), 1312–1319. https://doi.org/10.1001/jamapsychiatry.2013.2163 
Penninx, B. W. J. H., Guralnik, J. M., Havlik, R. J., Pahor, M., Ferrucci, L., Cerhan, J. R., & 
Wallace, R. B. (1998). Chronically Depressed Mood and Cancer Risk in Older Persons. 
JNCI: Journal of the National Cancer Institute, 90(24), 1888–1893. 
https://doi.org/10.1093/jnci/90.24.1888 
Peschansky, V. J., & Wahlestedt, C. (2014). Non-coding RNAs as direct and indirect modulators 
of epigenetic regulation. Epigenetics, 9(1), 3–12. https://doi.org/10.4161/epi.27473 
Peters, T. J., Buckley, M. J., Statham, A. L., Pidsley, R., Samaras, K., V Lord, R., Clark, S. J., & 
Molloy, P. L. (2015). De novo identification of differentially methylated regions in the 
human genome. Epigenetics & Chromatin, 8(1), 6. https://doi.org/10.1186/1756-8935-8-
6 
Philibert, R. A., Sandhu, H., Hollenbeck, N., Gunter, T., Adams, W., & Madan, A. (2008). The 
relationship of 5HTT (SLC6A4) methylation and genotype on mRNA expression and 
liability to major depression and alcohol dependence in subjects from the Iowa Adoption 
Studies. American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : The 
Official Publication of the International Society of Psychiatric Genetics, 0(5), 543–549. 
https://doi.org/10.1002/ajmg.b.30657 
154 
Pine, D. S., Cohen, E., Cohen, P., & Brook, J. (1999). Adolescent Depressive Symptoms as 
Predictors of Adult Depression: Moodiness or Mood Disorder? American Journal of 
Psychiatry, 156(1), 133–135. https://doi.org/10.1176/ajp.156.1.133 
Plant, D. T., Pariante, C. M., Sharp, D., & Pawlby, S. (2015). Maternal depression during 
pregnancy and offspring depression in adulthood: Role of child maltreatment. The British 
Journal of Psychiatry, 207(3), 213–220. https://doi.org/10.1192/bjp.bp.114.156620 
Pluess, M., Velders, F. P., Belsky, J., van IJzendoorn, M. H., Bakermans-Kranenburg, M. J., 
Jaddoe, V. W. V., Hofman, A., Arp, P. P., Verhulst, F. C., & Tiemeier, H. (2011). 
Serotonin Transporter Polymorphism Moderates Effects of Prenatal Maternal Anxiety on 
Infant Negative Emotionality. Biological Psychiatry, 69(6), 520–525. 
https://doi.org/10.1016/j.biopsych.2010.10.006 
Portales-Casamar, E., Lussier, A. A., Jones, M. J., MacIsaac, J. L., Edgar, R. D., Mah, S. M., 
Barhdadi, A., Provost, S., Lemieux-Perreault, L.-P., Cynader, M. S., Chudley, A. E., 
Dubé, M.-P., Reynolds, J. N., Pavlidis, P., & Kobor, M. S. (2016). DNA methylation 
signature of human fetal alcohol spectrum disorder. Epigenetics & Chromatin, 9(1), 25. 
https://doi.org/10.1186/s13072-016-0074-4 
Price, E. M., Cotton, A. M., Lam, L. L., Farré, P., Emberly, E., Brown, C. J., Robinson, W. P., & 
Kobor, M. S. (2013). Additional annotation enhances potential for biologically-relevant 
analysis of the Illumina Infinium HumanMethylation450 BeadChip array. Epigenetics & 
Chromatin, 6(1), 4. https://doi.org/10.1186/1756-8935-6-4 
Pruitt, K. D., Tatusova, T., & Maglott, D. R. (2005). NCBI Reference Sequence (RefSeq): A 
curated non-redundant sequence database of genomes, transcripts and proteins. Nucleic 
Acids Research, 33(Database Issue), D501–D504. https://doi.org/10.1093/nar/gki025 
155 
Puchalska, P., & Crawford, P. A. (2017). Multi-dimensional roles of ketone bodies in fuel 
metabolism, signaling, and therapeutics. Cell Metabolism, 25(2), 262–284. 
https://doi.org/10.1016/j.cmet.2016.12.022 
Quintyne, N. J., Reing, J. E., Hoffelder, D. R., Gollin, S. M., & Saunders, W. S. (2005). Spindle 
Multipolarity Is Prevented by Centrosomal Clustering. Science, 307(5706), 127–129. 
https://doi.org/10.1126/science.1104905 
Radtke, K. M., Ruf, M., Gunter, H. M., Dohrmann, K., Schauer, M., Meyer, A., & Elbert, T. 
(2011). Transgenerational impact of intimate partner violence on methylation in the 
promoter of the glucocorticoid receptor. Translational Psychiatry, 1(7), e21. 
https://doi.org/10.1038/tp.2011.21 
Raison, C. L., & Miller, A. H. (2011). Is Depression an Inflammatory Disorder? Current 
Psychiatry Reports, 13(6), 467–475. https://doi.org/10.1007/s11920-011-0232-0 
Raison, C. L., & Miller, A. H. (2013). Role of Inflammation in Depression: Implications for 
Phenomenology, Pathophysiology and Treatment. Inflammation in Psychiatry, 28, 33–48. 
https://doi.org/10.1159/000343966 
Rakyan, V. K., Down, T. A., Balding, D. J., & Beck, S. (2011). Epigenome-Wide Association 
Studies for common human diseases. Nature Reviews. Genetics, 12(8), 529–541. 
https://doi.org/10.1038/nrg3000 
Reiner, I., Van IJzendoorn, M. H., Bakermans-Kranenburg, M. J., Bleich, S., Beutel, M., & 
Frieling, H. (2015). Methylation of the oxytocin receptor gene in clinically depressed 
patients compared to controls: The role of OXTR rs53576 genotype. Journal of 
Psychiatric Research, 65, 9–15. https://doi.org/10.1016/j.jpsychires.2015.03.012 
156 
Reinius, L. E., Acevedo, N., Joerink, M., Pershagen, G., Dahlén, S.-E., Greco, D., Söderhäll, C., 
Scheynius, A., & Kere, J. (2012). Differential DNA Methylation in Purified Human 
Blood Cells: Implications for Cell Lineage and Studies on Disease Susceptibility. PLoS 
ONE, 7(7). https://doi.org/10.1371/journal.pone.0041361 
Reiss, F. (2013). Socioeconomic inequalities and mental health problems in children and 
adolescents: A systematic review. Social Science & Medicine, 90, 24–31. 
https://doi.org/10.1016/j.socscimed.2013.04.026 
Relton, C. L., Gaunt, T., McArdle, W., Ho, K., Duggirala, A., Shihab, H., Woodward, G., 
Lyttleton, O., Evans, D. M., Reik, W., Paul, Y.-L., Ficz, G., Ozanne, S. E., Wipat, A., 
Flanagan, K., Lister, A., Heijmans, B. T., Ring, S. M., & Davey Smith, G. (2015). Data 
Resource Profile: Accessible Resource for Integrated Epigenomic Studies (ARIES). 
International Journal of Epidemiology, 44(4), 1181–1190. 
https://doi.org/10.1093/ije/dyv072 
Renna, M. E., O’Toole, M. S., Spaeth, P. E., Lekander, M., & Mennin, D. S. (2018). The 
association between anxiety, traumatic stress, and obsessive–compulsive disorders and 
chronic inflammation: A systematic review and meta-analysis. Depression and Anxiety, 
35(11), 1081–1094. https://doi.org/10.1002/da.22790 
Rice, F., Jones, I., & Thapar, A. (2007). The impact of gestational stress and prenatal growth on 
emotional problems in offspring: A review. Acta Psychiatrica Scandinavica, 115(3), 
171–183. https://doi.org/10.1111/j.1600-0447.2006.00895.x 
Rice, Frances, Harold, G. T., & Thapar, A. (2002). Assessing the effects of age, sex and shared 
environment on the genetic aetiology of depression in childhood and adolescence. 
157 
Journal of Child Psychology and Psychiatry, 43(8), 1039–1051. 
https://doi.org/10.1111/1469-7610.00231 
Ronald, A., Pennell, C. E., & Whitehouse, A. J. O. (2010). Prenatal Maternal Stress Associated 
with ADHD and Autistic Traits in early Childhood. Frontiers in Psychology, 1, 223. 
https://doi.org/10.3389/fpsyg.2010.00223 
Roseboom, T., de Rooij, S., & Painter, R. (2006). The Dutch famine and its long-term 
consequences for adult health. Early Human Development, 82(8), 485–491. 
https://doi.org/10.1016/j.earlhumdev.2006.07.001 
Rotter, A., Bayerlein, K., Hansbauer, M., Weiland, J., Sperling, W., Kornhuber, J., & Biermann, 
T. (2013). CB1 and CB2 receptor expression and promoter methylation in patients with
cannabis dependence. European Addiction Research, 19(1), 13–20. 
https://doi.org/10.1159/000338642 
Roy, B., Shelton, R. C., & Dwivedi, Y. (2017). DNA methylation and expression of stress 
related genes in PBMC of MDD patients with and without serious suicidal ideation. 
Journal of Psychiatric Research, 89, 115–124. 
https://doi.org/10.1016/j.jpsychires.2017.02.005 
Ruscio, J., & Ruscio, A. M. (2000). Informing the continuity controversy: A taxometric analysis 
of depression. Journal of Abnormal Psychology, 109(3), 473–487. 
Rutter, M. (2006). Implications of Resilience Concepts for Scientific Understanding. Annals of 
the New York Academy of Sciences, 1094(1), 1–12. 
https://doi.org/10.1196/annals.1376.002 
Rutter, M. (2012). Resilience as a dynamic concept. Development and Psychopathology, 24(02), 
335–344. https://doi.org/10.1017/S0954579412000028 
158 
Rutter, M., Kim-Cohen, J., & Maughan, B. (2006). Continuities and discontinuities in 
psychopathology between childhood and adult life. Journal of Child Psychology and 
Psychiatry, and Allied Disciplines, 47(3–4), 276–295. 
Sabunciyan, S., Aryee, M. J., Irizarry, R. A., Rongione, M., Webster, M. J., Kaufman, W. E., 
Murakami, P., Lessard, A., Yolken, R. H., Feinberg, A. P., Potash, J. B., & Consortium, 
G. (2012). Genome-Wide DNA Methylation Scan in Major Depressive Disorder. PLoS
ONE, 7(4). https://doi.org/10.1371/journal.pone.0034451 
Saffari, A., Silver, M. J., Zavattari, P., Moi, L., Columbano, A., Meaburn, E. L., & Dudbridge, F. 
(2018). Estimation of a significance threshold for epigenome‐wide association studies. 
Genetic Epidemiology, 42(1), 20–33. https://doi.org/10.1002/gepi.22086 
Saxonov, S., Berg, P., & Brutlag, D. L. (2006). A genome-wide analysis of CpG dinucleotides in 
the human genome distinguishes two distinct classes of promoters. Proceedings of the 
National Academy of Sciences of the United States of America, 103(5), 1412–1417. 
https://doi.org/10.1073/pnas.0510310103 
Schroeder, J. W., Conneely, K. N., Cubells, J. F., Kilaru, V., Newport, D. J., Knight, B. T., 
Stowe, Z. N., Brennan, P. A., Krushkal, J., Tylavsky, F. A., Taylor, R. N., Adkins, R. M., 
& Smith, A. K. (2011). Neonatal DNA methylation patterns associate with gestational 
age. Epigenetics, 6(12), 1498–1504. https://doi.org/10.4161/epi.6.12.18296 
Schubert, K. O., Clark, S. R., Van, L. K., Collinson, J. L., & Baune, B. T. (2017). Depressive 
symptom trajectories in late adolescence and early adulthood: A systematic review. 
Australian & New Zealand Journal of Psychiatry, 51(5), 477–499. 
https://doi.org/10.1177/0004867417700274 
159 
Sequeira, M.-E., Lewis, S. J., Bonilla, C., Smith, G. D., & Joinson, C. (2017). Association of 
timing of menarche with depressive symptoms and depression in adolescence: Mendelian 
randomisation study. The British Journal of Psychiatry, 210(1), 39–46. 
https://doi.org/10.1192/bjp.bp.115.168617 
Sharp, C., Goodyer, I. M., & Croudace, T. J. (2006). The Short Mood and Feelings 
Questionnaire (SMFQ): A Unidimensional Item Response Theory and Categorical Data 
Factor Analysis of Self-Report Ratings from a Community Sample of 7-through 11-Year-
Old Children. Journal of Abnormal Child Psychology, 34(3), 365–377. 
https://doi.org/10.1007/s10802-006-9027-x 
Shenker, N., & Flanagan, J. M. (2012). Intragenic DNA methylation: Implications of this 
epigenetic mechanism for cancer research. British Journal of Cancer, 106(2), 248–253. 
https://doi.org/10.1038/bjc.2011.550 
Shi, M., Sun, H., Xu, Y., Wang, Z., Cui, H., Wang, C., Liu, W., An, G., & Hu, J. (2017). 
Methylation Status of the Serotonin Transporter Promoter CpG Island Is Associated With 
Major Depressive Disorder in Chinese Han Population: A Case-Control Study. The 
Journal of Nervous and Mental Disease, 205(8), 641–646. 
https://doi.org/10.1097/NMD.0000000000000600 
Shore, L., Toumbourou, J. W., Lewis, A. J., & Kremer, P. (2017). Review: Longitudinal 
trajectories of child and adolescent depressive symptoms and their predictors - a 
systematic review and meta-analysis. Child and Adolescent Mental Health, 23(2), 107–
120. 
Simonik, E. A., Cai, Y., Kimmelshue, K. N., Brantley-Sieders, D. M., Loomans, H. A., Andl, C. 
D., Westlake, G. M., Youngblood, V. M., Chen, J., Yarbrough, W. G., Brown, B. T., 
160 
Nagarajan, L., & Brandt, S. J. (2016). LIM-Only Protein 4 (LMO4) and LIM Domain 
Binding Protein 1 (LDB1) Promote Growth and Metastasis of Human Head and Neck 
Cancer (LMO4 and LDB1 in Head and Neck Cancer). PLoS ONE, 11(10). 
https://doi.org/10.1371/journal.pone.0164804 
Sosnowski, D. W., Booth, C., York, T. P., Amstadter, A. B., & Kliewer, W. (2018). Maternal 
prenatal stress and infant DNA methylation: A systematic review. Developmental 
Psychobiology, 60(2), 127–139. https://doi.org/10.1002/dev.21604 
Starnawska, A., Tan, Q., Soerensen, M., McGue, M., Mors, O., Børglum, A. D., Christensen, K., 
Nyegaard, M., & Christiansen, L. (2019). Epigenome-wide association study of 
depression symptomatology in elderly monozygotic twins. Translational Psychiatry, 9. 
https://doi.org/10.1038/s41398-019-0548-9 
Stenz, L., Zewdie, S., Laforge-Escarra, T., Prados, J., La Harpe, R., Dayer, A., Paoloni-
Giacobino, A., Perroud, N., & Aubry, J.-M. (2015). BDNF promoter I methylation 
correlates between post-mortem human peripheral and brain tissues. Neuroscience 
Research, 91, 1–7. https://doi.org/10.1016/j.neures.2014.10.003 
su, H., Xu, T., Ganapathy, S., Shadfan, M., Long, M., Huang, T., Thompson, I., & Yuan, Z.-M. 
(2013). Elevated snoRNA biogenesis is essential in breast cancer. Oncogene, 33. 
https://doi.org/10.1038/onc.2013.89 
Su, K.-P. (2012). Inflammation in psychopathology of depression: Clinical, biological, and 
therapeutic implications. BioMedicine, 2(2), 68–74. 
https://doi.org/10.1016/j.biomed.2012.03.002 
161 
Sullivan, P. F., Neale, M. C., & Kendler, K. S. (2000). Genetic Epidemiology of Major 
Depression: Review and Meta-Analysis. American Journal of Psychiatry, 157(10), 1552–
1562. https://doi.org/10.1176/appi.ajp.157.10.1552 
Taff, C. C., Campagna, L., & Vitousek, M. N. (2019). Genome-wide variation in DNA 
methylation is associated with stress resilience and plumage brightness in a wild bird. 
Molecular Ecology, 28(16), 3722–3737. https://doi.org/10.1111/mec.15186 
Taghizadeh, S. H., Kazeminezhad, S. R., Sefidgar, S. A. A., Yazdanpanahi, N., Tabatabaeifar, 
M. A., Yousefi, A., Lesani, S. M., Abolhasani, M., & Hashemzadeh Chaleshtori, M.
(2013). Investigation of LRTOMT gene (locus DFNB63) mutations in Iranian patients 
with autosomal recessive non-syndromic hearing loss. International Journal of Molecular 
and Cellular Medicine, 2(1), 41–45. 
Takai, D., & Jones, P. A. (2002). Comprehensive analysis of CpG islands in human 
chromosomes 21 and 22. Proceedings of the National Academy of Sciences, 99(6), 3740–
3745. https://doi.org/10.1073/pnas.052410099 
Tan, Y., Chen, Y., Du, M., Peng, Z., & Xie, P. (2019). USF2 inhibits the transcriptional activity 
of Smurf1 and Smurf2 to promote breast cancer tumorigenesis. Cellular Signalling, 53, 
49–58. https://doi.org/10.1016/j.cellsig.2018.09.013 
Tf, O., J, W., M, P., R, G., S, M., & Am, D. (2008). Prenatal exposure to maternal depression, 
neonatal methylation of human glucocorticoid receptor gene (NR3C1) and infant cortisol 
stress responses. Epigenetics, 3(2), 97–106. https://doi.org/10.4161/epi.3.2.6034 
Tobi, E. W., Goeman, J. J., Monajemi, R., Gu, H., Putter, H., Zhang, Y., Slieker, R. C., Stok, A. 
P., Thijssen, P. E., Müller, F., van Zwet, E. W., Bock, C., Meissner, A., Lumey, L. H., 
Eline Slagboom, P., & Heijmans, B. T. (2014). DNA methylation signatures link prenatal 
162 
famine exposure to growth and metabolism. Nature Communications, 5, 5592. 
https://doi.org/10.1038/ncomms6592 
Tradonsky, A., Rubin, T., Beck, R., Ring, B., Seitz, R., & Mair, S. (2012). A Search for Reliable 
Molecular Markers of Prognosis in Prostate CancerA Study of 240 Cases. American 
Journal of Clinical Pathology, 137(6), 918–930. 
https://doi.org/10.1309/AJCPF3QWIG8FWXIH 
Tsai, P.-C., & Bell, J. T. (2015). Power and sample size estimation for epigenome-wide 
association scans to detect differential DNA methylation. International Journal of 
Epidemiology, 44(4), 1429–1441. https://doi.org/10.1093/ije/dyv041 
Tsang, R. S. M., Mather, K. A., Sachdev, P. S., & Reppermund, S. (2017). Systematic review 
and meta-analysis of genetic studies of late-life depression. Neuroscience & 
Biobehavioral Reviews, 75, 129–139. https://doi.org/10.1016/j.neubiorev.2017.01.028 
Turner, N., Joinson, C., Peters, T. J., Wiles, N., & Lewis, G. (2014). Validity of the Short Mood 
and Feelings Questionnaire in late adolescence. Psychological Assessment, 26(3), 752–
762. https://doi.org/10.1037/a0036572
Uchida, S., Hara, K., Kobayashi, A., Otsuki, K., Yamagata, H., Hobara, T., Suzuki, T., Miyata, 
N., & Watanabe, Y. (2011). Epigenetic status of Gdnf in the ventral striatum determines 
susceptibility and adaptation to daily stressful events. Neuron, 69(2), 359–372. 
https://doi.org/10.1016/j.neuron.2010.12.023 
Uddin, M., Koenen, K. C., Aiello, A. E., Wildman, D. E., Santos, R. de los, & Galea, S. (2011). 
Epigenetic and inflammatory marker profiles associated with depression in a community-
based epidemiologic sample. Psychological Medicine, 41(5), 997–1007. 
https://doi.org/10.1017/S0033291710001674 
163 
Uddin, Monica, & Diwadkar, V. A. (2014). Inflammation and psychopathology: What we now 
know, and what we need to know. Social Psychiatry and Psychiatric Epidemiology, 
49(10), 1537–1539. https://doi.org/10.1007/s00127-014-0934-9 
Unternaehrer, E., Meyer, A. H., Burkhardt, S. C. A., Dempster, E., Staehli, S., Theill, N., Lieb, 
R., & Meinlschmidt, G. (2015). Childhood maternal care is associated with DNA 
methylation of the genes for brain-derived neurotrophic factor (BDNF) and oxytocin 
receptor (OXTR) in peripheral blood cells in adult men and women. Stress, 18(4), 451–
461. https://doi.org/10.3109/10253890.2015.1038992
Valkanova, V., Ebmeier, K. P., & Allan, C. L. (2013). CRP, IL-6 and depression: A systematic 
review and meta-analysis of longitudinal studies. Journal of Affective Disorders, 150(3), 
736–744. https://doi.org/10.1016/j.jad.2013.06.004 
Van den Bergh, B. R. H., & Marcoen, A. (2004). High antenatal maternal anxiety is related to 
ADHD symptoms, externalizing problems, and anxiety in 8- and 9-year-olds. Child 
Development, 75(4), 1085–1097. https://doi.org/10.1111/j.1467-8624.2004.00727.x 
van der Knaap, L. J., Riese, H., Hudziak, J. J., Verbiest, M. M. P. J., Verhulst, F. C., Oldehinkel, 
A. J., & van Oort, F. V. A. (2015). Adverse life events and allele-specific methylation of
the serotonin transporter gene (SLC6A4) in adolescents: The TRAILS study. 
Psychosomatic Medicine, 77(3), 246–255. 
https://doi.org/10.1097/PSY.0000000000000159 
van Mil, N. H., Steegers-Theunissen, R. P. M., Bouwland-Both, M. I., Verbiest, M. M. P. J., 
Rijlaarsdam, J., Hofman, A., Steegers, E. A. P., Heijmans, B. T., Jaddoe, V. W. V., 
Verhulst, F. C., Stolk, L., Eilers, P. H. C., Uitterlinden, A. G., & Tiemeier, H. (2014). 
164 
DNA methylation profiles at birth and child ADHD symptoms. Journal of Psychiatric 
Research, 49, 51–59. https://doi.org/10.1016/j.jpsychires.2013.10.017 
Vanwesemael, M., Schrauwen, I., Ceuppens, R., Alasti, F., Jorssen, E., Farrokhi, E., Chaleshtori, 
M. H., & Van Camp, G. (2011). A 1 bp deletion in the dual reading frame deafness gene
LRTOMT causes a frameshift from the first into the second reading frame. American 
Journal of Medical Genetics Part A, 155(8), 2021–2023. 
https://doi.org/10.1002/ajmg.a.34096 
Verhulst, B., Neale, M. C., & Kendler, K. S. (2015). The heritability of alcohol use disorders: A 
meta-analysis of twin and adoption studies. Psychological Medicine, 45(5), 1061–1072. 
https://doi.org/10.1017/S0033291714002165 
Voisin, S., Eynon, N., Yan, X., & Bishop, D. J. (2015). Exercise training and DNA methylation 
in humans. Acta Physiologica, 213(1), 39–59. https://doi.org/10.1111/apha.12414 
Waddington, C. H. (2014). The Strategy of the Genes. Routledge. 
Wang, J., Hodes, G. E., Zhang, H., Zhang, S., Zhao, W., Golden, S. A., Bi, W., Menard, C., 
Kana, V., Leboeuf, M., Xie, M., Bregman, D., Pfau, M. L., Flanigan, M. E., Esteban-
Fernández, A., Yemul, S., Sharma, A., Ho, L., Dixon, R., … Pasinetti, G. M. (2018). 
Epigenetic modulation of inflammation and synaptic plasticity promotes resilience 
against stress in mice. Nature Communications, 9(1), 477. 
https://doi.org/10.1038/s41467-017-02794-5 
Warde-Farley, D., Donaldson, S. L., Comes, O., Zuberi, K., Badrawi, R., Chao, P., Franz, M., 
Grouios, C., Kazi, F., Lopes, C. T., Maitland, A., Mostafavi, S., Montojo, J., Shao, Q., 
Wright, G., Bader, G. D., & Morris, Q. (2010). The GeneMANIA prediction server: 
Biological network integration for gene prioritization and predicting gene function. 
165 
Nucleic Acids Research, 38(Web Server issue), W214-220. 
https://doi.org/10.1093/nar/gkq537 
Watson, C. N., Belli, A., & Di Pietro, V. (2019). Small Non-coding RNAs: New Class of 
Biomarkers and Potential Therapeutic Targets in Neurodegenerative Disease. Frontiers in 
Genetics, 10. https://doi.org/10.3389/fgene.2019.00364 
Weaver, I. C. G., Cervoni, N., Champagne, F. A., D’Alessio, A. C., Sharma, S., Seckl, J. R., 
Dymov, S., Szyf, M., & Meaney, M. J. (2004). Epigenetic programming by maternal 
behavior. Nature Neuroscience, 7(8), 847–854. https://doi.org/10.1038/nn1276 
Webb, L. M., Phillips, K. E., Ho, M. C., Veldic, M., & Blacker, C. J. (2020). The Relationship 
between DNA Methylation and Antidepressant Medications: A Systematic Review. 
International Journal of Molecular Sciences, 21(3), 826. 
https://doi.org/10.3390/ijms21030826 
Wei, J.-W., Huang, K., Yang, C., & Kang, C.-S. (2016). Non-coding RNAs as regulators in 
epigenetics (Review). Oncology Reports, 37(1), 3–9. 
https://doi.org/10.3892/or.2016.5236 
Weinberger, A. H., Kashan, R. S., Shpigel, D. M., Esan, H., Taha, F., Lee, C. J., Funk, A. P., & 
Goodwin, R. D. (2017). Depression and cigarette smoking behavior: A critical review of 
population-based studies. The American Journal of Drug and Alcohol Abuse, 43(4), 416–
431. https://doi.org/10.3109/00952990.2016.1171327
Weinhold, B. (2006). Epigenetics: The Science of Change. Environmental Health Perspectives, 
114(3), A160–A167. 
Wu, D.-C., Zhang, M.-F., Su, S.-G., Fang, H.-Y., Wang, X.-H., He, D., Xie, Y.-Y., & Liu, X.-H. 
(2016). HEY2, a target of miR-137, indicates poor outcomes and promotes cell 
166 
proliferation and migration in hepatocellular carcinoma. Oncotarget, 7(25), 38052–
38063. https://doi.org/10.18632/oncotarget.9343 
Yamasaki, M., Hasegawa, S., Imai, M., Takahashi, N., & Fukui, T. (2016). High-fat diet-induced 
obesity stimulates ketone body utilization in osteoclasts of the mouse bone. Biochemical 
and Biophysical Research Communications, 473(2), 654–661. 
https://doi.org/10.1016/j.bbrc.2016.03.115 
Zhao, J., Goldberg, J., Bremner, J. D., & Vaccarino, V. (2013). Association between promoter 
methylation of serotonin transporter gene and depressive symptoms: A monozygotic twin 
study. Psychosomatic Medicine, 75(6), 523–529. 
https://doi.org/10.1097/PSY.0b013e3182924cf4 
Ziegler, C., Dannlowski, U., Bräuer, D., Stevens, S., Laeger, I., Wittmann, H., Kugel, H., Dobel, 
C., Hurlemann, R., Reif, A., Lesch, K.-P., Heindel, W., Kirschbaum, C., Arolt, V., 
Gerlach, A. L., Hoyer, J., Deckert, J., Zwanzger, P., & Domschke, K. (2015). Oxytocin 
Receptor Gene Methylation: Converging Multilevel Evidence for a Role in Social 
Anxiety. Neuropsychopharmacology, 40(6), 1528–1538. 
https://doi.org/10.1038/npp.2015.2 
Ziller, M. J., Gu, H., Müller, F., Donaghey, J., Tsai, L. T.-Y., Kohlbacher, O., De Jager, P. L., 
Rosen, E. D., Bennett, D. A., Bernstein, B. E., Gnirke, A., & Meissner, A. (2013). 
Charting a dynamic DNA methylation landscape of the human genome. Nature, 
500(7463), 477–481. https://doi.org/10.1038/nature12433 
Zonderman, A. B., Costa, P. T., & McCrae, R. R. (1989). Depression as a Risk for Cancer 
Morbidity and Mortality in a Nationally Representative Sample. JAMA, 262(9), 1191–
1195. https://doi.org/10.1001/jama.1989.03430090053032 
167 
Zumbrun, E. E., Sido, J. M., Nagarkatti, P. S., & Nagarkatti, M. (2015). Epigenetic Regulation of 
Immunological Alterations Following Prenatal Exposure to Marijuana Cannabinoids and 
its Long Term Consequences in Offspring. Journal of Neuroimmune Pharmacology, 
10(2), 245–254. https://doi.org/10.1007/s11481-015-9586-0 
